Departmental Publications

2016 Publications (Published between January 1, 2016 - June 30, 2016)

AUTOPSY

  1. None reported

CARDIOVASCULAR PATHOLOGY

  1. Anene DF, Rosenberg AZ, Kleiner DE, Cornish TC, Halushka MK. Utilization of HPASubC for the identification of sinusoid-specific proteins in the liver. J Proteome Res 2016 May 6;15(5):1623-9.
  2. Halushka MK, van der Wal AC. Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association For European Cardiovascular Pathology: II. Noninflammatory degenerative diseases - nomenclature and diagnostic criteria. Cardiovasc Pathol. 2016 May-Jun;25(3):247-57
  3. Halushka MK, Angelini A, Bartoloni G, Basso C, Batoroeva L, van der Wal AC. Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association For European Cardiovascular Pathology: II. Noninflammatory degenerative diseases - nomenclature and diagnostic criteria. Cardiovasc Pathol 2016 Mar 12;25(3):247-57.
  4. McCall MN, Baras AS, Crits-Christoph A, Ingersoll R, McAlexander MA, Witwer KW, Halushka MK. A benchmark for microRNA quantification algorithms using the OpenArray platform. BMC Bioninformatics 2016 Mar;17:138.
  5. Shao Q, Fallica J, Casin KM, Murphy E, Steenbergen C, Kohr MJ. Characterization of the sex-dependent myocardial S-nitrosothiol proteome. Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H505-15.

CLINICAL CHEMISTRY

  1. Sokoll LJ, Zhang Z, Chan DW, Reese AC, Bivalacqua TJ, Partin AW, Walsh PC. Do ultrasensitive prostate specific antigen measurements have a role in predicting long-term biochemical recurrence-free survival in men after radical prostatectomy? J Urol 2016 Feb;195(2):330-6.
  2. Sun S, Shah P, Eshghi ST, Yang W, Trikannad N, Yang S, Chen L, Aiyetan P, Höti N, Zhang Z, Chan DW, Zhang H. Comprehensive analysis of protein glycosylation by solid-phase extraction of N-linked glycans and glycosite-containing peptides. Nat Biotechnol. 2016 Jan;34(1):84-8.

CYTOPATHOLOGY

  1. Allison DB, Olson MT, Lilo M, Zhang ML, Rosenthal DL, VandenBussche CJ. Should BK polyoma virus cytopathic effect be best classified as atypical or benign in urine cytology specimens? Cancer Cytopathol. 2016 Jun;124(6):436-42.
  2. Lilo MT, Allison D, Wang Y, Ao MH, Gabrielson E, Geddes S, Zhang H, Askin F, Li QK. Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations. J Am Soc Cytopathol 2016 May-June;5(3):123-32.
  3. Rooper LM, Nikolskaia O, Carter J, Ning Y, Lin MT, Maleki Z. A single EBUS-TBNA procedure can support a large panel of immunohistochemical stains, specific diagnostic subtyping, and multiple gene analyses in the majority of non-small cell lung cancer cases. Hum Pathol. 2016 May;51:139-45.
  4. VandenBussche CJ. The Paris System for Reporting Urinary Cytology. Cytopathology 2016 Jun;27(3):153-6.
  5. Ahmed A, VandenBussche CJ, Ali SZ, Olson MT. The dilemma of "indeterminate" interpretations of pancreatic neuroendocrine tumors on fine needle aspiration. Diagn Cytopathol 2016 Jan;44(1):10-3.
  6. Allison DB, Miller JA, Coquia SF, Maleki Z. Ultrasonography-guided fine-needle aspiration with concurrent small core biopsy of neck masses and lymph nodes yields adequate material for HPV testing in head and neck squamous cell carcinomas. J Am Soc Cytopathol 2016 Jan/Feb;5(1):22-30.
  7. Cowan ML, Li QK, Illei PB. CDX-2 expression in primary lung adenocarcinoma. Appl Immunohistochem Mol Morphol. 2016 Jan;24(1):16-9.
  8. VandenBussche CJ, Rosenthal DL, Olson MT. Adequacy in voided urine cytology specimens: The role of volume and a repeat void upon predictive values for high-grade urothelial carcinoma. Cancer Cytopathol 2016 Mar;124(3):174-80.

GI/LIVER PATHOLOGY

  1. Illei PB, Alewine C, Zahurak M, Cowan ML, Montgomery E, Hassan R, Xiang L, Pastan I, Kelly RJ. Mesothelin expression in advanced gastroesophageal cancer represents a novel target for immunotherapy. Appl Immunohistochem Mol Morphol 2016 Apr;24(4):246-52.
  2. Molin MD, Kim H, Blackford A, Sharma R, Goggins M. Glucagon-like peptide-1 receptor expression in normal and neoplastic human pancreatic tissues. Pancreas 2016 Apr;45(4):613-9.
  3. Adsay V, Jang JY, Klimstra DS, Hruban RH; Members of the Verona Consensus Meeting, 2013. Pathologic evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary tract: recommendations of Verona Consensus Meeting. Ann Surg. 2016 Jan;263(1):162-77.
  4. Dudley JC, Lin MT, Le DT, Eshleman JR. Microsatellite instability as a biomarker for PD-1 blockade. Clin Cancer Res 2016 Feb;22:813-20.
  5. Gupta RK, Xie BH, Patton KT, Lisovsky M, Biurks E, Behrman SW, Klimstra D, Deshpande V. Follicular pancreatitis: a distinct form of chronic pancreatitis-an additional mimic of pancreatic neoplasms. Hum Pathol. 2016 Feb;48:154-62.
  6. Rezaee N, Barbon C, Zaki A, He J, Salman B, Hruban RH, Cameron JL, Herman JM, Ahuja N, Lennon AM, Weiss MJ, Wood LD*, Wolfgang CL*. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. HPB (Oxford) 2016 Mar; 18(3):236-46.

GENITOURINARY PATHOLOGY

  1. Cowan M, Springer S, Nguyen D, Taheri D, Guner G, Rodriguez MAM, Wang Y, Kinde I, Vandenbussche CJ, Olson MT, Cunha I, Fujita K, Ertoy D, Bivalacqua TJ, Kinzler K, Vogelstein B, Netto GJ, Papadopoulos N. High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder. Mod Pathol. 2016 May;29(5):511-5.
  2. Haffner MC, Barbieri CE. Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia. Eur Urol. 2016 May;69(5):831-3.
  3. Kawahara T, Aljarah AK, Shareef HK, Inoue S, Ide H, Patterson JD, Kashiwagi E, Han B, Li Y, Zheng Y, Miyamoto H. Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine. Prostate 2016 Jun;76(8):744-56.
  4. Kryvenko ON, Diaz M, Matoso A, Kates M, Cohen J, Swanson GP, Epstein JI. Prostate-specific antigen mass density-A measure predicting prostate cancer volume and accounting for overweight and obesity-related prostate-specific antigen hemodilution. Urology 2016 Apr;90:141-7.
  5. Kryvenko ON, Epstein JI. Changes in prostate cancer grading: including a new patient-centric grading system. Prostate 2016 Apr;76(5):427-33.
  6. Lotan TL, Wei W, Morais CL, Hawley ST, Fazli L, Hurtado-Coll A, Troyer D, McKenney JK, Simko J, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, Brooks JD. PTEN loss as determined by clinical-grade immunohistochemistry assay is associated with worse recurrence-free survival in prostate cancer. European Urology Focus 2016 June;2(2):180-8.
  7. Netto GJ. Role for anti-PD-L1 immune checkpoint inhibitor in advanced urothelial carcinoma. Lancet. 2016 May 7;387(10031):1881-2.
  8. Sadimin ET, Epstein JI. Round cell pattern of prostatic stromal tumor of uncertain malignant potential: a subtle newly recognized variant. Hum Pathol 2016 Jun;52:68-73.
  9. Wobker SE, Epstein JI. Differential diagnosis of intraductal lesions of the prostate. Am J Surg Pathol. 2016 Jun;40(6):e67-82.
  10. Ahearn TU, Pettersson A, Ebot EM, Gerke T, Greaff RE, Morais CL, Hicks JL, Wilson KM, Rider FR, Sesso HD, Fiorentino M, Flavin R, Finn S, Giovannucci EL, Loda M, Stampfer MJ, De Marzo AM, Mucci LA, Lotan TL. A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer. JNCI 2016 Feb;108(2): djv346 (9 pages).
  11. Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA; Grading Committee. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 2016 Feb;40(2):244-52.
  12. Epstein JI, Montironi R. Grading of prostate cancer in the 21st century. Urologia 2016 Mar 5;82(1):1-3.
  13. Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, Vickers AJ, Parwani AV, Reuter VE, Fine SW, Eastham JA, Wiklund P, Han M, Reddy CA, Ciezki JP, Nyberg T, Klein EA. A contemporary prostate cancer grading system: a validated alternative to the Gleason Score. Eur Urol 2016 Mar;69(3):428-35.
  14. Faraj SF, Bezerra SM, Yousefi K, Fedor H, Glavaris S, Han M, Partin AW, Humphreys E, Tosoian J, Johnson MH, Davicioni E, Trock BJ, Schaeffer EM, Ross AE, Netto GJ. Clinical validation of the 2005 ISUP Gleason Grading System in a cohort of intermediate and high risk men undergoing radical prostatectomy. PLoS One 2016 Jan;11(1):e0146189.
  15. Haffner MC, Weier C, Xu MM, Vaghasia A, Gürel B, Gümüşkaya B, Esopi DM, Fedor H, Tan HL, Kulac I, Hicks J, Isaacs WB, Lotan TL, Nelson WG, Yegnasubramanian S, De Marzo AM. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization. J Pathol 2016 Jan;238(1):31-41.
  16. Kates M, Sopko NA, Han M, Partin AW, Epstein JI. Importance of reporting the Gleason score at the positive surgical margin site: an analysis of 4,082 consecutive radical prostatectomy cases. J Urol Feb 2016;195:337-42.
  17. Kawahara T, Kashiwagi E, Li Y, Zheng Y, Miyamoto Y, Netto GJ, Ishiguro H, Miyamoto H. Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis. Mol Carcinog 2016 Feb;55(2):161-9.
  18. Kryvenko ON, Balise R, Prakash NS, Epstein JI. African-American men with Gleason score 3+3=6 prostate cancer produce less prostate specific antigen than caucasian men: a potential impact on active surveillance. Urol 2016 Feb;195(2):301-6.
  19. Matoso A, Chen YB, Rao V, Wang L, Cheng L, Epstein JI. Atypical renal cysts: a morphologic, immunohistochemical, and molecular study. Am J Surg Pathol 2016 Feb;40(2):202-11.
  20. Matoso A, Epstein JI. Grading of prostate cancer: past, present, and future. Curr Urol Rep. 2016 Mar;17(3):25.
  21. Munari E, Chaux A, Vaghasia AM, Taheri D, Karram S, Bezerra SM, Gonzalez Roibon N, Nelson WG, Yegnasubramanian S, Netto GJ, Haffner MC. Global 5-hydroxymethylcytosine levels are profoundly reduced in multiple genitourinary malignancies. PLoS One 2016 Jan 19;11(1):e0146302.
  22. Reis LO, Taheri D, Chaux A, Guner G, Mendoza Rodriguez MA, Bivalacqua TJ, Schoenberg MP, Epstein JI1, Netto GJ. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder. Hum Pathol 2016 Jan;47(1):20-5.
  23. Sadimin ET, Ye H, Epstein JI. Should the involvement of skeletal muscle by prostatic adenocarcinoma be reported on biopsies? Hum Pathol 2016 Mar;49:10-4.
  24. Schwartz LE, Khani F, Bishop JA, Vang R, Epstein JI. Carcinoma of the uterine cervix involving the genitourinary tract: a potential diagnostic dilemma. Am J Surg Pathol 2016 Jan;40(1):27-35.

GYNECOLOGIC PATHOLOGY

  1. Xing D, Schoolmeester JK, Ren Z, Isacson C, Ronnett BM. Lower female genital tract tumors with adenoid cystic differentiation: P16 expression and high-risk HPV detection. Am J Surg Pathol 2016 Apr;40(4):529-36.
  2. Bynum J, Murphy KM, DeScipio C, Beierl K, Adams E, Anderson D, Vang R, Ronnett BM. Invasive Complete Hydatidiform Moles: Analysis of a Case Series With Genotyping. Int J Gynecol Pathol Int J Gynecol Pathol. 2016 Mar;35(2):134-41.
  3. Peng S, Qiu J, Yang A, Yang B, Jeang J, Wang JW, Chang YN, Brayton C, Roden RB, Hung CF, Wu TC. Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease. Cell Biosci 2016 Feb 25;6:16.
  4. Sun YY, Peng S, Han L, Qiu J, Song L, Tsai Y, Yang B, Roden RB, Trimble CL, Hung CF, Wu TC. Local HPV recombinant vaccinia boost following priming with an HPV DNA vaccine enhances local HPV-specific CD8+ T-cell-mediated tumor control in the genital tract. Clin Cancer Res 2016 Feb 1;22(3):657-69.
  5. Vang R, Levine DA, Soslow RA, Zaloudek C, Shih IeM, Kurman RJ. Molecular alterations of TP53 are a defining feature of ovarian high-grade serous carcinoma: a rereview of cases lacking TP53 mutations in The Cancer Genome Atlas ovarian study. Int J Gynecol Pathol 2016 Jan;35(1):48-55.

HEMATOLOGIC PATHOLOGY

  1. Song JY, Venkataraman G, Fedoriw YD, Alikhan M, Kim Y, Weisenburger DD, Collins J, Liu Xueli, Duffield AS. Burkitt Leukemia limited to the bone marrow has a better prognosis than Burkitt Lymphoma with bone marrow involvement in adults. Leuk Lymphoma 2016 Apr;57(4):866-71.
  2. Crane GM, Duffield AS. Hematolymphoid lesions of the sinonasal tract. Semin Diagn Pathol 2016 Mar;33(2):71-80.

IMMUNOLOGY

  1. Martina MN, Noel S, Saxena A, Bandapalle S, Majithia R, Jie C, Arend LJ, Allaf ME, Rabb H, Rahim A Hamad A. Double-negative αβ T cells are early responders to AKI and are found in human kidney. J Am Soc Nephrol 2016 Apr;27(4):1113-23.
  2. Sadegh-Nasseri. A step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cells. F1000 Res - 2016;5:F1000 Faculty Rev-1305.
  3. Ricciuti A, Travison TG, Di Dalmazi G, Talor MV, DeVincentiis L, Manley RW, Bhasin S, Caturegli P*, Basaria S*. A Subset of men with age-related decline in testosterone have gonadotroph autoantibodies. J Clin Endocrinol Metab 2016 Apr;101(4):1535-41. (*= co-senior author)
  4. Schroeder LF, Guarner J, Elbireer A, Castle PE, Amukele T. Time for a model list of essential diagnostics. N Engl J Med. 2016 Jun 30;374(26):2511-4.
  5. Schroeder, LF, LaBarre P, Weigl BH, Amukele T. The next phase for point-of-care testing in resource-limited settings: noncommunicable disease. Point of Care 2016 June;15(2):93-5.
  6. Wu L, Diny NL, Ong S, Barin JG, Hou X, Rose NR, Talor MV, Čiháková D. Pathogenic IL-23 signaling is required to initiate

INFORMATICS

  1. None reported

MEDICAL MICROBIOLOGY

  1. Kanakry JA, Hegde AM, Durand CM, Massie AB, Greer AE, Ambinder RF, Valsamakis A. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood 2016 Apr 21;127(16):2007-17.
  2. Riedel S, Carroll KC. Early Identification and Treatment of Pathogens in Sepsis: Molecular Diagnostics and Antibiotic Choice. Clin Chest Med. 2016 Jun;37(2):191-207.
  3. Simner PJ, Doerr KA, Steinmetz LK, Wengenack NL. Mycobacterium and aerobic actinomycete culture: are two medium types and extended incubation times necessary? J Clin Microbiol 2016 Apr;54(4):1089-93.
  4. Suwantarat N, Carroll KC. Epidemiology and molecular characterization of multidrug-resistant Gram-negative bacteria in Southeast Asia. Antimicrob Risist Infect Control May 2016;5:15 (online journal)
  5. Kuo IC, Espinosa C, Forman M, Valsamakis A. A polymerase chain reaction-based algorithm to detect and prevent transmission of adenoviral conjunctivitis in hospital employees. Am J Ophthalmol 2016 Mar;163:38-44.
  6. Lyons JL, Zhang SX. Current laboratory approaches to diagnosis of CNS fungal infections. Future Microbiology 2016 February; 11:175-7.
  7. Suwantarat N, Romagnoli M, Carroll KC. Photo quiz: isolation of an unusual gram-positive coccus from a positive blood culture in a patient with pneumonia. Clin Microbiol 2016 Jan;54(1):1.
  8. Suwantarat N, Romagnoli M, Carroll KC. Answer to January 2016 Photo Quiz. J Clin Microbiol 2016 Jan;54(1):247.
  9. Suwantarat N, Weik C, Romagnoli M, Ellis BC, Kwiatkowski N, Carroll KC. Practical utility and accuracy of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of corynebacterium species and other medically relevant coryneform-like bacteria. Am J Clin Pathol 2016 Jan;145(1):22-8.

MOLECULAR PATHOLOGY

  1. Ho H, Skaist AM, Pallavajjalla A, Yonescu R, Batista D, Wheelan SJ, Ning Y. NUP98-PHF23 fusion is recurrent in acute myeloid leukemia and shares gene expression signature of leukemic stem cells. Leuk Res. 2016 Jun;45:1-7.
  2. Morsberger L, Powell K, Ning Y. A marker chromosome in post-transplant bone marrow. Molec Cytogenetics 2016 June;9:42.
  3. Zheng G, Tsai H, Tseng LH, Illei P, Gocke CD, Eshleman JR, Netto G, Lin MT. Test feasibility of next-generation sequencing assays in clinical mutation detection of small biopsy and fine needle aspiration specimens. Am J Clin Pathol 2016 May;145(5):696-702.

NEUROPATHOLOGY

  1. Pinto AL*, Chen L*, Friedman R, Grant PE, Poduri A, Takeoka M, Prabhu SP, Sahin M. Sturge-Weber syndrome: brain magnetic resonance imaging and neuropathology findings. Pediatr Neurol 2016 May;58:25-30. *Co-first author
  2. Rodriguez O, Schaefer ML, Wester B, Lee YC, Boggs N, Conner HA, Merkle AC, Fricke ST, Albanese C, Koliatsos VE. Manganese-Enhanced Magnetic Resonance Imaging as a Diagnostic and Dispositional Tool after Mild-Moderate Blast Traumatic Brain Injury. J Neurotrauma. 2016 Apr 1;33(7):662-71.
  3. Suarez MJ, Rivera-Michlig R, Dubovy S, Rodriguez FJ. Clinicopathologic Features of Ophthalmic Neoplasms Arising in the Setting of Xeroderma Pigmentosum. Ocul Oncol Pathol Apr-June 2016;2:112-21.
  4. Asch-Kendrick RJ, Burton E, Chen L, Nauen D. A 74-year-old man with a jugular foramen mass. Brain Pathol 2016 Jan;26(1):124-5.
  5. Eberhart C. Multiple cilia suppress tumour formation. Nat Cell Biol. 2016 Mar 30;18(4):368-9.
  6. Kahlert UD, Cheng M, Koch K, Marchionni L, Fan X, Raabe EH, Maciaczyk J, Glunde K, Eberhart C. Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells. Int J Cancer 2016 Mar ;138(5):1246-55.
  7. Nauen D, Haley L, Lin MT, Perry A, Giannini C, Burger PC, Rodriguez FJ. Molecular analysis of pediatric oligodendrogliomas highlights genetic differences with adult counterparts and other pediatric gliomas. Brain Pathol 2016 Mar;26(2):206-14.
  8. Rodriguez FJ. N for nucleus in neurofibromin: new role for an old tumor suppressor? J Neurochem 2016 Jan;136(1):11-2.

OPHTHALMIC PATHOLOGY

  1. Mahale A, Alkatan H, Alwadani S, Othman M, Suarez MJ, Price A, Al-Hussain H, Jastaneiah S, Yu W, Maktabi A, Deepak EP, Eberhart CG, Asnaghi L. Altered gene expression in conjunctival squamous cell carcinoma. Mod Pathol 2016 May;29(5):452-60.

SURGICAL PATHOLOGY

  1. Argani P, Zhong M, Reuter VE, Fallon JT, Epstein JI, Netto GJ, Antonescu CR. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers. Am J Surg Pathol. 2016 Jun;40(6):723-37.
  2. Bishop JA, Ha PK. Human papillomavirus detection in a "Digital" age. Cancer 2016 May 15;122(10):1502-4.
  3. Cowan ML, Thompson LD, Leon ME, Bishop JA. Low-Grade Fibromyxoid Sarcoma of the Head and Neck: A Clinicopathologic Series and Review of the Literature. Head Neck Pathol 2016 Jun;10(2):161-6.
  4. Thompson ED, Stelow EB, Mills SE, Westra WH, Bishop JA. Large cell neuroendocrine carcinoma of the head and neck: a clinicopathologic series of 10 cases with an emphasis on HPV status. Am J Surg Pathol 2016 Apr;40(4):471-8.
  5. Asch-Kendrick R, Cimino-Mathews A. The role of GATA3 in breast carcinomas: a review. Hum Pathol. 2016 Feb;48:37-47.
  6. Bishop JA. Recently described neoplasms of the sinonasal tract. Semin Diagn Pathol. 2016 Mar;33(2):62-70.
  7. Cowan ML, Argani P, Cimino-Mathews A. Benign and low-grade fibroepithelial neoplasms of the breast have low recurrence rate after positive surgical margins. Mod Pathol 2016 Mar;29(3):259-65.
  8. Ma C, Gocke CD, Hruban RH, Belchis DA. Mutational spectrum of intraepithelial neoplasia in pancreatic heterotopia. Hum Pathol 2016 Feb;48:117-21.
  9. Thompson E, Taube JM, Elwood H, Sharma R, Meeker A, Warzecha HN, Argani P, Cimino-Mathews A*, Emens LA*. The immune microenvironment of breast ductal carcinoma in situ. Mod Pathol 2016 Mar;29(3):249-58. * co-senior authors

TRANSFUSION MEDICINE

  1. Glynn SA, Klein HG, Ness PM. The red blood cell storage lesion: the end of the beginning. Transfusion 2016 June;56(6):1462-8.
  2. Kantor R, Smeaton L, SH Eshleman: AIDS Clinical Trials Group (ACTG) A5175 Study Team. Pre-treatment HIV drug resistance and HIV-1 subtype Care independently associated with virologic failure: Results from the multi-national PEARLS (ACTG A5175) clinical trial. Clin Infect Dis 2015 May;60(10):1541-9.
  3. Goel R, King KE, Takemoto CM, Ness PM, Tobian AA. Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012. Transfusion. 2016 Jun;56(6):1451-8.
  4. Heddle NM, Ness PM. CONSORT and clinical trial reporting: room for improvement. Transfusion. 2016 Apr;56(4):781-3.
  5. Thompson ED, Stelow EB, Mills SE, Westra WH, Bishop JA. Large cell neuroendocrine carcinoma of the head and neck: a clinicopathologic series of 10 cases with an emphasis on HPV status. Am J Surg Pathol 2016 Apr;40(4):471-8.
  6. Tobian AAR, Reed J, Njeuhmeli E. An evidence-based analysis of voluntary medical male circumcision devices. Nat Rev Urol 2016 May;13(5):295.
  7. Grabowski MK, Kong X, Gray RH, Serwadda D, Kigozi G, Gravitt PE, Nalugoda F, Reynolds SJ, Wawer MJ, Redd AD, Watya S, Quinn TC, Tobian AAR. Partner human papillomavirus viral load and incident human papillomavirus detection in heterosexual couples. J Infect Dis 2016 Mar;213(6):948-56.
  8. Hulse M, Fader AN, Shan H, Benneh N, Tobian AAR. Massive transfusion in an obstetric emergency. Transfusion 2016 Jan;56:23.
  9. Kaufman MR, Smelyanskaya M, Van Lith LM, Mallalieu B, Waxman A, Hatzhold K, Marcell AV, Kasedde S, Lija J, Hasen N, Ncube G, Samuelson JL, Bonnecwe C, Seifert-Ahanda K, Njeuhmeli E, Tobian AAR. Adolescent sexual and reproductive health services and implications for the provision of voluntary medical male circumcision: results of a systematic review of literature. PLoS One 2016 Mar;11(3):e0149892.




2015 Publications +

AUTOPSY

  1. Hooper JE, Cantor EL, Ehlen MS, Banerjee A, Malempati S, Stenzel P, Woltjer R, Gandour-Edwards R, Goodwin NC, Yang Y, Kaur P, Bult CJ, Airhart SD, Keller C. A patient-derived xenograft model of parameningeal embryonal rhabdomyosarcoma for preclinical studies. Sarcoma 2015 Dec; article ID 826124:7 pages.

CARDIOVASCULAR PATHOLOGY

  1. Baras AS, Mitchell CJ, Myers JR, Gupta S, Weng LC, Ashton JM, Cornish TC, Pandey A, Halushka MK. miRge - a multiplexed method of processing small RNA-Seq data to determine microRNA entropy. PLoS One 2015 Nov 16;10(11):e0143066 (eCollection 2015).
  2. Cornish TC, Chakravarti A, Kapoor A, Halushka MK. HPASubC: A suite of tools for user subclassification of human protein atlas tissue images. J Pathol Inform. 2015 Jun 23;6:36.
  3. Das S, Halushka MK. Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc Pathol. 2015 Jul-Aug;24(4):199-206.
  4. Gniadek TJ, Singer N, Barker N, Spevak PJ, Crain BJ, Valle D, Halushka MK. Cardiovascular pathologies in mucopolysaccharidosis type VII (Sly Syndrome). Cardiovasc Pathol 2015 Sep-Oct;24(5):322-6.
  5. Halushka MK, Eng G, Collins AB, Judge DP, Semigran MJ, Stone JR. Optimization of serum immunoglobulin free light chain analysis for subclassification of cardiac amyloidosis. J Cardiovasc Transl Res. 2015 Jun;8(4):264-8.
  6. Maleszewski JJ, Tazelaar HD, Horcher HM3, Hinkamp TJ, Conte JV, Porterfield JK, Halushka MK. IgG4-related disease of the aortic valve: a report of two cases and review of the literature. Cardiovasc Pathol. 2015 Jan-Feb;24(1):56-9703 860 6510.

CLINICAL CHEMISTRY

  1. Jialal I, Sokoll LJ. Clinical utility of lactate dehydrogenase: a historical perspective. Am J Clin Pathol. 2015 Feb;143(2):158-9.
  2. Li QK, Chen L, Ao MH, Chiu JH, Zhang Z, Zhang H, Chan DW. Serum fucosylated prostate-specific antigen (PSA) improves the differentiation of aggressive from non-aggressive prostate cancers. Theranostics. 2015 Jan 1;5(3):267-76.
  3. Li Y, Shah P, De Marzo AM, Van Eyk JE, Li Q, Chan DW, Zhang H. Identification of glycoproteins containing specific glycans using a lectin-chemical method. Anal Chem 2015 May;87(9):4683-7.
  4. Marzinke MA, Petrides AK, Steele K, Schweitzer MA, Magnuson TH, Reinblatt SP, Coughlin JW, Clarke W. Decreased escitalopram concentrations post-roux-en-Y gastric bypass surgery. Ther Drug Monit. 2015 Jun;37(3):408-12.
  5. Peake RW, Hartigan CR, Esposito CL, Kellogg MD, Gabler J, Wang S, Breaud A, Di Bussolo J, Moskowitz J, Clarke W. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry. Ther Drug Monit 2015 Apr;37(2):161-71.
  6. Petrides AK, Ness MA, Judge DP, Sokoll LJ, Marzinke MA. Fluctuating creatinine in the cardiac unit. Clin Chim Acta 2015 Jul 20;447:52-4.
  7. Shah P, Zhang B, Choi C, Yang S, Zhou J, Harlan R, Tian Y, Zhang Z, Chan DW, Zhang H. Tissue proteomics using chemical immobilization and mass spectrometry. Anal Biochem 2015 Jan 15;469:27-33.
  8. Sun S, Zhang H. Large-scale measurement of absolute protein glycosylation stoichiometry. Anal Chem. 2015 Jul 7;87(13):6479-82.
  9. Thomas SN, Harlan R, Chen J, Aiyetan P, Liu Y, Sokoll LJ, Aebersold R, Chan DW, Zhang H. Multiplexed targeted mass spectrometry-based assays for the quantification of N-linked glycosite-containing peptides in serum. Anal Chem 2015 Nov 3;87(21):10830-8.
  10. Thomas SN, Zhang H, Cotter RJ. Application of quantitative proteomics to the integrated analysis of the ubiquitylated and global proteomes of xenograft tumor tissues. Clin Proteomics 2015 May 20;12(1):14.
  11. Tian Y, Almaraz RT, Choi CH, Li QK, Saeui C, Li D, Shah P, Bhattacharya R, Yarema KJ, Zhang H. Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells. Clin Proteomics 2015 Apr 11;12(1):11.
  12. Tian Y, Choi CH, Li QK, Rahmatpanah FB, Chen X, Kim SR, Veltri R, Chia D, Zhang Z, Mercola D, Zhang H. Overexpression of periostin in stroma positively associated with aggressive prostate cancer. PLoS One 2015 Mar 17;10(3):e0121502.
  13. Toghi Eshghi S, Shah P, Yang W, Li X, Zhang H. GPQuest: a spectral library matching algorithm for site-specific assignment of tandem mass spectra to intact N-glycopeptides. Anal Chem 2015 May 19;87(10):5181-8.
  14. Yang S, Chen L, Sun S, Shah P, Yang W, Zhang B, Zhang Z, Chan DW, Kass DA, van Eyk JE, Zhang H. Glycoproteins identified from heart failure and treatment models. Proteomics. 2015 Jan;15(2-3):567-79.
  15. Yang S, Mishra S, Chen L, Zhou JY, Chan DW, Chatterjee S, Zhang H. Integrated glycoprotein immobilization method for glycopeptide and glycan analysis of cardiac hypertrophy. Anal Chem 2015 Oct 6;87(19):9671-8.
  16. Yang S, Wang M, Chen L, Yin B, Song G, Turko IV,. Phinney KW, Betenbaugh MJ, Zhang H, Li S. QUANTITY: an isobaric tag for quantitative glycomics. Sci Rep 2015 Nov 30;5:17585.

CYTOPATHOLOGY

  1. Bynum JP, Bishop J, Ali SZ. Cerebrospinal fluid cytology of an endolymphatic sac tumor. Diagn Cytopathol 2015 Apr;43(4):339-42.
  2. Bynum JP, Duffield A, Ali SZ. Impact of flow cytometry in liver cytopathology. Acta Cytol. 2015;59(1):51-60.
  3. Bovbel A, Zaheer A, Maleki Z. Cytomorphologic findings of intraosseous notochordal rest on touch preparation: a case report. Diagn Cytopathol 2015 Mar;43(3):243-6.
  4. Collins J, Rossi ED, Chandra A, Ali SZ. Terminology and nomenclature schemes for reporting thyroid cytopathology: an overview. Semin Diagn Pathol. 2015 Jul;32(4):258-63.
  5. Fazeli R., Schneider EB, Ali SZ, Zeiger MA, Olson MT. Diagnostic frequency ratios are insufficient to measure laboratory precision with The Bethesda System for Reporting Thyroid Cytopathology. Acta Cytologica 2015 May-June;59:225-32.
  6. Gurda GT, Zhang L, Wang Y, Chen L, Geddes S, Cho WC, Askin F, Gabrielson E, Li QK. Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases. Clin Transl Med 2015 Apr 21;4:16.
  7. Hipp J, Ali S, VandenBussche CJ. Poorly differentiated ("insular") thyroid carcinoma on fine-needle aspiration. Pathol Case Rev Oct 2015;20(5):210-3.
  8. Ho CY, VandenBussche CJ, Huppman AR, Chaudhry R, Ali SZ. Cytomorphologic and clinicoradiologic analysis of primary nonhematologic central nervous system tumors with positive cerebrospinal fluid. Cancer Cytopathol 2015 Feb;123(2):123-35.
  9. Nagarajan N, Najafian A, Schneider EB, Zeiger MA, Olson MT. Conventional smears versus liquid-based preparations for thyroid fine-needle aspirates: a systematic review and meta-analysis. J Am Soc Cytopathol Oct 2015;253-60.
  10. Nagarajan N, Schneider EB, Ali SZ, Zeiger MA, Olson MT. How do liquid-based preparations of thyroid fine-needle aspiration compare with conventional smears? An analysis of 5475 specimens. Thyroid. 2015 Mar;25(3):308-13.
  11. Nguyen DN, Kawamoto S, Cimino-Mathews, Illei PB, Rosenthal DL, VandenBussche CJ. Metastatic metaplastic breast carcinoma mimicking pulmonary squamous cell carcinoma on fine-needle aspiration. Diagnostic Cytopathol Oct 2015;43(10):844-9.
  12. Onur I, Rosenthal DL, VandenBussche CJ. Atypical urothelial tissue fragments in noninstrumented voided urine specimens are associated with low but significantly higher rates of urothelial neoplasia than benign-appearing urothelial tissue fragments. Cancer Cytopathol 2015 Mar;123(3):186-92.
  13. Onur I, Rosenthal DL, VandenBussche CJ. Benign-appearing urothelial tissue fragments in noninstrumented voided urine specimens are associated with low rates of urothelial neoplasia. Cancer Cytopathol. 2015 Mar;123(3):180-5.
  14. Sayah M, Vandenbussche C, Maleki Z. Epithelioid hemangioendothelioma in pleural effusion. Diagnostic Cytopathol Sept 2015;43(9):751-5.
  15. Uchida K, Ross H, Lotan T, Pignon JC, Signoretti S, Epstein JI, Illei PB. ΔNp63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity. Hum Pathol 2015 Mar;46(3):384-9.
  16. Vandenbussche CJ, Adams C, Ali SZ, Olson MT. Cytotechnologist performance for screening Hürthle cell atypia in indeterminate thyroid fine-needle aspirates. Acta Cytologica Oct 2015;59:377-83.
  17. VandenBussche CJ, Cimino-Mathews A, Park BH, Emens LA, Tsangaris TN, Argani P. Reflex estrogen receptor/progesterone receptor/human epidermal growth factor receptor 2 (ER/PR/Her2) analysis of breast cancers in needle core biopsy specimens dramatically increases health care costs. Am J Surg Pathol. 2015 Jul;39(7):939-47.
  18. Waters KM, Ali SZ, Erozan YS, Olson MT. Smoldering medullary thyroid carcinoma liver metastasis 37 years after resection of an organ-confined tumor. Diagn Cytopathol 2015 Jan;43(1):45-8.

GI/LIVER PATHOLOGY

  1. Arnold CA, Roth R, Arsenescu R, Harzman A, Lam-Himlin DM, Limketkai BN, Montgomery EA, Voltaggio L. Sexually transmitted infectious colitis vs inflammatory bowel disease: distinguishing features from a case-controlled study. Am J Clin Pathol 2015 Nov;144(5):771-81.
  2. Ayars M, Goggins M. Pancreatic cancer: Classifying pancreatic cancer using gene expression profiling. Nat Rev Gastroenterol Hepatol 2015 Nov;12(11):613-4.
  3. Banet N, Ning Y, Montgomery EA. Inflammatory myofibroblastic tumor of the placenta: a report of a novel lesion in 2 patients. Int J Gynecol Pathol 2015 Sep;34(5):419-23.
  4. Basturk O*, Hong SM*, Wood LD*, Adsay NV, Albores-Saavedra J, Biankin AV, Brosens LAA, Fukushima N, Goggins M, Hruban RH, Kato Y, Kern SE, Klimstra DS, Klöppel G, Krasinskas A, Longnecker DS, Matthaei H, Offerhaus GJA, Shimizu M, Takaori K, Terris B, Yachida S, Esposito I, Furukawa T. A revised classification system and recommendations from the Baltimore consensus meeting for neoplastic precursor lesions in the pancreas. Am J Surg Pathol 2015 Dec; 39(12):1730-41. (*equal authorship).
  5. Bhaijee F, Arnold C, Lam-Himlin D, Montgomery EA, Voltaggio L. Infectious mimics of inflammatory bowel disease. Diagnstc Histopathol 2015 July;21(7):267-75.
  6. Bhaijee F, Deyrup A, Montgomery E. Immunosupression-associated soft tissue tumors. Histopathology 2015 Nov;21(11): 432-7.
  7. Brosens LA, Hackeng WM, Offerhaus GJ, Hruban RH, Wood LD. Pancreatic adenocarcinoma pathology: changing "landscape". J Gastrointest Oncol 2015 Aug;6(4):358-74.
  8. Canto IM, Hruban RH. Diagnosis: A step closer to screening for curable pancreatic cancer? Nat Rev Gastroenterol Hepatol. 2015 Aug;12(8):431-2.
  9. Canto IM, Hruban RH. Managing pancreatic cysts: less is more? Gastroenterology. 2015 Apr;148(4):688-91.
  10. Celeiro-Muñoz C, Huebner TA, Robertson SA, Pittman ME, Singhi AD, Arnold CA, Bhaijee F, Voltaggio L, Montgomery EA. Tactile corpuscle-like bodies in gastrointestinal-type mucosa: a case series. Am J Surg Pathol 2015 Dec;39(12):1668-72.
  11. Dal Molin M, Zhang M, de Wilde RF, Ottenhof NA, Rezaee N, Wolfgang CL, Blackford A, Vogelstein B, Kinzler KW, Papadopoulos N, Hruban RH, Maitra A, Wood LD. Very long-term survival following resection for pancreatic cancer is not explained by commonly mutated genes: results of whole-exome sequencing analysis. Clin Cancer Res 2015 Apr 15;21(8):1944-50.
  12. Eshleman JR, Norris AL, Sadakari Y, Debeljak M, Borges M, Harrington C, Lin E, Brant A, Barkley T, Almario JA, Topazian M, Farrell J, Syngal S, Lee JH, Yu J, Hruban RH, Kanda M, Canto MI, Goggins M. KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound. Clin Gastroenterol Hepatol 2015 May;13(5):963-9.
  13. Khurram M, Montgomery E. Lanthanum carbonate-associated injury to the small intestine. Daignostic Histopathology 2015 Nov;21(11):452-4.
  14. Khurram M, Xie Y, Montgomery E. Recently described and recently re-evaluated soft tissue tumours. Diagnostic Histopathology 2015 Nov;21(11):445-51.
  15. Lennon AM, Wolfgang CL, Canto MI, Klein AP, Herman JM, Goggins M, Fishman EK, Kamel I, Weiss MJ, Diaz LA, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH. The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? Cancer Res. 2014 Jul 1;74(13):3381-9.
  16. Lin EI, Tseng LH, Gocke CD, Reil S, Le DT, Azad NS, Eshleman JR. Mutational profiling of colorectal cancers with microsatellite instability. Oncotarget 2015 Dec;6(39):42334-44.
  17. Matthaei H, Semaan A, Hruban RH. The genetic classification of pancreatic neoplasia. J Gastroenterol. 2015 May;50(5):520-32.
  18. Norris AL, Kamiyama H, Makohon-Moore A, Pallavajjala A, Morsberger LA, Lee K, Batista D, Iacobuzio-Donahue CA, Lin MT, Klein AP, Hruban RH, Wheelan SJ, Eshleman JR. Transflip mutations produce deletions in pancreatic cancer. Genes Chromosomes Cancer 2015 Aug;54(8):472-81.
  19. Norris AL, Roberts NJ, Jones S, Wheelan SJ, Papadopoulos N, Vogelstein B, Kinzler KW, Hruban RH, Klein AP, Eshleman JR. Familial and sporadic pancreatic cancer share the same molecular pathogenesis. Fam Cancer. 2015 Mar;14(1):95-103.
  20. Pea A, Hruban RH, Wood LD. Genetics of pancreatic neuroendocrine tumors: implications for the clinic. Expert Rev Gastroenterol Hepatol 2015;9(11):1407-19.
  21. Pittman ME, Brunt EM. Anatomic pathology of hepatocellular carcinoma: histopathology using classic and new diagnostic tools. Clin Liver Dis. 2015 May;19(2):239-59.
  22. Pittman ME, Montgomery EA. Distinctive clinicopathologic featuresof the common myxoid soft tissue lesions. Diagnostic Histopathology 2015 Nov;21(11):438-44.
  23. Pittman ME, Voltaggio L, Bhaijee F, Robertson SA, Montgomery EA. Autoimmune metaplastic atrophic gastritis: recognizing precursor lesions for appropriate patient evaluation. Am J Surg Pathol. 2015 Dec;39(12):1611-20.
  24. Rishi A, Goggins M, Wood LD, Hruban RH. Pathological and molecular evaluation of pancreatic neoplasms. Semin Oncol. 2015 Feb;42(1):28-39.
  25. Roberts NJ, Wolfgang CL, Wood LD, Zandi PP, Goggins M, Karchin R, Eshleman JR, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH, Klein AP. Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer. Cancer Discov. 2016 Feb;6(2):166-75.
  26. Singhi AD, Ishida H, Ali SZ, Goggins M, Canto M, Wolfgang CL, Meriden Z, Roberts N, Klein AP, Hruban RH. A histomorphologic comparison of familial and sporadic pancreatic cancers. Pancreatology 2015 July-Aug;15(4):387-91.
  27. Voltaggio L, Montgomery E. Gastrointestinal tract spindle cell lesions-just like real estate, it's all about location. Mod Pathol. 2015 Jan;28 Suppl 1:S47-66.
  28. Voltaggio L, Montgomery E. Polypoid stromal lesions of the intestines. Histopathology. 2015 Jan;66(1):88-101.
  29. Wood LD, Hruban RH. Genomic landscapes of pancreatic neoplasia. J Pathol Transl Med. 2015 Jan;49(1):13-22.
  30. Yu J, Blackford A, dal Molin M, Wolfgang CL, Goggins M. Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages. Gut. 2015 Nov;64(11):1783-9.

GENITOURINARY PATHOLOGY

  1. Bagnasco SM, Kraus ES. Intimal arteritis in renal allografts: new takes on an old lesion. Curr Opin Organ Transplant 2015 Jun;20(3):343-7.
  2. Bezerra SM, Chaux A, Ball MW, Faraj SF, Munari E, Gonzalez-Roibon N, Sharma R, Bivalacqua TJ, Burnett AL, Netto GJ. Human papillomavirus infection and immunohistochemical p16(INK4a) expression as predictors of outcome in penile squamous cell carcinomas. Hum Pathol 2015 Apr;46(4):532-40.
  3. Diolombi ML, Cheng L, Argani P, Epstein JI. Do clear cell papillary renal cell carcinomas have malignant potential? Am J Surg Pathol 2015 Dec;39(12):1621-34.
  4. Epstein JI. A new contemporary prostate cancer grading system. Ann Pathol 2015 Dec;35(6):474-6.
  5. Faraj SF, Chaux A, Gonzalez-Roibon N, Munari E, Cubilla AL, Shih IeM, Netto GJ. Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases. Hum Pathol 2015 May;46(5):761-6.
  6. Gordetsky J, Epstein JI. Intestinal metaplasia of the bladder with dysplasia: a risk factor for carcinoma? Histopathology 2015 Sep;67(3):325-30.
  7. Gordetsky J, Gorin MA, Canner J, Ball MW, Pierorazio PM, Allaf ME, Epstein JI. Frozen section during partial nephrectomy: does it predict positive margins? BJU Int. 2015 Dec;116(6):868-72.
  8. Heaphy CM, Gaonkar G, Peskoe SB, Joshu CE, De Marzo AM, Lucia MS, Goodman PJ, Lippman SM, Thompson IM, Jr., Platz EA, Meeker AK. Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial. Prostate. 2015 Aug;75(11):1160-6.
  9. Ide H, Miyamoto H. Steroid hormone receptor signals as prognosticators for urothelial tumor. Dis Markers Volume 2015 Dec (2015);840640:12 pages.
  10. Ishiguro H, Izumi K, Kashiwagi E, Zheng Y, Li Y, Kawahara T, Miyamoto H. Semenogelin I promotes prostate cancer cell growth via functioning as an androgen receptor coactivator and protecting against zinc cytotoxicity. Am J Cancer Res 2015 Mar; 5(2):738-47.
  11. Kalyesubula R, Lunyera J, Makanga G, Kirenga B, Amukele TK. A 4-year survey of the spectrum of renal disease at a National Referral Hospital Outpatient Clinic in Uganda. Kidney Int. 2015 Mar;87(3):663.
  12. Kawahara T, Ide H, Kashiwagi E, Patterson JD, Inoue S, Shareef HK, Aljarah AK, Zheng Y, Baras AS, Miyamoto H. Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation. Am J Cancer Res 2015 Oct;5(10):2959-68.
  13. Kawahara T, Kashiwagi E, Ide H, Li Y, Zheng Y, Ishiguro H, Miyamoto H. The role of NFATc1 in prostate cancer progression: Cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion. Prostate 2015 May;75:573-84.
  14. Kawahara T, Kashiwagi E, Ide H, Li Y, Zheng Y, Miyamoto Y, Netto GJ, Ishiguro H, Miyamoto H. Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1. Oncotarget 2015 Jan;6(3):1582-93.
  15. Kawahara T, Shareef HK, Aljarah AK, Ide H, Li Y, Kashiwagi E, Netto GJ, Zheng Y, Miyamoto H. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression. Oncotarget. 2015 Oct 6;6(30):29860-76.
  16. Khani F, Epstein JI. Prostate biopsy specimens with Gleason 3+3=6 and intraductal carcinoma: radical prostatectomy findings and clinical outcomes. Am J Surg Pathol 2015 Oct;39(10):1383-9.
  17. Kryvenko ON, Rosenberg AE, Jorda M, Epstein JI. Dedifferentiated liposarcoma of the spermatic cord: a series of 42 cases. Am J Surg Pathol 2015 Sep;39(9):1219-25.
  18. Kulac I, Haffner MC, Yegnasubramanian S, Epstein JI, De Marzo AM. Should Gleason 6 be labeled as cancer? Curr Opin Urol 2015 May;25(3):238-45.
  19. Lotan TL, Carvalho FL, Peskoe SB, Hicks JL, Good J, Fedor HL, Humphreys E, Han M, Platz EA, Squire JA, De Marzo AM, Berman DM. PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy. Mod Pathol 2015 Jan;28(1):128-37.
  20. Matoso A, Epstein JI. Epithelioid angiosarcoma of the bladder: A series of 9 cases. Am J Surg Pathol 2015 Oct;39(10):1377-82.
  21. Matoso A, Hassan O, Petrozzino F, Rao BV, Carter HB, Epstein JI. Radical prostatectomy findings in men on active surveillance: variable findings dependent on reason for surgery and entry criteria. J Urol. 2015 Sep;194(3):685-9.
  22. Morais CL, Han JS, Gordetsky J, Nagar MS, Anderson AE, Lee S, Hicks JL, Zhou M, Magi-Galluzzi C, Shah RB, Epstein JI, De Marzo AM, Lotan TL. Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy. Am J Surg Pathol 2015 Feb;39(2):169-78.
  23. Morais CL, Herawi M, Toubaji A, Albadine R, Hicks J, Netto GJ, De Marzo AM, Epstein JI, Lotan TL. PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas. Prostate 2015 Oct;75(14):1610-9.
  24. Munari E, Chaux A, Maldonado L, Compérat E, Varinot J, Bivalacqua TJ, Hoque MO, Netto GJ. Cyclin A1 expression predicts progression in pT1 Urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection. Histopathology 2015 Jan;66(2):262-9.
  25. Netto GJ. Molecular updates in prostate cancer. Surg Pathol Clinics 2015 Dec;8(4):561-80.
  26. Ozluk Y, Taheri D, Matoso A, Sanli O, Berker NK, Yakirevich E, Balasubramanian S, Ross JS, Ali SM, Netto GJ. Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma. Hum Pathol 2015 Dec;46(12):1951-5.
  27. Racusen LC, Bagnasco SM. Peritubular capillaritis in the renal allograft takes center stage. Kidney Int 2015 Aug;88(2):218-20.
  28. Rosenberg AZ, Naicker S, Winkler CA, Kopp JB. HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment. Nat Rev Nephrol 2015 March; 11(3): 150-60.
  29. Sfanos KS, Canene-Adams K, Hempel H, Yu SH, Simons BW, Schaeffer AJ, Schaeffer EM, Nelson WG, De Marzo AM. Bacterial prostatitis enhances 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced cancer at multiple sites. Cancer Prev Res (Phila). 2015 Aug;8(8):683-92.
  30. Shah RB, Bentley J, Jeffery Z, DeMarzo AM. Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling. Hum Pathol. 2015 May;46(5):698-706.
  31. Tan HL, Haffner MC, Esopi DM, Vaghasia AM, Giannico GA, Ross HM, Ghosh S, Hicks JL, Zheng Q, Sangoi AR, Yegnasubramanian S, Osunkoya AO, De Marzo AM, Epstein JI, Lotan TL. Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas. Mod Pathol. 2015 Mar;28(3):446-56.
  32. Tian W, Epstein JI. Invasive low-grade papillary urothelial carcinoma: an immunohistochemical study of 26 cases. Hum Pathol 2015 Dec;46(12):1836-41.
  33. Tian W, Guner G, Miyamoto H, Cimino-Mathews A, Gonzalez-Roibon N, Argani P, Li X, Sharma R, Subhawong AP, Rezaei K, Bivalacqua TJ, Epstein JI, Bishop JA, Netto GJ. Utility of uroplakin II expression as a marker of urothelial carcinoma. Hum Pathol 2015 Jan;46(1):58-64.
  34. Tsai H, Morais CL, Alshalalfa M, Tan HL, Haddad Z, Hicks J, Gupta N, Epstein JI, Netto G, Isaacs WB, Luo J, Mehra R, Vessella RL, Karnes RJ, Schaeffer EM, Davicioni E, De Marzo A, Lotan TL. Cyclin D1 loss distinguishes prostatic small-cell carcinoma from most prostatic adenocarcinomas. Clin Cancer Res2015 Dec;21(24):5619-29.
  35. Uchida K, Ross H, Lotan T, Pignon JC, Signoretti S, Epstein JI, Illei PB. ΔNp63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity. Hum Pathol. 2015 Mar;46(3):384-9.
  36. Yu SH, Zheng Q, Esopi D, Macgregor-Das A, Luo J, Antonarakis ES, Drake CG, Vessella R, Morrissey C, De Marzo AM, Sfanos KS. A paracrine role for IL6 in prostate cancer patients: lack of production by primary or metastatic tumor cells. Cancer Immunol Res 2015 Oct;3(10):1175-84.
  37. Zheng Y, Ishiguro H, Ide H, Inoue S, Kashiwagi E, Kawahara T, Jalalizadeh M, Reis LO, Miyamoto H. Compound A inhibits bladder cancer growth predominantly via glucocorticoid receptor transrepression. Mol Endocrinol 2015 Oct;29(10):1486-97.
  38. Zhong M, Tian W, Zhuge J, Zheng X, Huang T, Cai D, Zhang D, Yang XJ, Argani P, Fallon JT, Epstein JI. Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation. Am J Surg Pathol 2015 Jan;39(1):127-31.
  39. Wang CC, De Marzo AM, Lotan TL, Epstein JI. Overlap of CD44 expression between prostatic small cell carcinoma and acinar adenocarcinoma. Hum Pathol 2015 Apr;46(4):554-7.

GYNECOLOGIC PATHOLOGY

  1. Banet N, Gown AM, Shih IM, Kay Li Q, Roden RB, Nucci MR, Cheng L, Przybycin CG, Nasseri-Nik N, Wu LS, Netto GJ, Ronnett BM, Vang R. GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility. Am J Surg Pathol 2015 Jan;39(1):101-8.
  2. Banet N, Kurman RJ. Two types of gynecological pathology. Int J Gyn Pathol Jan 2015;34(1):3-8.
  3. Huang Z, Peng S, Knoff J, Yang B, Wu TC, Hung CF. Combination of proteasome and HDAC inhibitor enhances HPV16 E7-specific CD8+ T cell immune response and antitumor effects in a preclinical cervical cancer model. J Biomed Sci. 2015 Jan 16;22:7.
  4. Kurman RJ, Banet N. Re: Article by Natalie Banet and Robert J. Kurman: Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis; Int J Gynecol Pathol 2015;34:3-8. Int J Gynecol Pathol 2015 May;34(3):304-5.
  5. Morrison JC, Blanco LZ Jr, Vang R, Ronnett BM. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series. Am J Surg Pathol. 2015 Apr;39(4):442-53.
  6. Peng S, Wang JW, Karanam B, Wang C, Huh WK, Alvarez RD, Pai SI, Hung CF, Wu TC, Roden RB. Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer. PLoS One. 2015 Jan 5;10(1):e116389.
  7. Sun Y, Peng S, Qiu Y, Miao J, Yang B, Jeang J, Hung CF, Wu TC. Intravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors. Gene Ther 2015 Jul;22(7): 528-35.
  8. Wang JW, Hung CF, Huh WK, Trimble CL, Roden RB. Immunoprevention of human papillomavirus-associated malignancies. Cancer Prev Res (Phila). 2015 Feb;8(2):95-104.
  9. Wang JW, Jagu S, Wu WH, Viscidi RP, Macgregor-Das A, Fogel JM, Kwak K, Daayana S, Kitchener H, Stern PL, Gravitt PE, Trimble CL, Roden RB. Seroepidemiology of human papillomavirus 16 (HPV16) L2 and generation of L2-specific human chimeric monoclonal antibodies. Clin Vaccine Immunol. 2015 Jul;22(7):806-16.
  10. Wang JW, Jiang R, Peng S, Chang YN, Hung CF, Roden RB. Immunologic control of Mus musculus papillomavirus type 1. PLoS Pathog 2015 Oct 23;11(10):e1005243.
  11. Wang Y, Shwartz LE, Anderson D, Lin MT, Haley L, Wu RC, Vang R, Shih IeM, Kurman RJ. Molecular analysis of ovarian mucinouscarcinoma reveals different cell of origins. Oncotarget 2015 Sep 8;6(26):22949-58.
  12. Wang Y, Wu RC, Shwartz, Haley L, Lin MT, Shih IeM, Kurman RJ. Clonality analysis of combined Brenner and mucinous tumours of the ovary reveals their monoclonal origin. J Pathol. 2015 Oct;237(2):146-51.
  13. Yang B, Yang A, Peng S, Pang X, Roden RB, Wu TC, Hung CF. Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination. Cell Biosci 2015 Jun 25;5:35.
  14. Yu Y, Gaillard S, Phillip JM, Huang TC, Pinto SM, Tessarollo NG, Zhang Z, Pandey A, Wirtz D, Ayhan A, Davidson B, Wang TL*, Shih IeM*. Inhibition of spleen tyrosine kinase potentiates paclitaxel-induced cytotoxicity in ovarian cancer cells by stabilizing microtubules. Cancer Cell 2015 Jul;28(1):82-96.

HEMATOLOGIC PATHOLOGY

  1. Borowitz MJ, Wood BL, Devidas M, Loh ML, Raetz EA, Salzer WL, Nachman JB, Carroll AJ, Heerema NA, Gastier-Foster JM, Willman CL, Dai Y, Winick NJ, Hunger SP, Carroll WL, Larsen E. Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. Blood. 2015 Aug 20;126(8):964-71.
  2. Crane GM, Powell H, Kostadinov R, Rocafort PT, Rifkin DE, Burger PC, Ambinder RF, Swinnen LJ, Borowitz MJ, Duffield AS. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage. Oncotarget 2015 Oct 20;6(32):33849-66.
  3. Kern JB, Hii A, Kruse MJ, Szabo Z, Argani P, Hibbard MK, Gladstone DE, Meyer C, Zheng R, Borowitz MJ, Duffield AS. A Leukemic presentation of alveolar rhabdomyosarcoma in a 52-year-old woman without an identifiable primary tumor. Int J Surg Pathol 2015 Feb;23(1):757.
  4. Rodić N, Steranka JP, Makohon-Moore A, Moyer A, Shen P, Sharma R, Kohutek ZA, Huang CR, Ahn D, Mita P, Taylor MS, Barker NJ, Hruban RH, Iacobuzio-Donahue CA, Boeke JD, Burns KH. Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma. Nat Med 2015 Sep;21(9):1060-4.
  5. Su M, Alonso S, Jones JW, Yu J, Kane MA, Jones RJ, Ghiaur G. All-trans retinoic acid activity in acute myeloid leukemia: role of cytochrome P450 enzyme expression by the microenvironment. PLoS One 2015 Jun 5;10(6):e0127790.

IMMUNOLOGY

  1. Amukele TK, Schroeder LF, Jackson JB, Elbireer A. Most clinical laboratory testing in Kampala occurs in high-volume, high-quality laboratories or low-volume, low-quality laboratories. A tale of two cities. Am J Clin Pathol 2015 Jan;143(1):50-6.
  2. Amukele T, Sokoll LJ, Pepper D, Howard DP, Street J. Can unmanned aerial systems (drones) be used for the routine transport of chemistry, hematology, and coagulation laboratory specimens? PLoS One. 2015 Jul 29;10(7):e0134020.
  3. Dai H, Rahman A, Saxena A, Jaiswal AK, Mohamood A, Ramirez L, Noel S, Rabb H, Jie C, Hamad AR. Syndecan-1 identifies and controls the frequency of IL-17-producing naïve natural killer T (NKT17) cells in mice. Eur J Immunol 2015 Nov;45(11):3045-51.
  4. De Remigis A, de Gruijl TD, Uram JN, Tzou SC, Iwama S, Talor MV, Armstrong TD, Santegoets SJ, Slovin SF, Zheng L, Laheru DA, Jaffee EM, Gerritsen WR, van den Eertwegh AJ, Le DT, Caturegli P. Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival. Int J Cancer. 2015 Jan 1;136(1):127-37.
  5. Fontes JA, Rose NR, Čiháková D. The varying faces of IL-6: from cardiac protection to cardiac failure. Cytokine. 2015 Jul;74(1):62-68.
  6. Kim AR, Sadegh-Nasseri S. Determinants of immunodominance for CD4 T cells. Curr Opin Immonol 2015 June;34:9-15.
  7. Martina MN, Noel S, Saxena A, Rabb H, Hamad AR. Double negative (DN) αβ T cells: misperception and overdue recognition. Immunol Cell Biol 2015 Mar;93(3):305-10.
  8. Nagineni CN, Kommineni VK, Ganjbaksh N, Nagineni KK, Hooks JJ, Detrick B. Inflammatory cytokines induce expression of chemokines by human retinal cells: role in chemokine receptor mediated age-related macular degeneration. Aging Dis 2015 Nov 17;6(6):444-55.
  9. Ong S, Ligons DL, Barin JG, Wu L, Talor MV, Diny N, Fontes JA, Gebremariam E, Kass DA, Rose NR, Čiháková D. Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration. Am J Pathol 2015 Mar;185(3):847-61.
  10. Peterson DA, Planer JD, Guruge JL, Xue L, Downey-Virgin W, Goodman AL, Seedorf H, Gordon JI. Characterizing the interactions between a naturally primed immunoglobulin A and its conserved bacteroides thetaiotaomicron species-specific epitope in gnotobiotic mice. J Biol Chem 2015 May 15;290(20):12630-49.
  11. Perica K, Bieler JG, Schütz C, Varela JC, Douglass J, Skora A, Chiu YL, Oelke M, Kinzler K, Zhou S, Vogelstein B, Schneck JP. Enrichment and expansion with nanoscale artificial antigen presenting cells for adoptive immunotherapy. ACS Nano 2015 Jul 28;9(7):6861-71.
  12. Perica K, Kosmides AK, Schneck JP. Linking form to function: Biophysical aspects of artificial antigen presenting cell design. Biochim Biophys Acta 2015 Apr;1853(4):781-90.
  13. Ramirez L, Hamad AR. From non-obese diabetic to Network for the Pancreatic Organ Donor with Diabetes: New heights in type 1 diabetes research. World J Diabetes 2015 Nov 25;6(16):1309-11.
  14. Rose NR. In the Beginning. Focus IMAJ 2015 Feb;17:74-9.
  15. Rose NR. Molecular mimicry and clonal deletion: a fresh look. J Theor Biol 2015 Jun 21;375:71-6.
  16. Sadegh-Nasseri S, Kim A. Exogenous antigens bind MHC class II first, and are processed by cathepsins later. Mol Immunol 2015 Dec;68(2 Pt A):81-4.
  17. Sadegh-Nasseri S, Kim A. MHC Class II Auto-antigen processing and presentation is unconventional. Front Immunol 2015 Jul 22;6:372.
  18. Saxena A, Khosraviani S, Noel S, Mohan D, Donner T, Hamad AR. Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy. Cytokine. 2015 Jul;74(1):27-34.
  19. 19. Schroeder LF, Elbireer A, Jackson JB, Amukele TK. Laboratory diagnostics market in East Africa: a survey of test types, test availability, and test prices in Kampala, Uganda. PLoS One 2015 Jul 30;10(7):e0134578.

INFORMATICS

  1. Lai S, Gerstenblith G, Li J, Zhu H, Bluemke DA, Liu C-Y, Zimmerman SL, Chen S, Lai H, Treisman G. Chronic cocaine use and its association with myocardial steatosis evaluated by 1H magnetic resonance spectroscopy in African Americans. J Addict Med 2015 Jan-Feb 9(1):31-9.
  2. Lai H, Stitzer M, Treisman G, Moore R, Brinker J, Gerstenblith G, Kickler TS, Li J, Chen S, Fishman E, Lai S. Cocaine abstinence and reduced use associated with lowered marker of endothelial dysfunction in African Americans: a preliminary study. J Addict Med 2015 Jul-Aug;9(4):331-9.

MEDICAL MICROBIOLOGY

  1. Burbulis IE, Yamaguchi K, Nikolskaia OV, Prigge ST, Magez S, Bisser S, Reller ME, Grab DJ. Detection of pathogen-specific antibodies by loop-mediated isothermal amplification. Clin Vaccine Immunol 2015 Apr;22(4):374-80.
  2. Farley JE, Hayat MJ, Sacamano PL, Ross T, Carroll K. Prevalence and risk factors for methicillin-resistant Staphylococcus aureus in an HIV-positive cohort. Am J Infect Control 2015 Apr 1;43(4):329-35.
  3. Greer AE, Forman MS, Valsamakis A. Comparison of BKV quantification using a single automated nucleic acid extraction platform and 3 real-time PCR assays. Diagn Microbiol Infect Dis 2015 Aug;82(4):297-302.
  4. Kiweewa FM, Bakaki PM, McConnell MS, Musisi M, Namirembe C, Nakyiwa F, Kusasira F, Nakintu D, Ssemuwenba A, Mubiru M, Musoke P, Fowler MG. A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, "the Nevirapine Repeat Pregnancy study". BMC Public Health 2015 Sept:15;988.
  5. Lyons JL, Thakur KT, Lee R, Watkins T, Pardo CA, Carson KA, Markley B, Finkelman MA, Marr KA, Roos KL, Zhang SX. Utility of measuring (1,3) Β-D-glucan in cerebrospinal fluid for the diagnosis of fungal central nervous system infection. J Clin Microbiol 2015 Jan;53(1):319-22.
  6. Riedel S, Ross JE, Farrell DJ, Flamm RK, Jones RN. Determination of disk diffusion and MIC quality control guidelines for solithromycin, a novel fluoroketolide antibacterial against Neisseria gonorrhoeae. J Clin Microbiol 2015 Dec;53(12):3888-90.
  7. Sumpio BJ, Chitragari G, Moriguchi T, Shalaby S, Pappas-Brown V, Khan AM, Sekaran SD, Sumpio BE, Grab DJ. African Trypanosome-induced blood-brain barrier dysfunction under shear stress may not require ERK activation. Int J Angiol 2015 Mar;24(01):41-6.
  8. Suwantarat N, Adams LL, Romagnoli M, Carroll KC. Fatal case of Herbaspirillum seropedicae bacteremia secondary to pneumonia in an end-stage renal disease patient with multiple myeloma. Diagn Microbiol Infect Dis 2015 Aug;82(4):331-3.
  9. Suwantarat N, Dalton JB, Lee R, Green R, Memon W, Carroll KC, Riedel S, Zhang SX. Large-scale clinical validation of a lateral flow immunoassay for detection of cryptococcal antigen in serum and cerebrospinal fluid specimens. Diagn Microbiol Infect Dis 2015 May;82(1):54-6.
  10. Suwantarat N, Grundy M, Rubin M, Harris R, Miller JA, Romagnoli M, Hanlon A, Tekle T, Ellis BC, Witter FR, Carroll KC. Recognition of streptococcus pseudoporcinus colonization in women as a consequence of using matrix-assisted laser desorption ionization-time of flight mass spectrometry for group B streptococcus identification. J Clin Microbiol 2015 Dec;53(12):3926-30.

MOLECULAR PATHOLOGY

  1. Chen G, Dudley J, Tseng LH, Smith K, Gurda GT, Gocke CD, Eshleman JR, Lin MT. Lymph node metastases of melanoma: challenges for BRAF mutation detection. Hum Pathol 2015 Jan;46(1):113-9.
  2. Dudley J, Tseng LH, Rooper L, Harris M, Haley L, Chen G, Gocke CD, Eshleman JR, Lin MT. Challenges posed to pathologists in the detection of KRAS mutations in colorectal cancers. Arch Pathol Lab Med 2015 Feb;139(2):211-8.
  3. Gold B, Cankovic M, Furtado LV, Meier F, Gocke CD. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the Association for Molecular Pathology. J Mol Diagn May 2015;17(3):209-24.
  4. Haley L, Tseng LH, Zheng G, Dudley J, Anderson DA, Azad NS, Gocke CD, Eshleman JR, Lin MT. Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers. Mod Pathol 2015 Oct;28(10):1390-9.
  5. Jhaveri TZ, Woo J, Shang X, Park BH, Gabrielson E. AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer. Oncotarget 2015 Jun 20;6(17):14754-65.
  6. Lin MT, Tseng LH, Dudley J, Riel S, Tsai H, Zhen G, Pratz KW, Levis M, Gocke CD. A novel tandem duplication assay to detect minimal residual disease in FLT3/ITD AML. Molecular Diagnosis & Therapy 2015 Dec;19(6):409-17.
  7. Nauen DW, Guajardo A, Haley L, Powell K, Burger PC, Gocke CD. Chromosomal defects track tumor subpopulations and change in progression in oligodendroglioma. Coverg Sci Phys Oncol 2015 June;1(1):015001.
  8. Weiss K, Applegate C, Wang T, Batista DA. Familial TAB2 microdeletion and congenital heart defects including unusual valve dysplasia and tetralogy of fallot. Am J Med Genet A 2015 Nov;167(11):2702-6.
  9. Xi Y, Li J, Zhang P, Bai W, Gao N, Bai W, Zhang Y, Wu Y, Ning Y. Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma. Exp Mol Pathol. 2015 Oct;99(2):297-302.
  10. Zheng G, Tseng LH, Chen G, Haley L, Illei P, Gocke CD, Eshleman JR, Lin MT. Clinical detection and categorization of uncommon and concomitant mutations involving BRAF. BMC Cancer 2015 Oct;15:779.

NEUROPATHOLOGY

  1. Brandt WD, Schreck KC, Bar EE, Taylor I, Marchionni L, Raabe E, Eberhart CG, Rodriguez FJ. Notch signaling activation in pediatric low-grade astrocytoma. J Neuropathol Exp Neurol 2015 Feb;74(2):121-31.
  2. Eberhart CG, Orr BA. Molecular pathways: not a simple tube-the many functions of blood vessels. Clin Cancer Res 2015 Jan;21(1):18-23.
  3. Ho CY, Mobley BC, Gordish-Dressman H, VandenBussche CJ, Mason GE, Bornhorst M, Esbenshade AJ, Tehrani M, Orr BA, LaFrance DR, Devaney JM, Meltzer BW, Hofherr SE, Burger PC, Packer RJ, Rodriguez FJ. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation. Acta Neuropathol. 2015 Oct;130(4):575-85.
  4. Ho CY, Mosier S, Safneck J, Salomao DR, Miller NR, Eberhart CG, Gocke CD, Batista DA, Rodriguez FJ. Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningioma. Brain Pathol 2015 Mar;25(2):193-201.
  5. Iacono D, Zandi P, Gross M, Markesbery WR, Pletnikova O, Rudow G, Troncoso JC. APOε2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun Study. Oncotarget. 2015 Jun 10;6(16):14082-91.
  6. Kahlert UD, Suwala AK, Koch K, Natsumeda M, Orr BA, Hayashi M, Maciaczyk J, Eberhart CG. Pharmacologic Wnt inhibition reduces proliferation, survival, and clonogenicity of glioblastoma cells. J Neuropathol Exp Neurol. 2015 Sep;74(9):889-900.
  7. Kahlert UD, Suwala AK, Raabe EH, Siebzehnrubl FA, Suarez MJ, Orr BA, Bar EE, Maciaczyk J, Eberhart CG. ZEB1 promotes invasion in human fetal neural stem cells and hypoxic glioma neurospheres. Brain Pathol 2015 Nov;25(6):724-32.
  8. Lauterbach MD, Notarangelo PL, Lane KS, Koliatsos VE. Treatment of traumatic brain injury-induced dyskinesia with tetrabenazine: a case report. Psychosomatics 2015 Sep-Oct;56(5):567-71.
  9. Lim KJ, Brandt WD, Heth JA, Muraszko KM, Fan X, Bar EE, Eberhart CG. Lateral inhibition of Notch signaling in neoplastic cells. Oncotarget 2015 Jan 30;6(3):1666-77.
  10. Ling JP, Pletnikova O, Troncoso JC, Wong PC. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science 2015 Aug 7;349(6248):650-5.
  11. Pletnikova O, Rudow GL, Hyde TM, Kleinman JE, Ali SZ, Bharadwaj R, Gangadeen S, Crain BJ, Fowler DR, Rubio AI, Troncoso JC. Alzheimer lesions in the autopsied brains of people 30 to 50 years of age. Cogn Behav Neurol. 2015 Sep;28(3):144-52.
  12. Rodriguez FJ, Schniederjan MJ, Nicolaides T, Tihan T, Burger PC, Perry A. High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN). Acta Neuropathol 2015 Apr;129(4):609-10.
  13. Savonenko AV, Melnikova T, Wang Y, Ravert H, Gao Y, Koppel J, Lee D, Pletnikova O, Cho E, Sayyida N, Hiatt A, Troncoso J, Davies P, Dannals RF, Pomper MG, Horti AG. Cannabinoid CB2 receptors in a mouse nodel of Αβ amyloidosis: immunohistochemical analysis and suitability as a PET biomarker of neuroinflammation. PLoS One. 2015 Jun 18;10(6):e0129618.
  14. Shyam R, Ren Y, Lee J, Braunstein KE, Mao HQ, Wong PC. Intraventricular delivery of siRNA nanoparticles to the central nervous system. Mol Ther Nucleic Acids 2015 May 12;4:e242.
  15. Sun M, Oulabi I, Chen L. CRISPR/Cas9 genome editing system in Drosophila. Adv Tech Biol Med 2015 Sept;S1:003.
  16. Sun M, Chen L. Studying tauopathies in Drosophila: a fruitful model. Exp Neurol. 2015 Dec;274(Pt A):52-7.
  17. Vizcaíno MA, Shah S, Eberhart CG, Rodriguez FJ. Clinicopathologic implications of NF1 gene alterations in diffuse gliomas. Hum Pathol 2015 Sep;46(9):1323-30.
  18. Xu L. Animal model of repetitive mild traumatic brain injury for human traumatic axonal injury and chronic traumatic encephalopathy. Neural Regen Res 2015 Dec;10(11):1731-2

OPHTHALMIC PATHOLOGY

  1. Asnaghi L, Gezgin G, Tripathy A, Handa JT, Merbs SL, van der Velden PA, Jager MJ, Harbour JW, Eberhart CG. EMT-associated factors promote invasive properties of uveal melanoma cells. Mol Vis. 2015 Aug 25;21:919-29.
  2. Suarez MJ, River-Michlig R, Dubovy S, Rodriguez F. Clinicopathological features of ophthalmic neoplasms arising in the setting of xeroderma pigmentosum. Ocul Oncol Pathol 2016 Dec 2015;2:112-21.

SURGICAL PATHOLOGY

  1. Argani P. MiT family translocation renal cell carcinoma. Semin Diagn Pathol 2015 Mar;32(2):103-13.
  2. Argani P, Lewin JR, Edmonds P, Netto GJ, Prieto-Granada C, Zhang L, Jungbluth AA, Antonescu CR. Primary renal sclerosing epithelioid fibrosarcoma: report of 2 cases with EWSR1-CREB3L1 gene fusion. Am J Surg Pathol 2015 Mar;39(3):365-73.
  3. Baras AS, Gandhi N, Munari E, Faraj S, Shultz L, Marchionni L, Schoenberg M, Hahn N, Hoque M, Berman D, Bivalacqua TJ, Netto G. Identification and validation of protein biomarkers of response to neoadjuvant platinum chemotherapy in muscle invasive urothelial carcinoma. PLoS One 2015 Jul 31;10(7):e0131245.
  4. Bishop JA, Alaggio R, Zhang L, Seethala RR, Antonescu CR. Adamantinoma-like ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas. Am J Surg Pathol. 2015 Sep;39(9):1267-74.
  5. Bishop JA, Lewis JS Jr, Rocco JW, Faquin WC. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice. Semin Diagn Pathol 2015 Sep;32(5):344-51.
  6. Bishop JA, Thompson LD, Cardesa A, Barnes L, Lewis JS Jr, Triantafyllou A, Hellquist H, Stenman G, Hunt JL, Williams MD, Slootweg PJ, Devaney KO, Gnepp DR, Wenig BM, Rinaldo A, Ferlito A. Rhabdomyoblastic differentiation in head and neck malignancies other than rhabdomyosarcoma. Head Neck Pathol 2015 Dec;9(4):507-18.
  7. Bishop JA, Westra WH. Ciliated HPV-related carcinoma: a well-differentiated form of head and neck carcinoma that can be mistaken for a benign cyst. Am J Surg Pathol 2015 Nov;39(11):1591-5.
  8. Bishop JA, Yonescu R, Epstein JI, Westra WH. A subset of prostatic basal cell carcinomas harbor the MYB rearrangement of adenoid cystic carcinoma. Hum Pathol 2015 Aug;46(8):1204-8.
  9. Cimino-Mathews A, Foote JB, Emens LA. Immune targeting in breast cancer. Oncology (Williston Park) 2015 May;29(5):375-85.
  10. Gorin MA, Rowe SP, Allaf ME, Argani P. Angiomyolipoma with epithelial cysts: Add one to the differential of cystic renal lesions. Int J Urol 2015 Nov;22(11):1081-2.
  11. Heaphy CM, Asch-Kendrick R, Argani P, Meeker AK, Cimino-Mathews A. Telomere length alterations unique to invasive lobular carcinoma. Hum Pathol. 2015 Aug;46(8):1197-203.
  12. Holmes BJ, Maleki Z, Westra WH. The fidelity of p16 staining as a surrogate Marker of human papillomavirus status in fine-needle aspirates and core biopsies of neck node metastases: implications for HPV testing protocols. Acta Cytol 2015;59(1):97-103.
  13. Miller PD, McCarthy EF. Bisphosphonate-associated atypical sub-trochanteric femur fractures: Paired bone biopsy quantitative histomorphometry before and after teriparatide administration. Semin Arthritis Rheum. 2015 Apr;44(5):477-82.
  14. Rooper L, Sharma R, Bishop JA. Polymorphous low grade adenocarcinoma has a consistent p63+/p40- immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma. Head Neck Pathol 2015 Mar;9(1):79-84
  15. Smith NE, Epstein JI, Parwani AV, Netto GJ, Illei PB, Powell K, Allaf ME, Argani P. Smooth muscle and adenoma-like renal tumor: a previously unreported variant of mixed epithelial stromal tumor or a distinctive renal neoplasm? Hum Pathol. 2015 Jun;46(6):894-905.
  16. VandenBussche CJ, Cimino-Mathews A, Park BH, Emens LA, Tsangaris TN, Argani P. Reflex estrogen receptor/progesterone receptor/human epidermal growth factor receptor 2 (ER/PR/Her2) analysis of breast cancers in needle core biopsy specimens dramatically increases health care costs. Am J Surg Pathol 2015 Jul;39(7):939-47.

TRANSFUSION MEDICINE

  1. Chen I, Connor MB, Clarke W, Marzinke MA, Cummings V, Breaud A, Fogel JM, Laeyendecker O, Fields SD, Donnell D, Griffith S, Scott HM, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH. Antiretroviral drug use and HIV drug resistance among HIV-infected Black men who have sex with men: HIV Prevention Trials Network 061. J Acquir Immune Defic Synd. 2015 Aug;69(4):446-52.
  2. Chen I, Ou S-S, Marzinke MA, Breaud A, Hughes JP, Richardson, P, Haley DF, Lucas J, Rompalo A, Justman JE, Hodder SA, Eshleman SH. Antiretroviral drug use in a cohort of HIV-uninfected women in the United States: HIV Prevention Trials Network 064. PLoS One 2015 Oct 7;10(10):e0140074.
  3. Fogel JM, Piwowar-Manning E, Donohue K, Cummings V, Marzinke MA, Clarke W, Breaud A, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH. Determination of HIV status in African adults with discordant HIV rapid tests. J Acquir Immune Defic Syndr 2015 Aug;69(4):430-8.
  4. Goel R, Ness PM, Takemoto C, King KE, Krishnamurti L, Tobian AAR. Platelet transfusions in platelet consumptive disorders are associated with in-hospital arterial thrombotic complications and mortality. Blood 2015; 125(9):1470-6.
  5. Grabowski MK, Gray RH, Makumbi F, Kagaayi J, Redd AD, Kigozi G, Reynolds SJ, Nalugoda F, Lutalo T, Wawer MJ, Serwadda D, Quinn TC, Tobian AAR. Use of injectable hormonal contraception and women's risk for herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda. Lancet Global Health 2015 Aug;3:e478-86.
  6. Grabowski MK, Kigozi G, Gray RH, Armour B, Manucci J, Serwadda D, Redd AD, Nalugoda Patel EU, Wawer MJ, Quinn TC, Tobian AAR. Herpes simplex virus type 2 shedding from male circumcision wounds in Rakai Uganda. J Infect Dis 2015 Nov 15;212(10):1613-7.
  7. Kacker S, Ness PM, Shirey RS, Savage WJ, King KE, Tobian AAR. The future of red blood cell alloimmunization risk reduction. Transfusion 2015 Jan;55(1):222-4.
  8. Kacker S, Vassallo R, Keller MA, Westhoff CM, Frick KD, Sandler SG, Tobian AA. Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype. Transfusion. 2015 Sep;55(9):2095-103.
  9. Kantor R, Smeaton L, SH Eshleman: AIDS Clinical Trials Group (ACTG) A5175 Study Team. Pre-treatment HIV drug resistance and HIV-1 subtype Care independently associated with virologic failure: Results from the multi-national PEARLS (ACTG A5175) clinical trial. Clin Infect Dis 2015 May;60(10):1541-9.
  10. Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, Cipolle MD, Cohn CS, Fung MK, Grossman BJ, Mintz PD, O'Malley BA, Sesok-Pizzini DA, Shander A, Stack GE, Webert KE, Weinstein R, Welch BG, Whitman GJ, Wong EC, Tobian AAR. Platelet transfusion: a clinical practice guideline from the AABB. Annals of Internal Medicine 2015 Feb;162:205-13.
  11. Ness PM, English J. TRANSFUSION enhancements in the digital age. Transfusion 2015 Jan;55(1):10.
  12. Ness PM, Frank SM. Enhancing patient blood management: a long term FOCUS. The Lancet 2015 Mar;385(9974):1157-9.
  13. Pagano MB, Ness PM, Chajewski OS, King KE, Wu Y, Tobian AA. Hypotensive transfusion reactions in the era of prestorage leukoreduction. Transfusion 2015 Jul;55(7):1668-74.
  14. Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke M, Fiamma A, Donnell D, Kulich M, Mbwambo JKK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH. Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Africa. J Clin Virol 2015 Jan;62:75-9.
  15. Tobian AAR, Adamu T, Reed J, Kiggundu V, Yazdi Y, Njeuhmeli E. Voluntary medical male circumcision: moving from evidence to policy to scale-up in resource constrained settings. Nature Reviews Urology Dec 2015;12:661-70.
  16. Tobian AAR, Kigozi G, Manucci J, Grabowski MK, Serwadda D, Musoke R, Redd AD, Nalugoda F, Reynolds SJ, Kighoma N, Laeyendecker O, Lessler J, Gray RH, Quinn TC, Wawer MJ and the Rakai Health Sciences Program. HIV shedding from male circumcision wounds in HIV-infected men: a prospective cohort study. PLoS Medicine 2015;12(4):e1001820.
  17. Westhoff CM, Ness PM. The promise of extended donor antigen typing. Transfusion. 2015 Nov;55(11):2541-3.
  18. White MJ, Hazard SW 3rd, Frank SM, Boyd JS, Wick EC, Ness PM, Tobian AA. The evolution of perioperative transfusion testing and blood ordering. Anesth Analg 2015 Jun;120(6):1196-203.
  19. Yang B, Yang A, Peng S, Pang X, Roden RB, Wu TC, Hung CF. Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination. Cell Biosci 2015 Jun 25;5:35.

OTHER

  1. Caturegli P, McCarthy EF, Jackson BJ, Hruban RH. The Pathology residency program of the Johns Hopkins University School of Medicine: a model of its kind. Arch Pathol Lab Med 2015 Mar;139:400-6.

2014 Publications +

AUTOPSY

  1. Singer N, Aina-Mumuney A, Poling J, Burton EC. Fetal death resulting from an isolated congenital partial pericardial defect. Obstet Gynecol 2014 Feb;123(2 Pt 2):443-6.

CARDIOVASCULAR PATHOLOGY

  1. Das S, Bedja D, Campbell N, Dunkerly B, Chenna V, Maitra A, Steenbergen C. miR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo. PLoS One. 2014 May 8;9(5):e96820.
  2. Ferlito M, Wang Q, Fulton WB, Colombani PM, Marchionni L, Fox-Talbot K, Paolocci N, Steenbergen C. H2S increases survival during sepsis: protective effect of CHOP inhibition. J Immunol 2014 Feb 15;192(4):1806-14.
  3. Haider BA, Baras AS, McCall MN, Hertel JA, Cornish TC, Halushka MK. A critical evaluation of microRNA biomarkers in non-neoplastic disease. PLoS One 2014 Feb 26;9(2):e89565.
  4. Huang HW, Cowan M, Matthews J, Lin MT, Milner S, Halushka M Fatal myocardial microabscesses caused by methicillin-resistant Staphylococcus aureus in a burn patient. Hum Pathol: Case Reprts 2014 Mar;1(1):10-2.
  5. Kent OA, McCall MN, Cornish TC, Halushka MK. Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucl. Acids Res 2014 Jul;42(12):7528-38.
  6. Kohr MJ, Evangelista AM, Ferlito M, Steenbergen C, Murphy E. S-nitrosylation of TRIM72 at cysteine 144 is critical for protection against oxidation-induced protein degradation and cell death. J Mol Cell Cardiol. 2014 Apr;69:67-74.
  7. Kohr MJ, Murphy E, Steenbergen C. Glyceraldehyde-3-phosphate dehydrogenase acts as a mitochondrial trans-s-nitrosylase in the heart. PLoS One. 2014 Oct 27;9(10):e111448.
  8. Yano T, Ferlito M, Aponte A, Kuno A, Miura T, Murphy E, Steenbergen C. Pivotal role of mTORC2 and involvement of ribosomal protein S6 in cardioprotective signaling. Circ Res 2014 Apr 11;114(8):1268-80.
  9. Murphy E, Kohr M, Menazza S, Nguyen T, Evangelista A, Sun J, Steenbergen C. Signaling by S-nitrosylation in the heart. J Mol Cell Cardiol 2014 Aug;73C:18-25.

CLINICAL CHEMISTRY

  1. Baycin-Hizal D, Wolozny D, Colao J, Jacobson E, Tian Y, Krag SS, Betenbaugh MJ, Zhang H. Glycoproteomic and glycomic databases. Clin Proteomics 2014 Apr;11(1):15.
  2. Clarke W. What is needed for optimal therapeutic drug monitoring? Bioanalysis. 2014 Jan;6(2):113-5.
  3. Crutchfield CA, Clarke W. Present and Future Applications of High Resolution Mass Spectrometry in the Clinic. Discoveries 2014 Apr-Jun;2(2):e17.
  4. Emory JF, Seserko LA, Marzinke MA. Development and bioanalytical validation of a liquid chromatographic-tandem mass spectrometric (LC-MS/MS) method for the quantification of the CCR5 antagonist maraviroc in human plasma. Clin Chim Acta 2014 Apr 20;431:198-205.
  5. Harlan R, Zhang H. Targeted proteomics: a bridge between discovery and validation. Expert Rev Proteomics. 2014 Dec;11(6):657-61.
  6. Henemyre-Harris CL, Samols M, Wenick AS, Sokoll LJ. Glow stick or urine sample? Clin Chem. 2014 Feb;60(2):425-6.
  7. Li D, Chan DW. Proteomic cancer biomarkers from discovery to approval: it's worth the effort. Expert Rev Proteomics 2014 Apr;11(2):135-6.
  8. Marzinke MA, Breaud A, Parsons TL, Cohen MS, Piwowar-Manning E, Eshleman SH, Clarke W. The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood. Clin Chim Acta 2014 Jun 10;433:157-68.
  9. Marzinke MA, Clarke W, Wang L, Cummings V, Liu TY, Piwowar-Manning E, Breaud A, Griffith S, Buchbinder S, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Fields SD, Mayer KH, Wheeler DP, Koblin BA, Eshleman SH, Fogel JM. Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clin Infect Dis. 2014 Jan;58(1):117-20.
  10. Petrides AK, Clarke W, Marzinke MA. Application and utility of pharmacogenetics in the clinical laboratory. J Analyt Molecul Tech. 2014 Feb;1(1):15.
  11. Sartori DA, Chan DW. Biomarkers in prostate cancer: what's new? Curr Opin Oncol. 2014 May;26(3):259-64.
  12. Sun S, Zhou J, Yang W, and Zhang H*. Inhibition of protein carbamylation in urea solution using ammonium containing buffers. Anal Biochem 2014 Feb;446:76-81.
  13. Toghi Eshghi S, Yang S, Wang X, Shah P, Li X, Zhang H. Imaging of N-linked glycans from formalin-fixed paraffin-embedded tissue sections using MALDI mass spectrometry. ACS Chemical Biology 2014 Sept;9:2149-56.
  14. Wang X, Chen J, Li QK, Peskoe SB. Zhang B, Choi B, Platz EA, Zhang H. Overexpression of alpha (1,6) fucosyltransferase associated with aggressive prostate cancer. Glycobiology 2014 Oct;24(10):935-44.
  15. Yang W, Laeyendecker O, Wendel SK, Zhang B, Sun S, Zhou JY, Ao M, Moore RD, Jackson JB, Zhang H. Glycoproteomic study reveals altered plasma proteins associated with HIV elite suppressors. Theranostics. 2014 Sep;4(12):1153-63.
  16. Yang W, Shah P, Toghi Eshghi S, Yang S, Sun S. Ao M, Rubin A, Jackson, JB, Zhang H. Glycoform-analysis of recombinant and human deficiency virus envelope protein gp120 via higher energy C-trap dissociation and spectral-aligning strategy. Analytical Chemistry 2014 Jul;86:6959-67.
  17. Yang S, Zhang H. Glycomic analysis of glycans released from glycoproteins using chemical immobilization and mass spectrometry. Curr Protoc Chem Biol 2014 Sep 9;6(3):191-208.

CYTOPATHOLOGY

  1. Ahmed A, Novak A, Farhat Sheerin A, Boonyaarunnate T, Ali S, Olson MT. Accuracy of cytotechnologist evaluation of specimen adequacy and screening interpretation of malignancy in fine-needle aspiration of the liver. Acta Cytologica 2014; 58:367-72.
  2. Ao MH, Zhang H, Sakowski L, Sharma R, Illei PB, Gabrielson E, Askin F, Li QK. The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer. Hum Pathol 2014 May;45(5):926-34.
  3. Dudas R, Vandenbussche CV, Baras A, Ali SZ, Olson MT. Inexpensive telecytology solutions that use the raspberry Pi and iPhone. J Am Soc Cytopathol 2014 Jan;3:49-55.
  4. Guan H, Gurda G, Lennon MA, Hruban RH, Erozan YS. Intraductal tubulopapillary neoplasm of the pancreas on fine needle aspiration: case report with differential diagnosis. Diagn Cytopathol 2014 Feb;42(2):156-60.
  5. Holmes BJ, Sokoll LJ, Li QK. Measurement of fine-needle aspiration thyroglobulin levels increases the detection of metastatic papillary thyroid carcinoma in cystic neck lesions. Cancer Cytopathol July 2014;122(7):521-6.
  6. Mathur A, Najafian A, Schneider EB, Zeiger MA, Olson MT. Malignancy risk and reproducibility associated with atypia of undetermined significance on thyroid cytology. Surgery 2014 Dec;156(6):1471-6.
  7. Nauen D, Li QK. Cytological diagnosis of metastatic glioblastoma in the pleural effusion of a lung transplant patient. Diagn Cytopathol. 2014;42:619-23.
  8. Olson MT, Boonyaarunnate T, Aksoy Altinboga A, Ali SZ. 'Suspicious for a papillary thyroid carcinoma' before and after The Bethesda System for reporting thyroid cytopathology: Impact of standardized terminology. Acta Cytol 2014 Jan;58(1):15-22.
  9. Olson MT, Novak A, Boonyaarunnate T, Shahid H, Kirby J, Ali SZ. Cytotechnologist attended on-site evaluation of adequacy for bone and soft tissue fine needle aspiration. J Am Soc Cytopathol 2014 Mar; 3(2):60-6.
  10. Olson MT, Novak A, Trotter J, Sterling F, Kelly D, Sachs S, Cornish TC, Boonyaarunnate T, Toll A, Tatsas AD, Maleki Z, Erozan YS, Rosenthal DL. Reproducibility of The Johns Hopkins Hospital Template for Urologic Cytology Samples. J Am Soc Cytopathol 2014 May-June;3(3):156-64.
  11. Rodriguez E, Chen L, Ao MH1, Geddes S, Gabrielson E, Askin F, Zhang H, Li QK. Expression of transcript factors SALL4 and OCT4 in a subset of non-small cell lung carcinomas (NSCLC). Transl Respir Med 2014 Dec 2;2(1):10.
  12. Rooper LM, Ali SZ, Olson MT. A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: A retrospective analysis of 2540 cases. Cancer Cytopathol. 2014 Sep;122(9):657-65.
  13. Toll AD, Kelly D, Maleki Z. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests. Diagnostic Cytopathol 2014 July;42(7):576-81.
  14. VandenBussche CJ, Adams C, Ali SZ, Olson MT. Cytotechnologist performance for detecting nuclear atypia in indeterminate thyroid fine needle aspirates. Acta Cytol. 2014;58(3):239-47.
  15. VandenBussche CJ, Ho CY, Nugent SL, Ali SZ. Extraneural metastases of primary central nervous system tumors identified by fine needle aspiration: a retrospective analysis. Acta Cytol 2014 Mar-Apr;58(2):117-24.
  16. VandenBussche CJ, Illei PB, Lin MT, Ettinger DS, Maleki Z. Molecular alterations in non-small cell lung carcinomas of the young. Hum Pathol. 2014 Dec;45(12):2379-87.
  17. VandenBussche CJ, Maleki Z. Fine-needle aspiration of squamous-lined cysts of the pancreas. Diagnostic Cytopathol 2014 July;42(7):592-9.
  18. VandenBussche CJ, Olson MT, Adams C, Ali SZ. Cytotechnologist performance for screening microfollicular atypia in indeterminate thyroid fine-needle aspirates. Acta Cytol. 2014;58(5):432-8.
  19. VandenBussche CJ, Wakely PE Jr, Siddiqui MT, Maleki Z, Ali SZ. Cytopathologic characteristics of epithelioid vascular malignancies. Acta Cytol. 2014;58(4):356-66.

GI / LIVER PATHOLOGY

  1. Ali MA, Arnold CA, Singhi AD, Voltaggio L. Clues to uncommon and easily overlooked infectious diagnoses affecting the GI tract and distinction from their clinicopathologic mimics. Gastrointest Endosc. 2014 Oct;80(4):689-706.
  2. Chen G, Mosier S, Gocke CD, Lin MT, Eshleman JR. Cytosine deamination is a major cause of baseline noise in next-generation sequencing. Mol Diagn Ther 2014 Oct;18(5):587-93.
  3. Debeljak M, Freed DN, Welch JA, Haley L, Beierl K, Iglehart BS, Pallavajjala A, Gocke CD, Leffell MS, Lin MT, Pevsner J, Wheelan SJ, Eshleman JR. Haplotype counting by next-generation sequencing for ultrasensitive human DNA detection. J Molec Diagn 2014 Sept;16(5):495-503.
  4. Gurda GT, Zhu Q, Bai H, Pan D, Schwarz KB, Anders RA. The use of Yes-associated protein expression in the diagnosis of persistent neonatal cholestatic liver disease. Hum Pathol. 2014 May;45(5):1057-64.
  5. Jiao Y, Yonescu R, Offerhaus GJ, Klimstra DS, Maitra A, Eshleman JR, Herman JG, Poh W, Pelosof L, Wolfgang CL, Vogelstein B, Kinzler KW, Hruban RH, Papadopoulos N, Wood LD. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation. J Pathol 2014 Mar;232(4):428-35.
  6. Kim H, Saka B, Knight S, Borges M, Childs E, Klein AP, Wolfgang CL, Herman JM, Adsay V, Hruban RH, Goggins M. Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with a poorer prognosis. Clin Cancer Res 2014 Apr 1;20(7):1865-72.
  7. Le A, Stine ZE, Nguyen C, Afzal J, Sun P, Hamaker M, Siegel NM, Gouw AM, Kang BH, Yu SH, Cochran RL, Sailor KA, Song H, Dang CV. Tumorigenicity of hypoxic respiring cancer cells revealed by a hypoxia-cell cycle dual reporter. Proc Natl Acad Sci U S A. 2014;111(34):12486-91.
  8. Lennon AM, Wolfgang CL, Canto EK, Kamel I, Weiss MJ, Diaz LA, Papdopoulos N, Kinzler KW, Vogelstein B, Hruban RH. The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? Cancer Res July 2014;74:3381.
  9. Lin MT, Mosier SL, Thiess M, Beierl KF, Debeljak M, Tseng LH, Chen G, Yegnasubramanian S, Ho H, Cope L, Wheelan SJ, Gocke CD, Eshleman JR. Clinical Validation of KRAS, BRAF and EGFR Mutation Detection using Next Generation Sequencing. Am J Clin Pathol 2014 June;141(6):856-66.
  10. Ma C, Giardiello FM, Montgomery EA. Upper tract juvenile polyps in juvenile polyposis patients: dysplasia and malignancy are associated with foveolar, intestinal, and pyloric differentiation. Am J Surg Pathol 2014 Dec;38(12):1618-26.
  11. Ma C, Limketkai BN, Montgomery EA. Recently highlighted non-neoplastic pathologic entities of the upper GI tract and their clinical significance. Gastrointest Endosc. 2014 Dec;80(6):960-9.
  12. Matthaei H, Wu J, Dal Molin M, Shi C, Perner S, Kristiansen G, Lingohr P, Kalff JC, Wolfgang CL, Kinzler KW, Vogelstein B, Maitra A, Hruban RH. GNAS Sequencing Identifies IPMN-specific Mutations in a Subgroup of Diminutive Pancreatic Cysts Referred to as "Incipient IPMNs". Am J Surg Pathol 2014 Mar;38(3):360-3.
  13. McCall CM, Mosier S, Thiess M, Debeljak M, Pallavajjala A, Beierl K, Deak KL, Datto MB, Gocke CD, Lin MT, Eshleman JR. False positives in multiplex PCR-based next-generation sequencing have unique signatures. J Mol Diagn 2014 Sep;16(5):541-9.
  14. Montgomery E, Voltaggio L. Mesenchymal polyps. Diagn Histopathol 2014 Jan;20(1):19-29.
  15. Montgomery E, Voltaggio L, Vieth M. Inflammation, malignancy and immunology in gastrointestinal spindle cell tumors: what is beyond GIST?. Pathologe. 2014 Nov;35 Suppl 2:207-13.
  16. Piwowar-Manning E, Fogel JM, Laeyendecker O, Wolf S, Cummings V, Marzinke M, Clarke W, Breaud A, Wendel S, Wang L, Swanson P, Hackett J, Jr., Mannheimer S, del Rio C, Kuo I, Harawa NT, Koblin BA, Matthaei H, Wu J, dal Molin M, Shi C, Perner S, Kristiansen G, Lingohr P, Klaff JC, Wolfgang CL, Kinzler KW, Vogelstein B, Maitra A, Hruban RH. GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "Incipient IPMNs." Am J Surg Pathol 2014 Mar;38(3):360-3.
  17. Rodriguez E, Tellschow S, Steinberg DM, Montgomery E. Cytologic findings of gastric schwannoma: a case report. Diagn Cytopathol 2014 Feb;42(2):177-80.
  18. Sadakari Y, Kanda M, Maitani K, Borges M, Canto MI, Goggins M. Mutant KRAS and GNAS DNA concentrations in secretin-stimulated pancreatic fluid collected from the pancreatic duct and the duodenal lumen. Clin Transl Gastroenterol 2014 Nov;5:e62.
  19. Singhi AD, Arnold CA, Crowder CD, Lam-Himlin DM, Voltaggio L, Montgomery EA. Esophageal leukoplakia or epidermoid metaplasia: a clinicopathological study of 18 patients. Modern Pathol 2014 Jan;27:38-43.
  20. Slavik T, Montgomery EA. Cronkhite-Canada syndrome six decades on: the many faces of an enigmatic disease. J Clin Pathol. 2014 Oct;67(10):891-7.
  21. Taube JM, Klein A, Brahmer JR, Xu H, Pan X, Kim JH, Chen L, Pardoll DM, Topalian SL, Anders RA. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy. Clin Cancer Res Oct 2014;20:5064.
  22. Vieth M, Montgomery EA. Some observations on pyloric gland adenoma: an uncommon and long ignored entity! J Clin Pathol. 2014 Oct;67(10):883-90.
  23. Vieth M, Riddell RH, Montgomery EA. High-grade dysplasia versus carcinoma: east is east and west is west, but does it need to be that way? Am J Surg Pathol 2014 Nov;38(11):1453-6.
  24. Vincent A, Hong SM, Hu C, Omura N, Young A, Kim H, Yu J, Knight S, Ayars M, Griffith M, Van Seuningen I, Maitra A, Goggins M. Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth. Oncotarget. 2014 May 15;5(9):2575-87.
  25. Voltaggio L, Lam-Himlin D, Limketkai BN, Singhi AD, Arnold CA. Message in a bottle: decoding medication injury patterns in the gastrointestinal tract. J Clin Pathol 2014 Oct;67(10):903-12.
  26. Voltaggio L, Montgomery E. Gastric mesenchymal lesions other than gastrointestinal stromal tumor. Diagn Histopathol 2014 June;20(6):228-38.
  27. Wood LD. Update on Colorectal Polyps and Polyposis Syndromes. Diagn Histopathol. 2014 Jan;20:12-8.
  28. Wood LD, Klimstra DS. Pathology and genetics of pancreatic neoplasms with acinar differentiation. Semin Diagn Pathol. 2014 Nov;31(6):491-7.
  29. Wood LD, Salaria SN, Cruise MW, Giardiello FM, Montgomery EA. Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms. Am J Surg Pathol 2014 Mar;38(3):389-93.

GENITOURINARY PATHOLOGY

  1. Amin MB, Epstein JI*, et al; Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conference. Am J Surg Pathol. 2014 Aug;38(8):1017-22.
  2. Bagnasco SM, Gottipati S, Kraus E, Alachkar N, Montgomery RA, Racusen LC, Arend LJ. Sarcoidosis in native and transplanted kidneys: incidence, pathologic findings, and clinical course. PLoS One. 2014 Oct 20;9(10):e110778.
  3. Bagnasco SM, Zachary AA, Racusen LC, Arend LJ, Carter-Monroe N, Alachkar N, Nazarian SM, Lonze BE, Montgomery RA, Kraus ES. Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients. Transplantation 2014 Feb 27;97(4):440-5.
  4. Berman DM, Epstein JI. When is prostate cancer really cancer? Urol Clinic N Amer 2014 May;41:339-46.
  5. Bezerra SM, Lotan TL, Faraj SF, Karram S, Sharma R, Schoenberg M, Bivalacqua TJ, Netto GJ. GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin. Hum Pathol 2014 Aug;45(8):1682-7.
  6. Chaux A, Cubilla AL, Haffner MC, Lecksell KL, Sharma R, Burnett AL, Netto GJ. Combining routine morphology, p16INK4a immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: A tissue microarray study using classifier performance analyses. Urol Oncol 2014 Feb;32(2):171-7.
  7. Chaux A, Munari E, Cubilla AL, Hicks J, Lecksell K, Burnett AL, Netto GJ. Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases. Histopathology 2014 May;64(6):863-71.
  8. Cox R, Vang R, Epstein JI. Papillary cystadenoma of the epididymis and broad ligament: Morphological and immunohistochemical overlap with clear cell papillary renal cell carcinoma. Am J Surg Pathol 2014 May 2014;38:713-8.
  9. Darshan M, Zheng Q, Fedor HL, Wyhs N, Yegnasubramanian S, Lee P, Melamed J, Netto GJ, Trock BJ, De Marzo AM, Sfanos KS. Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network. Prostate 2014 Jan;74(1):61-9.
  10. Epstein JI, Amin MB, Beltran H, Lotan TL, Mosquera JM, Reuter VE, Robinson BD, Troncoso P, Rubin MA. Proposed morphologic classification of prostate cancer with neuroendocrine differentiation. Am J Surg Pathol 2014 Jun;38(6):756-67.
  11. Epstein JI, Egevad L, Humphrey PA, Montironi R; Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 2014 Aug;38(8):e6-e19.
  12. Faraj SF, Chaux A, Gonzalez-Roibon N, Munari E, Ellis C, Driscoll T, Schoenberg MP, Bivalacqua TJ, Shih IM, Netto GJ. ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder. Hum Pathol 2014 Nov;45(11):2233-9.
  13. Gonzalez-Roibon N, Kim JJ, Faraj SF, Chaux A, Bezerra SM, Munari E, Ellis C, Sharma R, Keizman D, Bivalacqua TJ, Schoenberg M, Eisenberger M, Carducci M, Netto GJ. Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy. Urology 2014 Jun;83(6):1444.e1-6.
  14. Gordetsky, J, Bivalacqua T, Schoenberg M, Epstein JI. Ureteral and urethral frozen sections during radical cystectomy/cystoprostatectomy: an analysis of denudation and atypia. Urology 2014 Sep;84(3):619-23.
  15. Gordetsky J, Epstein JI. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. Am J Surg Pathol 2014 Jul;38(7):941-5.
  16. Gurda GT, Vandenbussche CJ, Yonescu R, Gonzalez-Roibon N, Ellis CL, Batista DA, Netto GJ. Sacrococcygeal teratomas: clinico-pathological characteristics and isochromosome 12p status. Mod Pathol 2014 Apr;27(4):562-8.
  17. Gurel B, Lucia MS, Thompson IM Jr, Goodman PJ, Tangen CM, Kristal AR, Parnes HL, Hoque A, Lippman SM, Sutcliffe S, Peskoe SB, Drake CG, Nelson WG, De Marzo AM, Platz EA. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):847-56.
  18. Hurwitz LM, Heaphy CM, Joshu CE, Isaacs WB, Konishi Y, De Marzo AM, Isaacs SD, Wiley KE, Platz EA, Meeker AK. Telomere length as a risk factor for hereditary prostate cancer. Prostate 2014 Apr;74(4):359-64.
  19. Ishiguro H, Kawahara T, Zheng Y, Kashiwagi E, Li Y, Miyamoto H. Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity. Cancer Chemother Pharmacol 2014 Aug;74(2):249-55.
  20. Ishiguro H, Kawahara T, Zheng Y, Netto GJ, Miyamoto H. Reduced glucocorticoid receptor expression predicts bladder tumor recurrence and progression. Am J Clin Pathol 2014 Aug;142(2):157-64.
  21. Izumi K, Li Y, Ishiguro H, Zheng Y, Yao JL, Netto GJ, Miyamoto H. Expression of UDP-glucuronosyltransferase 1A in bladder cancer: association with prognosis and regulation by estrogen. Mol Carcinog 2014 Apr;53(4):314-24.
  22. Karram S, Kao CS, Osunkoya AO, Ulbright TM, Epstein JI. Idiopathic granulomatous orchitis: morphology and evaluation of its relationship to IgG4 related disease. Hum Pathol 2014 Apr;45(4):844-50.
  23. Kawahara T, Miyamoto H. Androgen receptor antagonists in the treatment of prostate cancer. Clin Immunol Endocr Metab Drugs 2014 Jun;1(1):11-9.
  24. Kryvenko ON, Carter HB, Trock BJ, Epstein JI. Biopsy criteria for determining appropriateness for active surveillance in the modern era. Urology 2014 Apr;83(4):869-74.
  25. Kryvenko ON, Jorda M, Argani P, Epstein JI. Diagnostic approach to eosinophilic renal neoplasms. Arch Pathol Lab Med 2014 Nov;138(11):1531-41
  26. Lee SL, Illei PB, Han JS, Epstein JI. Florid mesothelial hyperplasia of the tunica vaginalis mimicking malignant mesothelioma: A clinicopathologic study of 12 cases. Am J Surg Pathol 2014 Jan;38(1):54-9.
  27. Li Y, Ishiguro H, Kawahara T, Kashiwagi E, Izumi K, Miyamoto H. Loss of GATA3 in bladder cancer promotes cell migration and invasion. Cancer Biol Ther. 2014 Apr 1;15(4):428-35.
  28. Li Y, Ishiguro H, Kawahara T, Miyamoto Y, Izumi K, Miyamoto H. GATA3 in the urinary bladder: suppression of neoplastic transformation and down-regulation by androgens. Am J Cancer Res. 2014 Sep 6;4(5):461-73.
  29. Matoso A, Chen S, Plaza JA, Osunkoya AO, Epstein JI. Symplastic leiomyomas of the scrotum: a comparative study to usual leiomyomas and leiomyosarcomas. Am J Surg Pathol. 2014 Oct;38(10):1410-7.
  30. Matoso A, Ross HM, Chen S, Allbritton J, Epstein JI. Squamous neoplasia of the scrotum: a series of 29 cases. Am J Surg Pathol. 2014 Jul;38(7):973-81.
  31. Munari E, Marchionni L, Chitre A, Hayashi M, Martignoni G, Brunelli M, Gobbo S, Argani P, Allaf M, Hoque MO, Netto GJ. Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Hum Pathol 2014 Jun;45(6):1130-8.
  32. Nie X, Arend LJ. Novel roles of Pkd2 in male reproductive system development. Differentiation 2014 Mar-Apr;87(3-4):161-71.
  33. Partin AW, Van Neste L, Klein EA, Marks LS, Gee JR, Troyer DA, Rieger-Christ K, Jones JS, Magi-Galluzzi C3, Mangold LA, Trock BJ, Lance RS, Bigley JW, Van Criekinge W, Epstein JI. Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies. J Urol 2014 Oct;192(4):1081-7.
  34. Sfanos KS, Hempel HA, De Marzo AM. The role of inflammation in prostate cancer. Adv Exp Med Biol 2014;816:153-81.
  35. So JS, Epstein JI. Histologic features of pseudohyperplastic perineural invasion in prostatic adenocarcinoma: A mimicker of benign hyperplastic glands and high grade prostatic intraepithelial neoplasia. Am J Surg Pathol 2014 Jun;38(6):852-7.
  36. So J, Epstein JI. Variant of prostatic adenocarcinoma with paneth cell-like neuroendocrine differentiation readily misdiagnosed as gleason pattern 5. Hum Pathol 2014 Dec;45:2388-93.
  37. Tan HL, Sood A, Rahimi HA, Wang W, Gupta N, Hicks J, Mosier S, Gocke CD, Epstein JI, Netto GJ, Liu W, Isaacs WB, De Marzo AM, Lotan TL. Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma. Clin Cancer Res 2014 Feb 15;20(4):890-903.
  38. Tian W, Latour M, Epstein JI. Endometrial stromal sarcoma involving the urinary bladder: a study of 6 cases. Am J Surg Pathol 2014 Jul;38(7):982-9.
  39. Wang CC, Al-Hussain TO, Epstein JI. Rosai-Dorfman disease (RDD) of the testis and kidney: Analysis of 5 cases. Histopathology 2014 Dec;65:908-16.
  40. Wang C, Carter HC, Epstein JI. Value of transition zone biopsy in active surveillance of prostate cancer. J Urol 2014 June;191(6):1755-9.
  41. Zhang M, Wah C, Epstein JI. Metastatic renal cell carcinoma to the urinary bladder: a report of 11 cases. Am J Surg Pathol. 2014 Nov;38(11):1516-21.

GYNECOLOGIC PATHOLOGY

  1. Ardighieri L, Zeppernick F, Hannibal CG, Vang R, Cope L, Junge J, Kjaer SK, Kurman RJ, Shih IeM. Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants. J Pathol 2014 Jan;232(1):16-22.
  2. Banet N, Descipio C, Murphy KM, Beierl K, Adams E, Vang R, Ronnett BM. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping. Mod Pathol. 2014 Feb;27(2):238-54.
  3. Davidson B, Abeler VM, Førsund M, Holth A, Yang Y, Kobayashi Y, Chen L, Kristensen GB, Shih IeM, Wang TL. Gene expression signatures of primary and metastatic uterine leiomyosarcoma. Hum Pathol 2014 Apr;45(4):691-700.
  4. Elwood H, Kim J, Yemelyanova A, Ronnett BM, Taube JM. Basal cell carcinomas of the vulva: high-risk human papillomavirus DNA detection, p16 and BerEP4 expression. Am J Surg Pathol 2014 Apr;38(4):542-7.
  5. Gao M, Wu RC, Herlinger AL, Yap K, Kim JW, Wang TL, Shih IeM. Identification of the NAC1-regulated genes in ovarian cancer. Am J Pathol 2014 Jan;184(1):133-40.
  6. Guan B, Suryo Rahmanto Y, Wu RC, Wang Y, Wang Z, Wang TL, Shih IeM. Roles of deletion of arid1a, a tumor suppressor, in mouse ovarian tumorigenesis. J Natl Cancer Inst 2014 July;106(7):dju146.
  7. Guan B, Wu RC, Zhu H, Blackshaw S, Shih IeM, Wang TL. Notch3 interactome analysis identified WWP2 as a negative regulator of notch3 signaling in ovarian cancer. PLoS Genet 2014 Oct;10(10):e1004751.
  8. Gunderson CC, Dutta S, Fader AN, Maniar KP, Nasseri-Nik N, Bristow RE, Diaz-Montes TP, Palermo R, Kurman RJ. Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy. Gynecol Oncol 2014 Jan;132(1):33-7.
  9. Gurda GT, Baras AS, Kurman RJ. Ki-67 index as an ancillary tool in the differential diagnosis of proliferative endometrial lesions with secretory change. Int J Gynecol Pathol 2014 Mar;33(2):114-9.
  10. Jung JG, Stoeck A, Guan B, Wu RC, Zhu H, Blackshaw S, Shih IeM, Wang TL. Notch3 Interactome Analysis Identified WWP2 as a Negative Regulator of Notch3 Signaling in Ovarian Cancer. PLoS Genet 2014 Oct 30;10(10):e1004751.
  11. Kang TH, Knoff J, Yeh WH, Yang B, Wang C, Kim YS, Kim TW, Wu TC, Hung CF. Treatment of tumors with vitamin E suppresses myeloid derived suppressor cells and enhances CD8+ T cell-mediated antitumor effects. PLoS One. 2014 Jul 29;9(7):e103562.
  12. Knoff J, Yang B, Hung CF, Wu TC. Cervical cancer: development of targeted therapies beyond molecular pathogenesis. Curr Obstet Gynecol Rep 2014 Mar 1;3(1):18-32.
  13. Kuhn E, Ayhan A, Shih IeM, Seidman JD, Kurman RJ. The pathogenesis of atypical proliferative Brenner tumor: an immunohistochemical and molecular genetic analysis. Mod Pathol 2014 Feb;27(2):231-7.
  14. Kurman RJ, Shih IeM. Discovery of a cell: reflections on the checkered history of intermediate trophoblast and update on its nature and pathologic manifestations. Int J Gynecol Pathol. 2014 Jul;33(4):339-47.
  15. Maniar KP, Wang Y, Visvanathan K, Shih IM, Kurman RJ. Evaluation of microinvasion and lymph node involvement in ovarian serous borderline/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37 cases. Am J Surg Pathol. 2014 Jun;38(6):743-55.
  16. Nik NN, Vang R, Shih IeM, Kurman RJ. Origin and pathogenesis of pelvic (ovarian, tubal and primary peritoneal) serous carcinoma. Annu Rev Pathol 2014 Jan 24;9:27-45.
  17. Peng S, Song L, Knoff J, Wang JW, Chang YN, Hannaman D, Wu TC, Alvarez RD, Roden RB, Hung CF. Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells. Cell Biosci. 2014 Mar 4;4(1):11.
  18. Song L, Yang MC, Knoff J, Sun ZY, Wu TC, Hung CF. Cancer immunotherapy using a potent immunodominant CTL epitope. Vaccine. 2014 Oct;32(46):6039-48.
  19. Song L, Yang MC, Knoff J, Wu TC, Hung CF. Cancer immunotherapy employing an innovative strategy to enhance CD4+ T cell help in the tumor microenvironment. PLoS One. 2014 Dec;9(12):e115711.
  20. Soong RS, Song L, Trieu J, Knoff J, He L, Tsai YC, Huh W, Chang YN, Cheng WF, Roden RB, Wu TC, Trimble CL, Hung CF. Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract Leading to tumor control through IFNγ. Clin Cancer Res. 2014 Nov 1;20(21):5456-67.
  21. Soong RS, Song L, Trieu J, Lee SY, He L, Tsai YC, Wu TC, Hung CF. Direct T cell activation via CD40 ligand generates high avidity CD8+ T cells capable of breaking immunological tolerance for the control of tumors. PLoS One. 2014 Mar 24;9(3):e93162.
  22. Wang JW, Jagu S, Kwak K, Wang C, Peng S, Kirnbauer R, Roden RB. Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies. Virology 2014 Jan 20;449:304-16.
  23. Wu CY, Yang LH, Yang HY, Knoff J, Peng S, Lin YH, Wang C, Alvarez RD, Pai SI, Roden RB, Hung CF, Wu TC. Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumors. Clin Cancer Res. 2014 Feb 1;20(3):644-57.
  24. Wu RC, Ayhan A, Maeda D, Kim KR, Clarke BA, Shaw P, Chui MH, Rosen B, Shih IeM, Wang TL. Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy. J Pathol 2014 Mar;232(4):473-81.
  25. Wu RC, Wang TL, Shih IeM. The emerging roles of ARID1A in tumor suppression. Cancer Biol Ther. 2014 Jun;15(6):655-64.
  26. Yang B, Jeang J, Yang A, Wu TC, Hung CF. DNA vaccine for cancer immunotherapy. Hum Vaccin Immunother. 2014;10(11):3153-64.
  27. Yeh CT, Liang KH, Lin CC, Chang ML, Hsu CL, Hung CF. A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma. Int J Cancer 2014 Mar 1;134(5):1214-24.
  28. Yemelyanova A, Gown AM, Wu LS, Holmes BJ, Ronnett BM, Vang R. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations. Int J Gynecol Pathol 2014 Sep;33(5):492-9.

HEMATOLOGIC PATHOLOGY

  1. Borowitz MJ. Mixed phenotype acute leukemia. Cytometry B Clin Cytom. 2014 May;86(3):152-3.
  2. Crane GM, Ambinder RF, Shirley CM, Fishman EK, Kasamon YL, Taube JM, Borowitz MJ, Duffield AS. HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma. Am J Surg Pathol 2014 Mar;38(3):426-32.
  3. Crane GM, Xian RR, Burns KH, Borowitz MJ, Duffield AS, Taube JM. Primary effusion lymphoma presenting as a cutaneous intravascular lymphoma. J Cutan Pathol 2014 Dec;41(12):928-35.
  4. Monroe AK, Butler NJ, Duffield AS. Sclerouveitis associated with Rosai-Dorfman Disease in an HIV-infected patient. Ocul Immunol Inflamm 2014 Jun;22(3):236-8.
  5. Rodić N, Sharma R, Sharma R, Zampella J, Dai L, Taylor MS, Hruban RH, Iacobuzio-Donahue CA, Maitra A, Torbenson MS, Goggins M, Shih IM, Duffield AS, Montgomery EA, Gabrielson E, Netto GJ, Lotan TL, De Marzo AM, Westra W, Binder ZA, Orr BA, Gallia GL, Eberhart CG, Boeke JD, Harris CR, Burns KH. Long interspersed element-1 protein expression is a hallmark of many human cancers. Am J Pathol 2014 May;184(5):1280-6.

IMMUNOLOGY

  1. Caturegli P, De Remigis A, Rose NR.Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmun Rev. 2014 Apr-May;13(4-5):391-7
  2. Chin MS, Hooper LC, Hooks JJ, Detrick B. Identification of ∝-fodrin as an autoantigen in experimental coronavirus retinopathy (ECOR). J Neuroimmunol 2014 Jul 15;272(1-2):42-50.
  3. Chiu YL, Shan L, Huang H, Haupt C, Bessell C, Canaday DH, Zhang H, Ho YC, Powell JD, Oelke M, Margolick JB, Blankson JN, Griffin DE, Schneck JP. Sprouty-2 regulates HIV-specific T cell polyfunctionality. J Clin Invest 2014 Jan 2;124(1):198-208.
  4. Gocke CD. c-Myc immunohistochemistry in diffuse large B cell lymphoma. Pathol Case Revs 2014 Sept/Oct;19(5):234-8.
  5. Grunwald MR, Tseng LH, Lin MT, Pratz KW, Eshleman JR, Levis MJ, Gocke CD. Improved FLT3 internal tandem duplication PCR assay predicts outcome after allogeneic transplant for acute myeloid leukemia. Biol Blood Marrow Transplant. 2014 Dec;20(12):1989-95.
  6. Iwama S, De Remigis A, Callahan MK, Slovin SF, Wolchok JD, Caturegli P. Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody. Sci Transl Med 2014 Apr;6(230):230ra45.
  7. Karafin MS, Humphrey RL, Detrick B. Evaluation of monoclonal and oligoclonal gammopathies in a pediatric population in a major urban center. Am J Clin Pathol. 2014 Apr;141(4):482-7.
  8. Kim A, Hartman IZ, Poore B, Boronina T, Cole RN, Song N, Ciudad MT, Caspi RR, Jaraquemada D, Sadegh-Nasseri S. Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources. Nat Commun 2014 Nov;5:5369.
  9. Nagineni CN, Raju R, Nagineni KK, Kommineni VK, Cherukuri A, Kutty RK, Hooks JJ, Detrick B. Resveratrol suppresses expression of VEGF by human retinal pigment epithelial cells: potential nutraceutical for age-related macular degeneration. Aging Dis 2014 Apr;5(2):88-100.
  10. Outschoorn IM, Talor MV, Burek CL, Hoffman WH, Rose NR. Heritability analysis of IgG4 antibodies in autoimmune thyroid disease. Autoimmunity 2014 Aug;47(5):320-6.
  11. Perez-Munoz ME, Bergstrom K, Peng V, Schmaltz R, Jimenez-Cardona R, Marsteller N, McGee S, Clavel T, Ley R, Xia L, Peterson DA. Discordance between changes in the gut microbiota and pathogenicity in a mouse model of spontaneous colitis. Gut Microbes. 2014 May;5(3):286-95.
  12. Perica K, Medero ADL, Malarvizhi D, Chiu Y-L, Bieler JG, Niemöller M, Assenmacher M, Richter A, Edidin M, Oelke M, Schneck JP. Nanoscale artificial antigen presenting cells for T cell immunotherapy. Nanomedicine 2014 Jan;10(1):119-29.
  13. Perica K, Tu A, Richter A, Bieler JG, Edidin M, Schneck JP. Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activity. ACS Nano.2014 Mar 25;8(3):2252-60.
  14. Rose NR. Learning from myocarditis: mimicry, chaos and black holes. F1000Prime Rep. 2014 May;6:25.
  15. Schroeder LF, Amukele T. Medical laboratories in sub-Saharan Africa that meet international quality standards. Am J Clin Pathol 2014 Jun;141(6):791-5.
  16. Schütz C, Fleck M, Schneck JP, Oelke M. Killer artificial antigen presenting cells (KaAPC) for efficient in vitro depletion of human antigen-specific T cells. J Vis Exp 2014 Aug 11;(90).
  17. Sunshine JC, Perica K, Schneck JP, Green JJ. Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells. Biomaterials 2014 Jan;35(1):269-77.
  18. Wu L, Ong S, Talor MV, Barin JG, Baldeviano GC, Kass DA, Bedja D, Zhang H, Sheikh A, Margolick JB, Iwakura Y, Rose NR, Čiháková D. Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J Exp Med 2014 Jun;211(7):1449-64.

INFORMATICS

None reported.

MEDICAL MICROBIOLOGY

  1. Kuo IC, Espinosa C, Forman M, Pehar M, Maragakis LL, Valsamakis A. Detection and prevalence of adenoviral conjunctivitis among hospital employees using real-time polymerase chain reaction as an infection prevention tool. Infect Control Hosp Epidemiol. 2014 Jun;35(6):728-31.
  2. Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, Mwatha A, Eshleman SH, Richardson P, Allen M, George K, Andrew P, Zwerski S, Mofenson LM, Jackson JB; HPTN 046 Protocol Team. Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial. J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):366-74.
  3. Liu CM, Osborne BJ, Hungate BA, Shahabi K, Huibner S, Lester R, Dwan MG, Kovacs C, Contente-Cuomo TL, Benko E, Aziz M, Price LB, Kaul R. The semen microbiome and its relationship with local immunology and viral load in HIV infection. PLoS Pathog 2014 Jul 24;10(7):e1004262.
  4. Matovu JN, Onyango-Makumbi C, Namuli PE, Tanga EO, Kagawa MN, Nalwadda GK, Motevalli M, Semitala FC, O'Gara ET, Fowler MG. WHO 2010 infant feeding guidelines in resource-limited settings: attitudes of human immunodeficiency virus-infected women and other role players in Kampala, Uganda. S African J of Clin Nutrition Apr 2014;27(2):63-8.
  5. Riedel S. The value of postmortem microbiology cultures. J Clin Microbiol 2014 Apr;52(4):1028-33.
  6. Riedel S, Neoh KM, Eisinger SW, Dam LM, Tekle T, Carroll KC. Comparison of commercial antimicrobial susceptibility test methods for testing of Staphylococcus aureus and Enterococci against vancomycin, daptomycin, and linezolid. J Clin Microbiol 2014 June;52(6):2216-22.
  7. Salimnia H, Fairfax MR, Lephart P, Morgan M, Gilbreath JJ, Butler-Wu SM, Templeton KE, Hamilton FJ, Wu F, Buckner R, Fuller D, Davis TE, Abdelhamed AM, Jacobs MR, Miller A, Pfrommer B, Carroll KC. An international, prospective, multicenter evaluation of the combination of AdvanDx Staphylococcus QuickFISH BC with mecA XpressFISH for detection of methicillin-resistant Staphylococcus aureus isolates from positive blood cultures. J Clin Microbiol 2014 Nov;52(11):3928-32.
  8. Schieffer KM, Tan KE, Stamper PD, Somogyi A, Andrea SB, Wakefield T, Romagnoli M, Chapin KC, Wolk DM, Carroll KC. Multicenter evaluation of the SepsityperTM extraction kit and MALDI-TOF MS for direct identification of positive blood culture isolates using the BD BACTECTM FX and VersaTREK(®) diagnostic blood culture systems. J Appl Microbiol 2014 Apr;116(4):934-41.
  9. Sue PK, Gurda GT, Richard Lee R, Watkins T, Green R, Memon W, Milstone AM, Zelazny AM, Fahle GA, Pham TA, Gibas CF, Sutton DA, Wickes BL, Wiederhold NP, Zhang SX. First report of Westerdykella dispersa as a cause of an angioinvasive fungal infection in a neutropenic host. J Clin Microbiol 2014 Dec;52(12):4407-11.
  10. Suwantarat N, Carroll KC, Tekle T, Ross T, Maragakis LL, Cosgrove SE, Milstone AM. High prevalence of reduced chlorhexidine susceptibility in organisms causing central line associated blood stream infections. Infect Control Hosp Epidemiol. 2014 Sep;35(9):1183-6.
  11. Suwantarat N, Lee R, Carroll KC, Zhang SX. Questionable utility of galactomannan testing for diagnosis of Exserohilum rostratum infection. J Clin Microbiol 2014 Jul;52(7):2742-3.
  12. Suwantarat N, Roberts A, Prestridge J, Seeley R, Speser S, Harmon C, Zhang C, Henciak S, Stamper PD, Ross T, Carroll KC. Comparison of five chromogenic media for recovery of vancomycin-resistant enterococci from fecal samples. J Clin Microbiol 2014 Nov;52:4039-42
  13. Suwantarat N, Romagnoli M, Wakefield T, Carroll KC. Ventriculoperitoneal shunt infection caused by Bifidobacterium breve. Anaerobe 2014 Aug;28:1-3.
  14. Suwantarat N, Watkins T, Lee R, Carroll KC, Zhang SX. False positive reaction of L-canavanine glycine bromothymol blue medium with candida famata. J Clin Microbiol 2014 Apr;52(4):1308-9 (letter).

MOLECULAR PATHOLOGY

  1. Dudley JC, Gurda GT, Tseng LH, Anderson DA, Chen G, Taube JM, Gocke CD, Eshleman JR, Lin MT. Tumor cellularity as a quality assurance measure for accurate clinical detection of BRAF mutations in melanoma. Mol Diagn Ther. 2014 Aug;18(4):409-18.
  2. Henderson LB, Applegate CD, Wohler E, Sheridan MB, Hoover-Fong J, Batista DA. The impact of chromosomal microarray on clinical management: a retrospective analysis. Genet Med. 2014 Sep;16(9):657-64.
  3. Lee RW, Bodurtha J, Cohen J, Fatemi A, Batista D. Deletion 12p12 involving SOX5 in two children with developmental delay and dysmorphic features. Pediatr Neurol 2013 Apr;48(4):317-20.
  4. Lin MT, Mosier SL, Thiess M, Beierl KF, Debeljak M, Tseng LH, Chen G, Yegnasubramanian S, Ho H, Cope L, Wheelan SJ, Gocke CD, Eshleman JR. Clinical Validation of KRAS, BRAF and EGFR Mutation Detection using Next Generation Sequencing. Am J Clin Pathol 2014 June;141(6):856-66.
  5. Ning Y, Slovak ML, Schultz RA, Gojo I, Baer MR. Cryptic chromosome abnormalities in a patient with mixed phenotype acute leukemia. Leuk Lymphoma 2014 Mar;55(3):680-2.
  6. Olson MT, Harrington C, Beierl K, Chen G, Thiess M, O'Neill A, Taube J, Zeiger MA, Lin MT, Eshleman JR. BRAF pyrosequencing analysis aided by a lookup table. Am J Clin Pathol 2014 May;141:639-47.
  7. Tseng LH, Tang JL, Haley L, Beierl K, Gocke CD, Eshleman JR, Lin MT. Microsatellite instability confounds engraftment analysis of hematopoietic stem-cell transplantation. Appl Immunohistochem Mol Morphol 2014 Jul;22(6):416-20.

NEUROPATHOLOGY

  1. Ahsan S, Raabe EH, Haffner MC, Vaghasia A, Warren KE, Quezado M, Ballester LY, Nazarian J, Eberhart CG, Rodriguez FJ. Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma. Acta Neuropathol Commun 2014 Jun 3;2(1):59.
  2. Andrilopoulou E, Ellis CL, Crain BJ. 63-year-old woman with dysphonia, dysphagia, and sleep apnea. Brain Pathol 2014 Jul;24(4):423-4.
  3. Batra VV, Mines M, Rodriguez FJ. Diagnostic Review of Neurofibromatosis Type 1. Path Case Reviews 2013 Mar/Apr;19(2):57-65.
  4. Blue ME, Wilson M, Beaty CA, George TJ, Arnaoutakis GJ, Haggerty KA, Jones M, Brawn J, Manmohan S, Lange MS, Johnston MV, Baumgartner WA, Troncoso JC. Brain injury in canine models of cardiac surgery. J Neuropathol Exp Neurol 2014 Dec;73(12):1134-43.
  5. Codispoti K, Mosier S, Ramsey R, Lin MT, Rodriguez FJ. Genetic and Pathologic Evolution of Early Secondary Gliosarcoma. Brain Tumor Pathol 2014 Jan;31(1):40-6.
  6. Ding D, Lim KS, Eberhart CG. Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres. Acta Neuropathol Commun 2014 Mar 31;2(1):31.
  7. Fayzullina A, Martin LJ. Skeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA). PLoS One. 2014 Mar;9(3):e93329.
  8. Ho CY, Troncoso JC, Knox D, Stark W, Eberhart CG. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients. Brain Pathol 2014 Jan;24(1):25-32.
  9. Iacono D, Resnick SM, O'Brien R, Zonderman AB, An Y, Pletnikova O, Rudow G, Crain B, Troncoso JC. Mild cognitive impairment and asymptomatic Alzheimer Disease subjects: equivalent beta-amyloid and tau loads with divergent cognitive outcomes. J Neuropathol Exp Neurol 2014 Apr;73(4):295-304.
  10. Mahairaki V, Ryu J, Peters A, Chang Q, Li T, Park TS, Burridge PW, Talbot CC Jr, Asnaghi L, Martin LJ, Zambidis ET, Koliatsos VE. Induced pluripotent stem cells from familial Alzheimer's disease patients differentiate into mature neurons with amyloidogenic properties. Stem Cells Dev. 2014 Dec 15;23(24):2996-3010.
  11. Martin LJ, Semenkow S, Hanaford A, Wong M. The mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice. Neurobiol Aging 2014 May;35:1132-52.
  12. Orr BA, Gallia GL, Dogan A, Rodriguez FJ. IgA/kappa-restricted crystal storing histiocytosis involving the central nervous system characterized by proteomic analysis. Clin Neuropathol 2014 Jan-Feb;33(1):23-8.
  13. Rodriguez FJ, Raabe EH. mTOR: a new therapeutic target for pediatric low-grade glioma? CNS Oncol 2014 Mar;3(2):89-91.
  14. Rodriguez EF, Sepah YJ, Jang HS, Ibrahim M, Nguyen QD, Rodriguez FJ. Cytologic features in vitreous preparations of patients with suspicion of intraocular lymphoma. Diagn Cytopathol. 2014 Jan;42(1):37-44.
  15. Rodriguez FJ, Tihan T, Lin D, McDonald W, Nigro J, Feuerstein B, Jackson S, Cohen K, Burger PC. Clinicopathologic Features of Pediatric Oligodendrogliomas. Am J Surg Pathol 2014 Aug;38(8):1058-70.
  16. Rossi SL, Mahairaki V, Zhou L, Song Y, Koliatsos VE. Remodeling of the piriform cortex after lesion in adult rodents. Neuroreport. 2014 Sep 10;25(13):1006-12.
  17. Ryu J, Horkayne-Szakaly I, Xu L, Pletnikova O, Leri F, Eberhart C, Troncoso JC, Koliatsos VE. The problem of axonal injury in the brains of veterans with histories of blast exposure. Acta Neuropathol Commun. 2014 Nov;2(1):153.
  18. Vizcaíno MA, Caccamo DV, Fox E, Rodriguez FJ. Pleomorphic xanthoastrocytoma: report of two cases with unconventional clinical presentations. Clin Neuropathol 2014 Nov/Dec;33(6):380-7.

OPHTHALMIC PATHOLOGY

  1. AlWadani S, Robinson S, Myers R, Akpek EK, Eberhart CG. No increase in IgG4-positive plasma cells in limbal Rosai-Dorfman disease. Cornea 2014 Aug;33(8):844-7.
  2. Asnaghi L, Alkatan H, Mahale A, Othman M, Alwadani S, Al-Hussain H, Jastaneiah S, Yu W, Maktabi A, Edward DP, Eberhart CG. Identification of multiple DNA copy number alterations including frequent 8p11.22 amplification in conjunctival squamous cell carcinoma. Invest Ophthalmol Vis Sci. 2014 Dec 9;55(12):8604-13.
  3. Asnaghi L, Lin MH, Lim KS, Lim KJ, Tripathy A, Wendeborn M, Merbs SL, Handa JT, Sodhi A, Bar EE, Eberhart CG. Hypoxia promotes uveal melanoma invasion through enhanced notch and MAPK activation. PlosOne 2014 Aug28;9(8):e105372.
  4. Cameron JD, Rodriguez FJ, Rushing E, Horkayne-Szakaly I, Eberhart C. An 80-year experience with optic nerve glioma cases at the Armed Forces Institute of Pathology: evolution from museum to molecular evaluation suggests possibe interventions in the cellular senescence and microglial pathways (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2014;112:11-25.
  5. Rajaii F, Asnaghi L, Enke R, Merbs SL, Handa JT, Eberhart CG. The demethylating agent 5-Aza reduces the growth, invasiveness, and clonogenicity of uveal and cutaneous melanoma. Invest Ophthalmol. Vis Sci 2014;55(10):6178-86.
  6. Rajan Kd A, Burris C, Iliff N, Grant M, Eshleman JR, Eberhart CG. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma. Am J Ophthalmol 2014 Mar;157(3):640-7.e1-2.

SURGICAL PATHOLOGY

  1. Asch-Kendrick RJ, Samols MA, Lilo MT, Subhawong AP, Sharma R, Illei PB, Argani P, Cimino-Mathews A. NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. J Clin Pathol 2014 Sep;67(9):768-71.
  2. Belchis DA. Cancer: it's all in the family. Pathol Case Revs 2014 Mar/Apr;19(2):41-2.
  3. Belchis DA. Lymphangioleiomyomatosis is a systemic disorder related to mutated tuberous sclerosis complex. Pathol Case Revs 2014 Mar/Apr;19(2):101-5.
  4. Bishop JA. Editorial: Capturing human papillomavirus status: utilizing liquid-phase HPV assays on FNAs of metastatic head and neck cancers. J Am Soc of Cytopathol 2014 Jul-Aug;3(4):171-2.
  5. Bishop JA. Non-squamous variants of human papillomavirus-related head and neck carcinoma. Diagn Histopathol 2014 Aug;20(8):301-7.
  6. Bishop JA, Antonescu CR, Westra WH. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract. Am J Surg Pathol. 2014 Sep;38(9):1282-9.
  7. Belchis D, Cowan M, Mortman K, Rezvani B. Adenocarcinoma arising in an extralobar sequestration: a case report and review of the literature. Lung Cancer 2014 Apr;84(1):92-5.
  8. Bishop JA, Montgomery EA, Westra WH. Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes. Am J Surg Pathol. 2014 Feb;38(2):257-64.
  9. Bishop JA, Yonescu R, Batista D, Warnock GR, Westra WH. Glandular odontogenic cysts (GOCs) lack MAML2 rearrangements: a finding to discredit the putative nature of GOC as a precursor to central mucoepidermoid carcinoma. Head Neck Pathol 2014 Sep;8(3):287-90.
  10. Bishop JA, Yonescu R, Batista D, Yemelyanova A, Ha PK, Westra WH. Mucoepidermoid carcinoma does not harbor transcriptionally active high risk human papillomavirus even in the absence of the MAML2 translocation. Head Neck Pathol 2014 Sep;8(3):298-302.
  11. Cimino-Mathews A, Sharma R, Illei PB, Vang R, Argani P. A subset of malignant phyllodes tumors express p63 and p40: a diagnostic pitfall in breast core needle biopsies. Am J Surg Pathol. 2014 Dec;38(12):1689-96.
  12. Ellis CL, Eble JN, Subhawong AP, Martignoni G, Zhong M, Ladanyi M, Epstein JI, Netto GJ, Argani P.
  13. Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage. Mod Pathol 2014 Jun;27(6):875-86.
  14. Gonzalez-Roibon N, Faraj SF, Munari E, Bezerra SM, Albadine R, Sharma R, Argani P, Allaf ME, Netto GJ. Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms. Hum Pathol 2014 Feb;45(2):244-8.
  15. Holmes BJ, Westra WH. The expanding role of cytopathology in the diagnosis of HPV-related squamous cell carcinoma of the head and neck. Diagn Cytopathol 2014 Jan;42(1):85-93.
  16. Lee S, Han JS, Chang A, Ross HM, Montironi R, Yorukoglu K, Lane Z, Epstein JI. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases. Hum Pathol 2013 Mar;44(3):427-31.
  17. Poling JS, Ma XJ, Bui S, Luo Y, Koch WM, Westra WH. Human papillomavirus (HPV) status of non-tobacco related squamous cell carcinomas of the lateral tongue. Oral Oncol 2014 Apr;50(4):306-10.
  18. Poling JS, Tsangaris TN, Argani P, Cimino-Mathews A. Frozen section evaluation of breast carcinoma sentinel lymph nodes: a retrospective review of 1,940 cases. Breast Cancer Res Treat 2014 Nov;148(2):355-61.
  19. Smith NE, Deyrup AT, Mariño-Enriquez A, Fletcher JA, Bridge JA, Illei PB, Netto GJ, Argani P. VCL-ALK Renal cell carcinoma in children with sickle-cell trait: the eighth Sickle-cell Nephropathy? Am J Surg Pathol 2014 Jun;38(6):858-63.
  20. Smith NE, Illei PB, Allaf M, Gonzalez N, Morris K, Hicks J, Demarzo A, Reuter VE, Amin MB, Epstein JI, Netto GJ, Argani P. t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases. Am J Surg Pathol 2014 May;38(5):604-14.
  21. Tilson MP, Bishop JA. Utility of p40 in the differential diagnosis of small round blue cell tumors of the sinonasal tract. Head Neck Pathol 2014 Jun;8(2):141-5
  22. Tilson MP, Gallia GL, Bishop JA. Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas. Head Neck Pathol 2014 Mar;8(1):59-65
  23. Westra WH. Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral Oncol 2014 Sep;50(9):771-9.
  24. Xing M, Liu R, Liu X, Murugan AK, Zhu G, Zeiger MA, Pai S, Bishop J. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol. 2014 Sep 1;32(25):2718-26

TRANSFUSION MEDICINE

  1. Chen I, Cummings V, Fogel JM, Marzinke MA, Clarke W, Connor MB, Griffith S, Buchbinder S, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH. Low-level Viremia early in HIV infection. J Acquir Immune Defic Syndr 2014 Dec 1;67(4):405-8.
  2. Coates TJ, Kulich M, Zelaya CE, Celantano DD, Chariyalertsak S, Chingono A, Gray G, Mbwambo JKK, Morin FS, Richter L, Sweat M, van Rooven H, McGrath N, Fiamma A, Laeyendecker O, Piwowar-Manning E, Szerekes G, Donnell D, Eshleman SH. Outcomes from NIMH Project Accept (HPTN 043): A cluster-randomized trial of community mobilization, mobile HIV testing, post-test support services, and real-time performance feedback. Lancet Global Health 2014 May;2:e267-e277.
  3. Cousins MM, Konikoff J, Laeyendecker O, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH. HIV diversity as a biomarker for HIV incidence estimation: including a high resolution melting diversity assay in a multi-assay algorithm. J Clin Microbiol 2014 Jan;52(1):115-21.
  4. Cousins MM, Konikoff J, Sabin D, Khaki L, Longosz AF, Laeyendecker O, Celum C, Buchbinder SP, Seage GR III, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH. A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation. PLoS One 2014 Jun 26;9(6):e101043.
  5. Frank SM, Oleyar MJ, Ness PM, Tobian AA. Reducing unnecessary preoperative Blood orders and costs by implementing an updated institution-specific maximum surgical blood order schedule and a remote electronic blood release system. Anesthesiology 2014 Sep;121(3):501-9.
  6. Grabowski MK, Gray RH, Serwadda D, Kigozi G, Gravitt PE, Nalugoda F, Reynolds SJ, Wawer MJ, Watya S, Quinn TC, Tobian AAR. High risk human papillomavirus viral load and persistence among HIV-negative and HIV-positive men. Sex Transm Infect 2014 Jun;90(4):337-43.
  7. Kacker S, Frick KD, Gaydos CA, Tobian AAR. Male circumcision cost-effective articles ignore methodological problems and ethical concerns - reply. JAMA Pediatr 2013;167:198-200.
  8. Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AAR. Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients. Transfusion 2014 Jan;54(1):86-97.
  9. Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA. Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease. Transfusion. 2014 Aug;54(8):2034-44.
  10. Katz LM, Tobian AAR. Ebola virus disease, transmission risk to laboratory personnel and pretransfusion testing. Transfusion Dec 2014;54:3247-51.
  11. Marzinke MA, Clarke W, Wang L, Cummings V, Liu TY, Piwowar-Manning E, Breaud A, Griffith S, Buchbinder S, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Fields SD, Mayer KH, Wheeler DP, Koblin BA, Eshleman SH, Fogel JM. Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clin Infect Dis 2014 Jan;58(1):117-20.
  12. Moore R, Blankson JN, Eshleman SH. Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening. HIV Clin Trials 2014 Mar;15(2):62-8.
  13. Morris BJ, Tobian AA. Circumcision is a religious/cultural procedure, not a medical procedure-reply. JAMA Pediatr 2014 Mar 1;168(3):294.
  14. Pagano MB, Murinson BB, Tobian AAR, King KE. Efficacy of therapeutic plasma exchange for treatment of stiff-person syndrome. Transfusion 2014 July;54(7):1851-6.
  15. Piwowar-Manning E, Fogel JM, Laeyendecker O, Wolf S, Cummings V, Marzinke M, Clarke W, Breaud A, Wendel S, Wang L, Swanson P, Hackett J, Jr., Mannheimer S, del Rio C, Kuo I, Harawa NT, Koblin BA, Moore R, Blankson JN, Eshleman SH. Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening. HIV Clin Trials. 2014 Mar-Apr;15(2):62-8.
  16. Redd AD, Tobian AAR. The death of HIV long-term non-progression? Lancet HIV 2014 Oct;1:e8-e9.
  17. Savage WJ, Hamilton R, Tobian AAR, Milne G, Kaufman RM, Savage JH, Borge D, Ness PM. Defining risk factors and presentation of allergic reactions to platelet transfusion. J Allergy Clin Immunol 2014 Jun;133(6):1772-5.e9.
  18. Tobian AAR, Fuller AK, Uglik K, Tisch DJ, Borge PD, Benjamin RJ, Ness PM, King KE. The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment. Transfusion. 2014 Jun;54(6):1523-9.
  19. Tobian AA, Gaydos C, Gray RH, Kigozi G, Serwadda D, Quinn N, Grabowski MK, Musoke R, Ndyanabo A, Nalugoda F, Wawer MJ, Quinn TC. Male circumcision and Mycoplasma genitalium infection in female partners: a randomised trial in Rakai, Uganda. Sex Transm Infect 2014 Mar;90(2):150-4.
  20. Tobian AA, Kacker S, Quinn TC. Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections. Annu Rev Med 2014 Jan;65:293-306.
  21. Tobian AAR, Quinn TC. Prevention of syphilis: another positive benefit for male circumcision. Lancet Glob Health 2014 Nov;2(11):e623-4.


2013 Publications +

AUTOPSY

  1. Burton EC, Mossa-Basha M. To image or to autopsy? Ann Intern Med 2012 Jan17;156(2)158-9.
  2. Gibbs WN, Opatowsky MJ, Burton EC. AIRP best cases in radiologic-pathologic correlation: cerebral fat embolism syndrome in sickle cell β-thalassemia. Radiographics. 2012 Sep-Oct;32(5):1301-6.

CARDIOVASCULAR PATHOLOGY

  1. Kent OA, Fox-Talbot K, Halushka MK. RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets. Oncogene 2013 May 16;32(20):2576-85.
  2. Maleszewski JJ, Murray DL, Dispenzieri A, Grogan M, Pereira NL, Jenkins SM, Judge DP, Caturegli P, Vrana JA, Theis JD, Dogan A, Halushka MK. Relationship between monoclonal gammopathy and cardiac amyloid type. Cardiovasc Pathol 2013 May-Jun;22(3):189-94.
  3. Murphy E, Steenbergen C. Did a classic preconditioning study provide a clue to the identity of the mitochondrial permeability transition pore? Circ Res 2013 Sep 13;113(7):852-5.
  4. Park JK, Rosen A, Saffitz JE, Asimaki A, Litovsky SH, Mackey-Bojack SM, Halushka MK. Expression of cathepsin K and tartrate-resistant acid phosphatase is not confined to osteoclasts but is a general feature of multinucleated giant cells: systematic analysis. Rheumatology (Oxford) 2013 Aug;52(8):1529-33.
  5. Selvin E, Coresh J, Halushka MK.. Response to comments on: Selvin et al. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes 2013;62:2116–21. Diabetes 2013 Oct;62(10):e27.
  6. Vander Heide RS, Steenbergen C. Cardioprotection and myocardial reperfusion: pitfalls to clinical application. Circ Res 2013 Aug;113(4):464-77.

CLINICAL CHEMISTRY

  1. Breaud AR, Henemyre-Harris CL, Schools S, Emezienna N, Clarke W. Rapid quantification of the aminoglycoside arbekacin in serum using high performance liquid chromatography-tandem mass spectrometry. Clin Chim Acta 2013 Mar 15;418:102-6.
  2. Clarke W, Rhea JM, Molinaro R. Challenges in implementing clinical liquid chromatography-tandem mass spectrometry methods - seeing the light at the end of the tunnel. J Mass Spectrom 2013 Jul;48(7):755-67.
  3. Fuzery AK, Breaud AR, Emezienna N, Schools S, Clarke W. A rapid and reliable method for the quantitation of hydroxychloroquine in serum using turbulent flow liquid chromatography-tandem mass spectrometry. Clin Chim Acta 2013 June;421:79-84.
  4. Fuzery AK, Levin J, Chan MM, Chan DW. Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges. Clin Proteomics 2013 Oct;10(1):13.
  5. Li D, Chiu H, Chen J, Zhang H, Chan DW. Integrated analyses of proteins and their glycans in a magnetic bead-based multiplex assay format. Clin Chem 2013 Jan;59(1):315-24.
  6. Li D, Chiu H, Zhang H, Chan DW. Analysis of serum protein glycosylation by a differential lectin immunosorbant assay (dLISA). Clin Proteomics 2013 Sep 9;10(1):12.
  7. Li QK, Gabrielson E, Askin F, Chan DW, Zhang H. Glycoproteomics using so-called 'fluid-biopsy' specimens in the discovery of lung cancer biomarkers. Promise and challenge. Proteomics Clin Appl 2013 Jan;7(1-2):55-69.
  8. Li QK, Shah P, Li Y, Aiyetan PO, Chen J, Yung R, Molena D, Gabrielson E, Askin F, Chan DW, Zhang H. Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma. J Proteome Res 2013 Aug;12(8):3689–96.
  9. Marzinke MA, Breaud AR, Clarke W. The development and clinical validation of a turbulent-flow liquid chromatography-tandem mass spectrometric method for the rapid quantitation of docetaxel in serum. Clin Chim Acta 2013 Feb 18;417:12-8.
  10. Marzinke MA, Choi CH, Chen L, Shih IeM, Chan DW, Zhang H. Proteomic analysis of temporally stimulated ovarian cancer cells for biomarker discovery. Mol Cell Proteomics 2013 Feb;12(2):356-68.
  11. Olson MT, Breaud A, Harlan R, Emezienna N, Schools S, Yergey AL, Clarke W. Alternative calibration strategies for the clinical laboratory: application to Nortriptyline therapeutic drug monitoring. Clin Chem 2013 Jun;59(6):920-7.
  12. Seserko LA, Emory JF, Hendrix CW, Marzinke MA. The development and validation of an UHPLC-MS/MS method for the rapid quantification of the antiretroviral agent dapivirine in human plasma. Bioanalysis 2013 Nov;5(22):2771-83.
  13. Shah P, Yang S, Sun S, Aiyetan P, Yarema KJ, Zhang H. Mass spectrometric analysis of sialylated glycans with use of solid-phase labeling of sialic acids. Anal Chem 2013 Apr 2;85(7):3606-13.
  14. Sun S, Zhang B, Aiyetan P, Zhou JY, Shah P, Yang W, Levine DA, Zhang Z, Chan DW, Zhang H. Analysis of N-glycoproteins using genomic N-glycosite prediction. J Proteome Res 2013 Dec 6;12(12):5609-15.

CYTOPATHOLOGY

  1. Ali SZ, Fish SA, Lanman R, Randolph GW, Sosa JA. Use of the afirma® gene expression classifier for preoperative identification of benign thyroid nodules with indeterminate fine needle aspiration cytopathology. PLoS Curr 2013 Feb 11;5.
  2. Bishop JA, Yonescu R, Batista DA, Westra WH, Ali SZ. Cytopathologic features of mammary analogue secretory carcinoma. Cancer Cytopathol 2013 May;121(5):228-33.
  3. Bishop JA, Zhang W, Ioffe OB, Ali SZ. Aspiration cytopathology of peripancreatic space: a clinicoradiologic and cytopathologic analyses of 42 cases. Korean J Pathol 2013 Jun;47:258-64.
  4. Boonyaarunnate T, Olson MT, Ali SZ. Impact of flow cytometry in thyroid cytopathology. Acta Cytologica 2013 Nov-Dec;57(6):562-6.
  5. Boonyaarunnate T, Olson MT, Ali SZ. 'Suspicious for a Follicular Neoplasm' before and after the Bethesda System for reporting thyroid cytopathology: impact of standardized terminology. Acta Cytol 2013 Sept;57(5):455-63
  6. Boonyaarunnate T, Olson MT, Bishop JA, Yang GC, Ali SZ. Cribriform morular variant of papillary thyroid carcinoma: clinical and cytomorphological features on fine-needle aspiration. Acta Cytol 2013 Mar-Apr;57(2):127-33.
  7. Cimino-Mathews A, Illei PB. Cytologic and histologic findings of iron pill-induced injury of the lower respiratory tract. Diagn Cytopathol 2013 Oct;41(10):901-3.
  8. Collins JA, Novak A, Ali SZ, Olson MT. Cytotechnologists and on-site evaluation of adequacy. Korean J Pathol 2013 Oct;47(5):405–10.
  9. Guan H, Vandenbussche CJ, Erozan YS, Rosenthal DL, Tatsas AD, Olson MT, Zheng R, Auger M, Ali SZ. Can the tall cell variant of papillary thyroid carcinoma be distinguished from the conventional type in fine needle aspirates? A cytomorphologic study with assessment of diagnostic accuracy. Acta Cytol 2013 Sept-Oct;57(5):534-42.
  10. Illei PB, Maleki Z, Lin MT. EGFR/KRAS/BRAF mutation analysis of metastatic lung adenocarcinoma in spinal fluid. J Am Soc Cytopathol 2013 Oct;2(1 Sup):S17-8.
  11. Holmes BJ, Castelino-Prabhu S, Rosenthal DL, Ali SZ. Xanthogranuloma of bone: a challenging imitator of malignancy. Acta Cytol 2013 Mar-Apr;57(2):198-202.
  12. LeBlanc RE, Maleki Z. Herpes simplex viral cytopathic effect in urine cytology. Diagn Cytopathol 2013 Jan;41(1):61-2.
  13. Li QK, Gabrielson E, Askin F, Chan DW, Zhang H. Glycoproteomics using so-called 'fluid-biopsy' specimens in the discovery of lung cancer biomarkers. Promise and challenge. Proteomics Clin Appl 2013 Jan;7(1-2):55-69.
  14. Li QK, Nugent SL, Straseski J, Cooper D, Riedel S, Askin FB, Sokoll LJ. Thyroglobulin measurements in fine-needle aspiration cytology of lymph nodes for the detection of metastatic papillary thyroid carcinoma. Cancer Cytopathol 2013 Aug;121(8):440-8.
  15. Li Y, Wang X, Ao M, Gabrielson E, Askin F, Zhang H, Li QK. Aberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistry. Clin Proteomics 2013 Nov 1;10(1):15.
  16. Maleki Z, Erozan Y, Geddes S, Li QK. Endorectal ultrasound-guided fine needle aspiration: A useful diagnostic tool for peri-rectal and intraluminal lesions. Acta Cytol 2013 Jan;57:9-18.
  17. Munfus-McCray D, Cui M, Zhang Z, Gabrielson E, Askin F, Li QK. Comparison of EGFR and KRAS mutations in primary and unpaired metastatic lung adenocarcinoma with potential chemotherapy effect. Hum Pathol 2013 Jul;44(7):1286-92.
  18. Olson MT, Boonyaarunnate T, Aragon Han P, Umbricht CB, Ali SZ, Zeiger MA. A tertiary center's experience with second review of 3885 thyroid cytopathology specimens. J Clin Endocrinol Metab 2013 Apr;98(4):1450-7.
  19. Olson MT, Novak A, Kirby J, Boonyaarunnate T, Ali SZ. Cytotechnologist-attended on-site evaluation of adequacy for metastatic disease involving bone and soft tissue. Acta Cytologica 2013 Nov-Dec;57:550-6.
  20. Olson MT, Nuransoy A, Ali SZ. Malignant pleural effusion resulting from metastasis of thyroid primaries: a cytomorphological analysis. Acta Cytol 2013 Mar-Apr;57(2):177-83.
  21. Olson MT, Siddiqui MT, Ali SZ. The differential diagnosis of squamous cells in pancreatic aspirates: from contamination to adenosquamous carcinoma. Acta Cytol 2013 Mar-Apr;57(2):139-46.
  22. Olson MT, Wakely PE Jr, Ali SZ. Metastases to the pancreas diagnosed by fine-needle aspiration. Acta Cytol 2013 Sept-Oct;57(5):473-80.
  23. Owens C, VandenBussche C, Burroughs F, Rosenthal DL. A review of reporting systems and terminology for urine cytology. Cancer Cytopathol 2013 Jan;121(1):9-14.
  24. Rodriquez E, Netto G, Li QK. Intrapancreatic accessory spleen: a potential cause of misdiagnosis at EUS FNA. A case report and review of literature. Diagn Cytopathol 2013;41:466-9.
  25. Rosenthal DL, Vandenbussche CJ, Burroughs FH, Sathiyamoorthy S, Guan H, Owens C. The Johns Hopkins Hospital template for urologic cytology samples: part I-creating the template. Cancer Cytopathol. 2013 Jan;121(1):15-20.
  26. Sathiyamoorthy S, Ali SZ. Malignant melanoma in neo-bladder urinary cytology: a brief report. Diagn Cytopathol 2013 Nov;41(11):997-9.
  27. Sathiyamoorthy S, Ali SZ. Urinary cytology of prostatic duct adenocarcinoma - a clinicopathologic analysis. Acta Cytol 2013 Mar - Apr;57(2):184-8.
  28. Subhawong AP, Subhawong TK, Vandenbussche CJ, Siddiqui MT, Ali SZ. Lymphoproliferative disorders of the kidney on fine-needle aspiration: cytomorphology and radiographic correlates in 33 cases. Acta Cytol 2013 Feb;57(1):19-25.
  29. Toll AD, Ali SZ. Urinary cytomorphology and clinical correlates of prostatic small cell neuroendocrine carcinoma. Acta Cytol. 2013 Sept;57(5):495-500.
  30. Toll AD, Wakely PE Jr, Ali SZ. Acral myxoinflammatory fibroblastic sarcoma: cytopathologic findings on fine-needle aspiration. Acta Cytol 2013 Mar-Apr;57(2):134-8.
  31. Vandenbussche CJ, Gocke CD, Li QK. Fine-needle aspiration of metastatic papillary thyroid carcinoma found in the liver. Diagn Cytopathol 2013 May;41(5):418-24.
  32. Zhao P, Maleki Z. Strongyloides stercoralis in bronchoalveolar lavage specimen processed as Prussian blue stain. Diagn Cytopathol 2013 Feb;41(2):141-3.
  33. Zheng G, Ettinger DS, Maleki Z. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors. Acta Cytol 2013 May-June;57(3):281-90.

GI / LIVER PATHOLOGY

  1. Dal Molin M, Matthaei H, Wu J, Blackford A, Debeljak M, Rezaee N, Wolfgang CL, Butturini G, Salvia R, Bassi C, Goggins MG, Kinzler KW, Vogelstein B, Eshleman JR, Hruban RH, Maitra A. Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg Oncol 2013 Nov;20(12):3802-8.
  2. Harrington CT, Lin EI, Olson MT, Eshleman JR. Fundamentals of pyrosequencing. Arch Pathol Lab Med. 2013 Sep;137(9):1296-303.
  3. Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, Niknafs N, Guthrie VB, Maitra A, Argani P, Offerhaus GJA, Roa JC, Roberts LR, Gores GJ, Popescu I, Alexandrescu ST, Dima S, Fassan M, Simbolo M, Mafficini A, Capelli P, Lawlor RT, Ruzzenente A, Guglielmi A, TortoraG, de Braud F, Scarpa A, Jarnagin W, Klimstra D, Karchin R, Velculescu VE, Hruban RH, Vogelstein B, Kinzler KW, Papadopoulos N, Wood LD. Exome sequencing reveals frequent inactivating mutations in BAP1, ARID1A, and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet 2013 Dec;45(12):1470-3.
  4. Kamiyama H, Rauenzahn S, Shim JS, Karikari CA, Feldmann G, Hua L, Kamiyama M, Schuler FW, Lin MT, Beaty RM, Karanam B, Liang H, Mullendore ME, Mo G, Hidalgo M, Jaffee E, Hruban RH, Jinnah HA, Roden RB, Jimeno A, Liu JO, Maitra A, Eshleman JR. Personalized chemotherapy profiling using cancer cell lines from selectable mice. Clin Cancer Res 2013 Mar 1;19(5):1139-46.
  5. Kanda M, Knight S, Topazian M, Syngal S, Farrell J, Lee J, Kamel I, Lennon AM, Borges M, Young A, Fujiwara S, Seike J, Eshleman J, Hruban RH, Canto MI, Goggins M. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut 2013 Jul;62(7):1024-33.
  6. Kanda M, Sadakari Y, Borges M, Topazian M, Farrell J, Syngal S, Lee J, Kamel I, Lennon AM, Knight S, Fujiwara S, Hruban RH, Canto MI, Goggins M. Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol 2013 Jun;11(6):719-30.e5
  7. Le A, Dang CV. Studying Myc's role in metabolism regulation. Methods Mol Biol 2013;1012:213-9.
  8. Lewis GH, Wang H, Bellizzi AM, Klein AP, Askin FB, Schwartz LE, Schulick RD, Wolfgang CL, Cameron CL, O'Reilly EM, Yu KH, Hruban RH. Prognosis of minimally invasive carcinoma arising in mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 2013 Apr;37(4):601-5.
  9. Li A, Yu J, Kim H, Wolfgang CL, Canto MI, Hruban RH, Goggins M. MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res 2013 Jul 1;19(13):3600-10.
  10. Lin J, Bigge J, Ulbright TM, Montgomery E. Anastomosing hemangioma of the liver and gastrointestinal tract: an unusual variant histologically mimicking angiosarcoma. Am J Surg Pathol 2013 Nov;37(11):1761-5.
  11. Macgregor-Das AM, Iacobuzio-Donahue CA. Molecular pathways in pancreatic carcinogenesis. J Surg Oncol 2013 Jan;107(1):8-14.
  12. Makohon-Moore A, Iacobuzio-Donahue CA. Considerations for sequencing analyses of pancreatic cancer progression and metastasis. Methods Mol Biol 2013;980:121-9.
  13. Matthaei H, Dal Molin M, Maitra A. Identification and analysis of precursors to invasive pancreatic cancer. Methods Mol Biol 2013;980:1-12.
  14. McCall CM, Shi C, Cornish TC, Klimstra DS, Tang LH, Basturk O, Mun LJ, Ellison TA, Wolfgang CL, Choti MA, Schulick RD, Edil BH, Hruban RH. Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate. Am J Surg Pathol 2013 Nov;37(11):1671-7.
  15. Robertson S, Hyder O, Dodson R, Nayar SK, Poling J, Beierl K, Eshleman JR, Lin MT, Pawlik TM, Anders RA. The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome. Hum Pathol 2013 Dec;44(12):2768-73.
  16. Salaria SN, Abu Alfa AK, Cruise MW, Wood LD, Montgomery EA. Lichenoid esophagitis: clinicopathologic overlap with established esophageal lichen planus. Am J Surg Pathol 2013 Dec;37(12):1889-94.
  17. Sharma P, Montgomery E. Gastrointestinal dysplasia. Pathology JRCPA Apr 2013;45(3):273-85.
  18. Singhi AD, Norwood S, Liu TC, Sharma R, Wolfgang CL, Schulick RD, Zeh HJ, Hruban RH. Acinar cell cystadenoma of the pancreas: a benign neoplasm or non-neoplastic ballooning of acinar and ductal epithelium? Am J Surg Pathol 2013 Sep;37(0):1329-35.
  19. Streppel MM, Pai S, Campbell NR, Hu C, Yabuuchi S, Canto MI, Wang JS, Montgomery EA, Maitra A. MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1. Clin Cancer Res 2013 Aug 1;19(15):4067-78.
  20. Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH. Recent progress in pancreatic cancer. CA cancer J Clin 2013 Sep;63(5):318-48.
  21. Wood LD. Pancreatic cancer genomes: toward molecular subtyping and novel approaches to diagnosis and therapy. Mol Diagn Ther 2013 Oct;17(5):287-97.
  22. Wood LD, Heaphy CM, Daniel HJ, Naini BV, Lassman CR, Arroyo MR, Kamel IR, Cosgrove D, Boitnott J, Meeker AK, Torbenson M. Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphologic and molecular features. Mod Pathol 2013 Dec; 26(12):1586-93.
  23. Yabuuchi S, Pai SG, Campbell NR, de Wilde RF, De Oliveira E, Korangath P, Streppel MM, Rasheed ZA, Hidalgo M, Maitra A, Rajeshkumar NV. Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. Cancer Lett 2013 Jul 10;335(1):41-51.
  24. Yachida S, Iacobuzio-Donahue CA. Evolution and dynamics of pancreatic cancer progression. Oncogene. 2013 Nov 7;32(45):5253-60.
  25. Yegnasubramanian S, Maitra A. Aiming for the outliers: cancer precision medicine through targeting kinases with extreme expression. Cancer

GENITOURINARY PATHOLOGY

  1. Al-Hussain TO, Cheng L, Zhang S, Epstein JI. Tubulocystic carcinoma of the kidney with poorly differentiated foci: A series of 3 cases with FISH analysis. Hum Pathol 2013 Jul;44:1406-11.
  2. Bagnasco S, Kraus E, Sis B. Diagnostic criteria for kidney transplant rejection: a call to action. Lancet 2013 Apr 27;381(9876):1458.
  3. Brimo F, Montironi R, Egevad L, Erbersdobler A, Lin DW, Nelson JB, Rubin MA, van der Kwast T, Amin M, Epstein JI. Contemporary grading for prostate cancer: Implications for patient care. Eur Urol 2013 May;63:892-901.
  4. Chang A, Brimo F, Montgomery EA, Epstein JI. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma. Hum Pathol 2013 Aug;44(8):1563-8.
  5. Chaux A, Albadine R, Schultz L, Hicks J, Carducci MA, Argani P, Allaf M, Netto GJ. Dysregulation of the mammalian target of rapamycin pathway in chromophobe renal cell carcinomas. Hum Pathol 2013 Oct;44(10):2323-30.
  6. Chaux A, Compérat E, Varinot J, Hicks J, Lecksell K, Solus J, Netto GJ. High levels of phosphatase and tensin homolog expression are associated with tumor progression, tumor recurrence, and systemic metastases in pT1 urothelial carcinoma of the bladder: a tissue microarray study of 156 patients treated by transurethral resection. Urology 2013 Jan;81(1):116-22.
  7. Chaux A, Han JS, Lee S, Gonzalez-Roibon N, Sharma R, Burnett AL, Cubilla AL, Netto GJ. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra. Hum Pathol. 2013 Dec;44(12):2760-7.
  8. Chaux A, Munari E, Katz B, Sharma R, Lecksell K, Cubilla AL, Burnett AL, Netto GJ. The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases. Hum Pathol 2013 Dec;44(12):2690-5.
  9. Diolombi M, Ross HM, Mercalli F, Sharma R, Epstein JI. Nephrogenic adenoma: a report of 3 unusual cases infiltrating into perinephric adipose tissue. Am J Surg Pathol 2013 Apr;37(4):532-8.
  10. Ellis CL, Chang AG, Cimino-Mathews A, Argani P, Youssef RF, Kapur P, Montgomery EA, Epstein JI. GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder. Am J Surg Pathol 2013 Nov;37(11):1756-60.
  11. Ellis CL, Partin AW, Han M, Epstein JI. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: Correlation with findings at radical prostatectomy and prognosis. J Urol 2013 Dec;190(6):2068-73.
  12. Ellis CL, Walsh PC, Partin AW, Epstein JI. Multiple cores of Gleason score 6 correlate with favourable findings at radical prostatectomy. BJU Int 2013 Jun;111(8):E306-9.
  13. Faraj SF, Albadine R, Chaux A, Gonzalez-Roibon N, Hicks J, Humphreys E, Partin A, Netto GJ. Activation of mammalian target of rapamycin signaling pathway markers in minute adenocarcinoma of the prostate. Urology 2013 Nov;82(5):1083-9.
  14. Georgiades C, Rodriguez R, Azene E, Weiss C, Chaux A, Gonzalez-Roibon N, Netto G. Determination of the nonlethal margin inside the visible "ice-ball" during percutaneous cryoablation of renal tissue. Cardiovasc Intervent Radiol 2013 Jun;36(3):783-90.
  15. Giannico GA, Ross HM, Lotan T, Epstein JI. Aberrant expression of p63 in adenocarcinoma of the prostate: A radical prostatectomy study. Am J Surg Pathol 2013 Sep;37(9):1401-6.
  16. Gonzalez-Roibon N, Albadine R, Sharma R, Faraj SF, Illei PB, Argani P, Ertoy D, Allaf ME, Netto GJ. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas. Hum Pathol 2013 Dec;44(12):2651-7.
  17. Gonzalez-Roibon ND, Chaux A, Al-Hussain T, Osunkoya AO, Bezerra SM, Hicks J, Epstein JI, Netto GJ. Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladder. Hum Pathol 2013 Apr;44(4):612-22.
  18. Gonzalez-Roibon N, Han JS, Lee S, Feng Z, Arslankoz S, Smith N, Pierorazio PM, Humphreys E, Deweese TL, Partin AW, Bivalacqua TJ, Han M, Trock B, Netto GJ. Comparison of biochemical recurrence free survival between periprostatic and pelvic lymph node metastases of prostate cancer. Int J Surg Pathol 2013 Aug;21(4):352-7.
  19. Gonzalez-Roibon N, Katz B, Chaux A, Sharma R, Munari E, Faraj SF, Illei PB, Torbenson M, Netto GJ. Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors. Hum Pathol 2013 Jul;44(7):1293-9.
  20. Green WM, Hicks JL, De Marzo AD, Illei PB, Epstein JI. Immunohistochemical evaluation of TMPRSS2-ERG gene fusion in adenosis of the prostate. Hum Pathol 2013 Sep;44(9):1895-901.
  21. Heaphy CM, Yoon GS, Peskoe SB, Joshu CE, Lee TK, Giovannucci E, Mucci LA, Kenfield SA, Stampfer MJ, Hicks JL, De Marzo AM, Platz EA, Meeker AK. Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death. Cancer Discovery 2013 Oct;3(10):1130-41.
  22. Hempel HA, Burns KH, De Marzo AM, Sfanos KS. Infection of xenotransplanted human cell lines by murine retroviruses: a lesson brought back to light by XMRV. Front Oncol 2013 Jun 17;3:156.
  23. Kakiuchi Y, Choy B, Gordetsky J, Izumi K, Wu G, Rashid H, Joseph JV, Miyamoto H. Role of frozen section analysis of surgical margins during robot-assisted laparoscopic radical prostatectomy: a 2,608-case experience. Hum Pathol 2013 Aug;44(8):1556-62.
  24. Kao S, Epstein JI. Tubular adenoma of the urinary tract: a newly described entity. Hum Pathol 2013 Sep;44(9):1890-4.
  25. Kinde I, Munari E, Faraj SF, Hruban RH, Schoenberg M, Bivalacqua T, Allaf M, Springer S, Wang Y, Diaz LA Jr, Kinzler KW, Vogelstein B, Papadopoulos N, Netto GJ. TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine. Cancer Res 2013 Dec 15;73(24):7162-7.
  26. Kryvenko ON, Epstein JI. Pseudocarcinomatous urothelial hyperplasia of the bladder: clinical findings and followup of 70 patients. J Urol 2013 Jun;189(6):2083-6.
  27. Kryvenko ON, Epstein JI. Testicular hemangioma: a series of 8 cases. Am J Surg Pathol 2013 Jun;37(6):860-6.
  28. Kryvenko ON, Roquero L, Gupta NS, Lee MW, Epstein JI. Low-grade clear cell renal cell carcinoma mimicking hemangioma of the kidney: a series of 4 cases. Arch Pathol Lab Med 2013 Feb;137(2):251-4.
  29. Lee S, Han JS, Chang A, Ross HM, Montironi R, Yorukoglu K, Lane Z, Epstein JI. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases. Hum Pathol 2013 Mar;44(3):427-31.
  30. Lee S, Han JS, Ross HM, Epstein JI. Massive localized lymphedema of the male external genitalia: A clinicopathologic study of 7 cases. Hum Pathol 2013 Feb;44(2):277-81.
  31. Li Y, Zheng Y, Izumi K, Ishiguro H, Ye B, Li F, Miyamoto H. Androgen activates β-catenin signaling in bladder cancer cells. Endocr Relat Cancer 2013 June 1;20(3):293-304.
  32. Lotan TL, Gumuskaya B, Rahimi H, Hicks JL, Iwata T, Robinson BD, Epstein JI, De Marzo AM. Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia. Mod Pathol 2013 Apr;26(4):587-603.
  33. Mak TN, Yu SH, De Marzo AM, Brüggemann H, Sfanos KS. Multilocus sequence typing (MLST) analysis of Propionibacterium acnes isolates from radical prostatectomy specimens. Prostate 2013 May;73(7):770-7.
  34. Munari E, Fujita K, Faraj S, Chaux A, Gonzalez-Roibon N, Hicks J, Meeker A, Nonomura N, Netto GJ. Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma. Hum Pathol 2013 Dec;44(12):2668-76.
  35. Neto GJ. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"? Adv Anat Pathol 2013 May;20(3):175-203.
  36. Nie X, Arend LJ. Pkd1 is required for male reproductive tract development. Mech Dev 2013 Nov-Dec;130(11-12):567-76.
  37. Pan CC, Epstein JI. Common chromosomal aberrations detected by array comparative genomic hybridization in specialized stromal tumors of the prostate. Mod Pathol 2013 Nov:1536-43.
  38. Pierorazio PM, Walsh PW, Partin AW, Epstein JI. Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. BJU Int 2013 May;111:753-60.
  39. Sfanos KS, Isaacs WB, DeMarzo AM. Infections and inflammation in prostate cancer. Am J Clin and Exp Urol Dec 2013;1(1):3-11.
  40. Shinohara DB, Vaghasia AM, Yu SH, Mak TN, Brüggemann H, Nelson WG, De Marzo AM, Yegnasubramanian S, Sfanos KS. A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. Prostate 2013 Jun;73(9):1007-15.
  41. So JS, Epstein JI. GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma. Mod Pathol 2013 Oct;26(10):1365-70.
  42. Tavora F, Kryvenko ON, Epstein JI. Mesenchymal tumours of the bladder and prostate: an update. Pathology 2013 Feb;45(2):104-15.
  43. Venigalla S, Wu G, Miyamoto H. The impact of frozen section analysis during partial nephrectomy on surgical margin status and tumor recurrence: A clinicopathologic study of 433 cases. Clin Genitourin Cancer 2013 Dec;11(4):527-36.
  44. Zhang M, Amberson JB, Epstein JI. Two sequential diagnoses of atypical foci suspicious for carcinoma on prostate biopsy: a follow-up study of 179 cases. Urology 2013 Oct;82(4):861-4.
  45. Zhang M, Kao S, Ulbright TM, Epstein JI. Testicular fibrothecoma: a morphological and immunohistochemical study of 16 cases. Am J Surg Pathol 2013 Aug;37(8):1208-14.

GYNECOLOGIC PATHOLOGY

  1. Anchoori RK, Karanam B, Peng S, Wang JW, Jiang R, Tanno T, Orlowski RZ, Matsui W, Zhao M, Rudek MA, Hung CF, Chen X, Walters KJ, Roden RB. A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer. Cancer Cell 2013 Dec 9;24(6):791-805.
  2. Bagby C, Ronnett BM, Yemelyanova A, Maleki Z, Kuhn E, Vang R. Clinically occult tubal and ovarian high-grade serous carcinomas presenting in uterine samples: diagnostic pitfalls and clues to improve recognition of tumor origin. Int J Gynecol Pathol 2013 Sep;32(5):433-43.
  3. Chang CL, Hsu YT, Wu CC, Lai YZ, Wang C, Yang YC, Wu TC, Hung CF. Dose-dense chemotherapy improves mechanisms of antitumor immune response. Cancer Res 2013 Jan 1;73(1):119-27.
  4. Guan B, Magomi T, Wang TL, Shih IeM. Establishing isogenic inducible cell lines using founder reporter lines and recombinase-mediated cassette exchange. Biotechniques 2013 Nov;55(5):233-42.
  5. Kang TH, Knoff J, Yang B, Tsai YC, He L, Hung CF, Wu TC. Control of spontaneous ovarian tumors by CD8+ T cells through NKG2D-targeted delivery of antigenic peptide. Cell Biosci 2013 Dec 20;3(1):48.
  6. Kang TH, Mao CP, La V, Chen A, Hung CF, Wu TC. Innovative DNA vaccine to break immune tolerance against tumor self-antigen. Hum Gene Ther 2013 Feb;24(2):181-8.
  7. Kang TH, Mao CP, Lee SY, Chen A, Lee JH, Kim TW, Alvarez RD, Roden RB, Pardoll D, Hung CF, Wu TC. Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity. Cancer Res 2013 Apr 15;73(8):2493-504.
  8. Kuhn E, Ayhan A, Shih IeM, Seidman JD, Kurman RJ. Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium. Eur J Cancer 2013 Dec;49(18):3839-49.
  9. Kurman RJ, Visvanathan K, Shih IeM. Bokhman's dualistic model of endometrial carcinoma. Revisited. Gynecol Oncol 2013 May;129(2):271-2.
  10. Lee SY1, Huang Z, Kang TH, Soong RS, Knoff J, Axenfeld E, Wang C, Alvarez RD, Chen CS, Hung CF, Wu TC. J Mol Med (Berl). 2013 Oct;91(10):1221-31.
  11. Lee SY, Kang TH, Knoff J, Huang Z, Soong RS, Alvarez RD, Hung CF, Wu TC. Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects. Cancer Immunol Immunother. 2013 Jul;62(7):1175-85.
  12. Lewis GH, DeScipio C, Murphy KM, Haley L, Beierl K, Mosier S, Tandy S, Cohen DS, Lytwyn A, Elit L, Vang R, Ronnett BM. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including some with a molar component: morphology, p57 immunohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease. Int J Gynecol Pathol 2013 Mar;32(2):199-214.
  13. Maeda D, Shih IeM. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol 2013 Jan;20(1):45-52.
  14. Maniar KP, Ronnett BM, Vang R, Yemelyanova A. Coexisting high-grade vulvar intraepithelial neoplasia (VIN) and condyloma acuminatum: independent lesions due to different HPV types occurring in immunocompromised patients. Am J Surg Pathol. 2013 Jan; 37(1):53-60.
  15. Mao TL, Ardighieri L, Ayhan A, Kuo KT, Wu CH, Wang TL, Shih IeM. Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma. Am J Surg Pathol. 2013 Sep;37(9):1342-8.
  16. Mao TL, Shih IM. The roles of ARID1A in gynecologic cancer. J Gynecol Oncol. 2013 Oct;24(4):376-81.
  17. Sheu JJ, Choi JH, Guan B, Tsai FJ, Hua CH, Lai MT, Wang TL, Shih IeM. Rsf-1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development. J Pathol 2013 Mar;229(4):559-68.
  18. Soong RS, Trieu J, Lee SY, He L, Tsai YC, Wu TC, Hung CF. Xenogeneic human p53 DNA vaccination by electroporation breaks immune tolerance to control murine tumors expressing mouse p53. PLoS One. 2013 Feb;8(2):e56912.
  19. Vang R, Shih IeM, Kurman RJ. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. Histopathology 2013 Jan;62(1):44-58.
  20. Yap KL, Shah PS, Bolon B, Wu RC, Gao M, Wang F, Faiola F, Huso D, Wang TL, Wang JL, Shih IM. Loss of NAC1 expression is associated with defective cell fate specification and bony patterning in the murine vertebral axis. PLoS One 2013 Jul;8:e69099.
  21. Yemelyanova A, Gravitt PE, Ronnett BM, Rositch AF, Ogurtsova A, Seidman J, Roden RB. Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management. Mod Pathol 2013 Feb;26(2):268-74.

HEMATOLOGIC PATHOLOGY

  1. Babatz TD, Burns KH. Functional impact of the human mobilome. Curr Opin Genet Dev 2013 Jun;23(3):264-70.
  2. Gnanakkan VP, Jaffe AE, Dai L, Fu J, Wheelan SJ, Levitsky HI, Boeke JD, Burns KH. TE-array--a high throughput tool to study transposon transcription. BMC Genomics 2013 Dec 10;14:869.
  3. Halper-Stromberg E, Steranka J, Giraldo-Castillo N, Fuller T, Desiderio S, Burns KH. Fine mapping of V(D)J recombinase mediated rearrangements in human lymphoid malignancies. BMC Genomics 2013 Aug 19;14:565.
  4. Rodić N, Burns KH. Long interspersed element-1 (LINE-1): passenger or driver in human neoplasms? PLoS Genet 2013 Mar;9(3):e1003402.
  5. Rodić N, Zampella JG, Cornish TC, Wheelan SJ, Burns KH. Translocation junctions in TCF3-PBX1 acute lymphoblastic leukemia/lymphoma cluster near transposable elements. Mob DNA 2013 Oct 17;4(1):22.
  6. Samols MA, Smith NE, Gerber JM, Vuica-Ross M, Gocke CD, Burns KH, Borowitz MJ, Cornish TC, Duffield AS. Software-automated counting of Ki-67 proliferation index correlates with pathologic grade and disease progression of follicular lymphomas. Am J Clin Pathol 2013 Oct;140(4):579-87.
  7. Takemoto CM, Streiff MB, Shermock KM, Kraus PS, Chen J, Jani J, Kickler T. Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance. Am J Clin Pathol. 2013 Apr;139(4):450-6.
  8. Tilson MP, Jones RJ, Sexauer A, Griffin CA, Morsberger LA, Batista DA, Small D, Burns KH, Gocke CD, Vuica-Ross M, Borowitz MJ, Duffield AS. Targeted pathologic evaluation of bone marrow donors identifies previously undiagnosed marrow abnormalities. Biol Blood Marrow Transplant. 2013 Aug;19(8):1254-9.

IMMUNOLOGY

  1. Amukele TK, Soko D, Katundu P, Kamanga M, Sun J, Kumwenda NI, Taha TE. Vitamin D levels in Malawian infants from birth to 24 months. Arch Dis Child 2013 Mar;98(3):180-3.
  2. Barin JG, Baldeviano GC, Talor MV, Wu L, Ong S, Fairweather D, Bedja D, Stickel NR, Fontes JA, Cardamone AB, Zheng D, Gabrielson KL, Rose NR, Ciháková D. Fatal Eosinophilic Myocarditis Develops in the Absence of IFN-γ and IL-17A. J Immunol 2013 Oct 15;191(8):4038-47.
  3. Barin JG, Ciháková D. Control of inflammatory heart disease by CD4(+) T cells. Ann N Y Acad Sci 2013 May;1285(1):80-96.
  4. Caturegli P Dr, De Remigis A, Chuang K, Dembele M, Iwama A, Iwama S. Hashimoto Thyroiditis: celebrating the centennial through the lens of The Johns Hopkins Hospital Surgical Pathology records. Thyroid 2013 Feb;23(2):142-50.
  5. Elbireer AM, Jackson JB, Sendargire H, Opio A, Bagenda D, Amukele TK. The good, the bad, and the unknown: quality of clinical laboratories in Kampala, Uganda. PLoS ONE 2013 May;8(5):e6466.
  6. Hoffman WH, Passmore GG, Hannon DW, Talor MV, Fox P, Brailer C, Haislip D, Keel C, Harris G, Rose NR, Fiordalisi I, Čiháková D. Increased systemic Th17 cytokines are associated with diastolic dysfunction in children and adolescents with diabetic ketoacidosis. PLoS One. 2013 Aug 27;8(8):e71905.
  7. Iwama S, Welt CK, Romero CJ, Radovick S, Caturegli P. Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells. J Clin Endocrinol Metab 2013 Oct;98(10):3920-5.
  8. Kim A, Ishizuka I, Hartman I, Poluektov Y, Narayan K, Sadegh-Nasseri S. Studying MHC class II peptide loading and editing in vitro. Methods Mol Biol 2013;960:447-59.
  9. Poluektov YO, Kim A, Hartman IZ, Sadegh-Nasseri S. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation. PLoS One 2013 Aug 8;8(8):e71228.
  10. Poluektov YO, Kim A, Sadegh-Nasseri S. HLA-DO and its role in MHC class II antigen presentation. Front Immunol 2013 Aug;4(article260):1-5.
  11. Ramirez L, Hamad AR. Status of autoimmune diabetes 20-year after generation of BDC2.5-TCR transgenic non-obese diabetic mouse. World J Diabetes 2013 Aug 15;4(4):88-91. 12. Zheng G, Chaux A, Sharma R, Netto G, Caturegli P. LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma. Exp Mol Pathol 2013 Feb;94(1):29-32.

INFORMATICS

  1. Lai H, Fishman EK, Gerstenblith G, Brinker B, Hong T, Chen S, Li J, Tong W, Detrick B, Lai S. Vitamin D deficiency is associated with coronary artery calcification in cardiovascularly asymptomatic African Americans with HIV infection. Vasc Health Risk Manag 2013;9:493-500.

MEDICAL MICROBIOLOGY

  1. Bell WR, Dalton JB, McCall CM, Karram S, Pearce DT, Memon W, Lee R, Carroll KC, Lyons JL, Gireesh ED, Trivedi JB, Cettomai D, Smith BR, Chang T, Tochen L, Ratchford JN, Harrison DM, Ostrow LW, Stevens RD, Chen L, Zhang SX. Iatrogenic Exserohilum infection of the central nervous system: mycological identification and histopathological findings. Mod Pathol 2013 Feb;26(2):166-70.
  2. Burnham CA, Carroll KC. Diagnosis of clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 2013 Jul;26(3):604-30.
  3. Carroll KC, Buchan BW, Tan S, Stamper PD, Riebe KM, Pancholi P, Kelly C, Rao A, Fader R, Cavagnolo R, Wilson W, Goering RV, Trevino EA, Weissfeld AS, Ledeboer NA. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid test. J Clin Microbiol 2013 Dec;51(12):4120-5.
  4. Choi KS, Dumler JS. Anaplasma phagocytophilum, interferon gamma production and Stat1 signaling. Microbiol Immunol 2013 Mar;57(3):207-12.
  5. Eisinger SW, Schwartz M, Dam L, Riedel S. Evaluation of the BD Vacutainer Plus Urine C&S Preservative Tubes Compared With Nonpreservative Urine Samples Stored at 4°C and Room Temperature. Am J Clin Pathol 2013 Sep;140(3):306-13.
  6. Farley JE, Ross T, Krall J, Hayat M, Caston-Gaa A, Perl T, Carroll KC. Prevalence, risk factors, and molecular epidemiology of methicillin-resistant Staphylococcus aureus nasal and axillary colonization among psychiatric patients on admission to an academic medical center. Am J Infect Control 2013 Mar;41(3):199-203.
  7. Grab DJ, Nenortas E, Bakshi R, Nikolskaia OV, Friedman JE, Shapiro TA. Membrane active chelators as novel anti-African trypanosome and anti-malarial drugs. Parasitol Int 2013 Oct;62(5):461-3.
  8. Hirsch HH, Lautenschlager I, Pinsky BA, Cardeñoso L, Aslam S, Cobb B, Vilchez RA, Valsamakis A. An international multicenter performance analysis of cytomegalovirus load tests. Clin Infect Dis 2013 Feb;56(3):367-73.
  9. LeBlanc RE, Meriden Z, Sutton DA, Thompson EH, Neofytos D, Zhang SX. Cunninghamella echinulata causing fatally invasive fungal sinusitis. Diagn Microbiol Infect Dis 2013 Aug;76(4):506-9.
  10. Liu CM, Soldanova K, Nordstrom L, Dwan MG, Moss OL, Contente-Cuomo TL, Keim P, Price LB, Lane AP. Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis. Int Forum Allergy Rhinol 2013 Oct;3(10):775-81.
  11. Lyons JL, Roos KL, Marr KA, Neumann H, Trivedi JB, Kimbrough DJ, Steiner L, Thakur KT, Harrison DM, Zhang SX. Cerebrospinal fluid (1,3) β-D-glucan detection as an aid to diagnose iatrogenic fungal meningitis. J Clin Microbiol 2013 April;51(4):1285-7.
  12. Reller ME, Akoroda U, Nagahawatte A, Devasiri V, Kodikaarachchi W, Strouse JJ, Chua R, Hou Y, Chow A, Sessions OM, Ostbye T, Gubler DJ, Woods CW, Bodinayake C. Chikungunya as a cause of acute febrile illness in southern Sri Lanka. PLoS One 2013 Dec 2;8(12):e8225.
  13. Reller ME, Chen WH, Dalton J, Lichay MA, Dumler JS. Multiplex 5' nuclease quantitative real-time PCR for clinical diagnosis of malaria and species-level identification and epidemiologic evaluation of malaria-causing parasites, including Plasmodium knowlesi. J Clin Microbiol 2013 Sep;51(9):2931-8.
  14. Riedel S, Carroll KC. Laboratory detection of sepsis: biomarkers and molecular approaches. Clin Lab Med 2013 Sep;33(3):413-37.
  15. Tamma PD, Girdwood SC, Gopaul R, Tekle T, Roberts AA, Harris AD, Cosgrove SE, Carroll KC. The use of cefepime for treating AmpC B-lactamase-producing Enterobacteriaceae. Clin Infect Dis 2013; 57:781-8.
  16. Wormser GP, Schriefer M, Aguero-Rosenfeld ME, Levin A, Steere AC, Nadelman RB, Nowakowski J, Marques A, Johnson BJ, Dumler JS. Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagn Microbiol Infect Dis 2013 Jan;75(1):9-15.
  17. Zhang SX. Enhancing molecular approaches for diagnosis of fungal infections. Future Microbiol 2013 Dec;8:1599-611.

MOLECULAR PATHOLOGY

  1. Beierl K, Tseng LH, Beierl R, Haley L, Gocke CD, Eshleman JR, Lin MT. Detection of minor clones with internal tandem duplication mutations of FLT3 gene in acute myeloid leukemia using delta-PCR. Diagn Mol Pathol 2013 Mar;22(1):1-9.
  2. Henderson LB, Corson VL, Saul DO, Anderson C, Millard S, Batista DA, Blakemore KJ, Descipio C. First trimester diagnosis of holoprosencephaly secondary to a ring chromosome 7. Case Rep Genet 2013 Feb;2013:578202.
  3. Lee RW, Bodurtha J, Cohen J, Fatemi A, Batista D. Deletion 12p12 involving SOX5 in two children with developmental delay and dysmorphic features. Pediatr Neurol 2013 Apr;48(4):317-20.
  4. Lin MT, Tseng LH, Beierl K, Thiess M, Chase N, Stafford A, Levis M, Eshleman JR, Gocke CD. Tandem duplication PCR: an ultra-sensitive assay for the detection of internal tandem duplications of the FLT3 gene. Diagn Mol Pathol 2013 Sep;22(3):149-55.
  5. Ning Y, Foss A, Kimball AS, Neill N, Matz T, Schultz R. Characterization of a case of follicular lymphoma transformed into B-lymphoblastic leukemia. Mol Cytogenet 2013 Aug 28;6(1):34.

NEUROPATHOLOGY

  1. Bell RW, Jusue-Torres I, Quinones-Hinojosa A, Rodriguez F. Inflammatory myofibroblastic tumor involving the central nervous system. Path Case Rev 2013 Nov-Dec;18(6):257-61.
  2. Chu Q, Orr BA, Semenkow S, Bar EE, Eberhart CG. Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo notch blockade. Clin Cancer Res 2013 Jun 15;19(12):3224-33.
  3. Heaphy CM, Schreck KC, Raabe E, Mao XG, An P, Chu Q, Poh W, Jiao Y, Rodriguez FJ, Odia Y, Meeker AK, Eberhart CG. A glioblastoma neurosphere line with alternative lengthening of telomeres. Acta Neuropathol 2013 Oct;124(4):607-8.
  4. Ho CY, Bar E, Giannini C, Marchionni L, Karajannis MA, Zagzag D, Gutmann DH, Eberhart CG, Rodriguez FJ. MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2. Neuro Oncol 2013 Jan;15(1):69-82.
  5. Hütt-Cabezas M, Karajannis MA, Zagzag D, Shah S, Horkayne-Szakaly I, Rushing EJ, Cameron JD, Jain D, Eberhart CG, Raabe EH, Rodriguez FJ. Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target. Neuro Oncol 2013 Dec;15(12):1604-14.
  6. Laclair KD, Manaye KF, Lee DL, Allard JS, Savonenko AV, Troncoso JC, Wong PC. Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice. Mol Neurodegener 2013 Jun 13;8:18.
  7. Martin LJ, Katzenelson A, Koehler RC, Chang Q. The olfactory bulb in newborn piglet is a reservoir of neural stem and progenitor cells. PLoS One 2013 Nov 21;8(11):e81105.
  8. Martin LJ, Wong M. Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms. Neurotherapeutics 2013 Oct;10(4):722-33
  9. Magalhães J, Rostad S, Foltz G, Pytel P, Rodriguez FJ. Cellular pleomorphism in papillary tumors of the pineal region. Brain Tumor Pathol 2013 Apr;30(2):93-8.
  10. Melnikova T, Fromholt S, Kim HS, Lee D, Xu G, Price A, Moore BD, Golde TE, Felsenstein KM, Savonenko AV, Borchelt DR. Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis. J Neurosci 2013 Feb;33(9):3765-79.
  11. Nguyen DN, Heaphy CM, de Wilde RF, Orr BA, Odia Y, Eberhart CG, Meeker AK, Rodriguez FJ. Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol 2013 May;23(3):237-43.
  12. Odia Y, Orr BA, Robert Bell W, Eberhart CG, Rodriguez FJ. cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome. J Neurooncol 2013 Nov;115(2):249-59.
  13. Rodriguez FJ, Lim KS, Bowers D, Eberhart CG. Pathological and molecular advances in pediatric low-grade astrocytoma. Annu Rev Pathol 2013 Jan 24;8:361-79.
  14. Wong M, Gertz B, Chestnut BA, Martin LJ. Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS. Front Cell Neurosci 2013 Dec 25;7:279.
  15. Woodworth GF, Garzon-Muvdi T, Ye X, Blakeley JO, Weingart JD, Burger PC. Histopathological correlates with survival in reoperated glioblastomas. J Neurooncol 2013 Jul;113(3):485-93.

OPHTHALMIC PATHOLOGY

  1. Asnaghi L, Handa JT, Merbs SL, Harbour JW, Eberhart CG. A role for Jag2 in promoting uveal melanoma dissemination and growth. Invest Ophthalmol Vis Sci 2013 Jan 9;54(1):295-306. 2. Rajaii F, Ghafourian A, Eberhart CG. Intratarsal keratinous cyst - an emerging entity. Case Rep Ophthalmol. 2013 Oct 5;4(3):160-4.

SURGICAL PATHOLOGY

  1. Belchis DA, Shekitka K, Gocke CD. Multi-institutional retrospective cohort study of spontaneous pneumothorax. Pathol Res Pract 2013 Aug;209(8):486-9.
  2. Bishop JA. Unmasking MASC: bringing to light the unique morphologic, immunohistochemical and genetic features of the newly recognized mammary analogue secretory carcinoma of salivary glands. Head Neck Pathol 2013 Mar;7(1):35-9.
  3. Bishop JA, Guo TW, Smith DF, Wang H, Ogawa T, Pai SI, Westra WH. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol 2013 Feb;37(2):185-92.
  4. Bishop JA, Ogawa T, Stelow EB, Moskaluk CA, Koch WM, Pai SI, Westra WH. Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract. 2013 Jun;37(6):836-44.
  5. Bishop JA, Yonescu R, Batista D, Begum S, Eisele DW, Westra WH. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma. Hum Pathol 2013 Oct;44(10):1982-8.
  6. Bishop JA, Yonescu R, Batista D, Eisele DW, Westra WH. Most nonparotid "acinic cell carcinomas" represent mammary analog secretory carcinomas. Am J Surg Pathol 2013 Jul;37(7):1053-7.
  7. Cimino-Mathews A, Hicks JL, Sharma R, Vang R, Illei PB, De Marzo A, Emens LA, Argani P. A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway. Hum Pathol 2013 Nov;44(11):2494-500.
  8. Cimino-Mathews A, Subhawong AP, Elwood H, Warzecha HN, Sharma R, Park BH, Taube JM, Illei PB, Argani P. Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas. Hum Pathol 2013 Jun;44(6):959-65.
  9. Cimino-Mathews A, Subhawong AP, Illei PB, Sharma R, Halushka MK, Vang R, Fetting JH, Park BH, Argani P. GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas. Hum Pathol 2013 Jul;44(7):1341-9.
  10. Green WM, Yonescu R, Morsberger L, Morris K, Netto GJ, Epstein JI, Illei PB, Allaf M, Ladanyi M, Griffin CA, Argani P. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service. Am J Surg Pathol 2013 Aug;37(8):1150-63..
  11. McCarthy EF. Fibro-osseous lesions of the maxillofacial bones. Head Neck Pathol 2013 Mar;7(1):5-10.
  12. Rooper L, Gocke CD, Belchis, DA. Pleural fluid cytology of the polymorphous variant of EBV-positive diffuse large B-cell Lymphoma: first report and distinction from a reactive process. Case Rep Pathol 2013;2013:459279. Ruzevick J, Olivi A, Westra WH. Metastatic squamous cell carcinoma to the brain: an unrecognized pattern of distant spread in patients with HPV-related head and neck cancer. J Neurooncol 2013 May;112(3):449-54.
  13. Schwartz LE, Begum S, Westra WH, Bishop JA. GATA3 immunohistochemical expression in salivary gland neoplasms. Head Neck Pathol 2013 Dec;7(4):311-5.
  14. Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, Hes O, Moch H, Montironi R, Tickoo SK, Zhou M, Argani P; ISUP Renal Tumor Panel. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol 2013 Oct;37(10):1469-89.
  15. Vandenbussche CJ, Khouri N, Sbaity E, Tsangaris TN, Vang R, Tatsas A, Cimino-Mathews A, Argani P. Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively. Am J Surg Pathol 2013 Jun;37(6):913-23.
  16. Zheng G, Martignoni G, Antonescu C, Montgomery E, Eberhart C, Netto G, Taube J, Westra W, Epstein JI, Lotan T, Maitra A, Gabrielson E, Torbenson M, Iacobuzio-Donahue C, Demarzo A, Shih IeM, Illei P, Wu TC, Argani P. A broad survey of cathepsin k immunoreactivity in human neoplasms. Am J Clin Pathol 2013 Feb;139(2):151-9.

TRANSFUSION MEDICINE

  1. Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH. HIV incidence estimation using multiple biomarkers. Am J Epidemiol 2013 Feb;177:264-72.
  2. Brookmeyer R, Laeyendecker O, Donnell D, Eshleman SH. Cross-sectional HIV incidence estimation in HIV prevention research. J AIDS 2013 Jul;63:S233-S237.
  3. Cousins MM, Donnell D, Eshleman SH. Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high-resolution melting diversity assay. J Mol Diagn 2013 Jan;15(1):130-7.
  4. Davis MA, Gray RH, Grabowski MK, Serwadda D, Kigozi G, Gravitt PE, Nalugoda F, Watya S, Wawer MJ, Quinn TC, Tobian AA. Male circumcision decreases high-risk human papillomavirus viral load in female partners: a randomized trial in Rakai, Uganda. Int J Cancer 2013 Sep 1;133(5):1247-52.
  5. Elbireer A, Le Chasseur J, Jackson B. Improving laboratory data entry quality using Six Sigma. Int J Health Care Qual Assurance 2013 July;26(6):496-509.
  6. Eshleman SH, Hughes JP, Laeyendecker O, Wang J, Brookmeyer R, Johnson-Lewis L, Mullis CE, Hackett J Jr, Vallari AS, Justman J, Hodder S. Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. J Infect Dis 2013 Jan;207(2):223-31.
  7. Fogel J, Mwatha A, Richardson P, Brown E, Chipato T, Alexandre M, Moodley D, Elbireer A, Mirochnick M, George K, Mofenson LM, Zwerski S, Coovadia HM, Eshleman SH. Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants. Pediatr Infect Dis J 2013 Apr;32(4):e164-e169.
  8. Fogel JM, Wang L, Parsons TL, Ou SS, Piwowar-Manning E, Chen Y, Mudhune VO, Hosseinipour MC, Kumwenda J, Hakim JG, Chariyalertsak S, Panchia R, Sanne I, Kumarasamy N, Grinsztejn B, Makhema J, Pilotto J, Santos BR, Mayer KH, McCauley M, Gamble T, Bumpus NN, Hendrix CW, Cohen MS, Eshleman SH. Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). J Infect Dis 2013 Nov;208(10):1624-8.
  9. Jackson JB, Tao X, Sneed L, Humphrey-Carothers F, Bernacki E. Cost of annual tuberculosis screening of healthcare workers with negative tuberculin skin test results. Infect Control Hosp Epidemiol 2013 Jun;34(6):642-3.
  10. James MM, Laeyendecker O, Sun J, Hoover DR, Mullis CE, Cousins MM, Coates T, Moore RD, Kelen GD, Fowler MG, Kumwenda JJ, Mofenson LM, Kumwenda NI, Taha TE, Eshleman SH. Antibody maturation and viral diversification in HIV-infected women. PLoS One 2013 Feb;8(2): e57350.
  11. Kacker S, Frick KD, Gaydos CA, Tobian AAR. Male circumcision cost-effective articles ignore methodological problems and ethical concerns - reply. JAMA Pediatr 2013;167:198-200.
  12. Kacker S, Frick KD, Tobian AA. Constructing a model: economic evaluations in transfusion medicine, Part 3. Transfusion 2013 Sep;53(9):1885-7.
  13. Kacker S, Frick KD, Tobian AAR. Data and interpretation: economic evaluations in transfusion medicine part 4. Transfusion 2013 Oct;53:2130-3.
  14. Kacker S, Frick KD, Tobian AAR. Establishing a framework: economic evaluations in transfusion medicine part 2. Transfusion 2013 Aug;53(8):1634-6.
  15. Kacker S, Frick KD, Tobian AA. The costs of transfusion: economic evaluations in transfusion medicine, Part 1. Transfusion 2013 Jul;53(7):1383-5.
  16. Kacker S, Frick KD, Quinn TC, Gray RH, Tobian AAR. Financial implications of male circumcision scale-up for the prevention of HIV and other sexually transmitted infections in a sub-Saharan African community. Sex Transm Dis 2013 Jul;40(7):559-68.
  17. Kacker S, Tobian AAR. Male circumcision: integrating tradition and medical evidence. Isr Med Assoc J 2013;15:37-8.
  18. Kacker S, Ness PM, Savage WJ, Frick KD, McCullough J, King KE, Tobian AAR. Costs and effectiveness of platelet additive solution to prevent allergic transfusion reactions. Transfusion 2013 Nov; 53:2609-18.
  19. Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH. HIV Incidence determination in the United States: A multiassay approach. J Infect Dis 2013 Jan;207(2):232-9.
  20. Laeyendecker O, Kulich M, Donnell D, Komárek A, Omelka M, Mullis CE, Szekeres G, Piwowar-Manning E, Fiamma A, Gray RH, Lutalo T, Morrison C, Salata RA, Chipato T, Celum C, Kahle EM, Taha TE, Kumwenda NI, Abdool Karim, Q, Naranbhai V, Lingpappa J, Sweat MD, Coates T, Eshleman SH. Development of methods for cross-sectional incidence HIV estimation in a large community-randomized trial. PLoS One 2013 Nov;8(11):e78818.
  21. Laeyendecker O, Piwowar-Manning E, Fiamma A, Kulich M, Donnell D, Bassuk D, Mullis CE, Chin C, Vallari A, Hackett J, Jr., Clarke W, Marzinke M, Szekeres G, Gray G, Richter L, Mbwambo J, Chariyalertsak S, Chingono A, Celantano D, Morin SF, Sweat M, Coates T, Eshleman SH. Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH Project Accept (HIV Prevention Trials Network 043). PLoS ONE 2013 July11;8(7):e68349
  22. Liu CM, Hungate BA, Tobian AAR, Serwadda D, Ravel J, Lester R, Kigozi G, Aziz M, Galiwango RM, Nalugoda F, Contente-Cuomo TL, Wawer MJ, Keim P, Gray RH, Price LB. Male circumcision significantly reduces prevalence and load of anaerobic bacteria. mBio 2013 Apr;4(2):e00076-1.
  23. Morris BJ, Tobian AAR. Legal threat to infant male circumcision. JAMA Pediatr 2013 Oct;167:890-1.
  24. Redd AD, Quinn TC, Tobian AAR. Frequency and implications of HIV superinfection. Lancet Infecti Dis 2013 Jul;13(7):622-8.
  25. Savage WJ, Tobian AA, Savage JH, Wood RA, Schroeder JT, Ness PM. Scratching the surface of allergic transfusion reactions. Transfusion 2013 Jun;53(6):1361-71.
  26. Tobian AAR, Grabowski MK, Kigozi G, Gravitt PE, Eaton K, Serwadda D, Nalugoda F, Wawer MJ, Quinn TC, Gray RH. High-risk human papillomavirus prevalence is associated with HIV infection among heterosexual men in Rakai, Uganda. Sex Transm Infect 2013 Mar;89(2):122-7.
  27. Tobian AA, Grabowski MK, Kigozi G, Redd AD, Eaton KP, Serwadda D, Cornish TC, Nalugoda F, Watya S, Buwembo D, Nkale J, Wawer MJ, Quinn TC, Gray RH. Human papillomavirus clearance in men is associated with HIV acquisition and increased foreskin dendritic cell density in Rakai, Uganda. J Infect Dis 2013 Jun;207(11):1713-22.
  28. Tobian AA, Grabowski MK, Serwadda D, Newell K, Ssebbowa P, Franco V, Nalugoda F, Wawer MJ, Gray RH, Quinn TC, Reynolds SJ; Rakai Health Sciences Program. Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy. J Infect Dis 2013 Sep 1;208(5):839-46.
  29. Tobian A, Kacker S. Some comments on male circumcision. Isr Med Assoc J 2013 Jul;15(7):393.
  30. Tobian AAR, Kigozi G, Wawer MJ, Serwadda D, Quinn TC, Gray RH. Herpes simplex virus type-2 (HSV-2) assay specificity and male circumcision to reduce HSV-2 acquisition. AIDS 2013;27:147-9.
  31. Treml A, King KE. Red blood cell alloimmunization: lessons from sickle cell disease. Transfusion. 2013 Apr;53(4):692-5.
  32. Wang J, Liu J, Yao F, Wen G, Li J, Huang Y, Lü Y, Wen X, Wright D, Yu Q, Guo N, Ness P, Shan H; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) and International Component. Prevalence, incidence, and residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors. Transfusion 2013 Jun;53(6):1240-9.
  33. Weiskopf RB, Ness PM. Transfusion for remote damage control resuscitation. Transfusion. 2013 Jan;53(1):8-12.

2012 Publications +

AUTOPSY

  1. Burton EC, Mossa-Basha M. To image or to autopsy? Ann Intern Med 2012 Jan17;156(2)158-9.
  2. Gibbs WN, Opatowsky MJ, Burton EC. AIRP best cases in radiologic-pathologic correlation: cerebral fat embolism syndrome in sickle cell β-thalassemia. Radiographics. 2012 Sep-Oct;32(5):1301-6.

CARDIOVASCULAR PATHOLOGY

  1. Das S, Ferlito M, Kent OA, Fox-Talbot K, Wang R, Liu D, Raghavachari N, Yang Y, Wheelan SJ, Murphy E, Steenbergen C. Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res. 2012 Jun 8;110(12):1596-603.
  2. Das S, Steenbergen C. Mitochondrial adenine nucleotide transport and cardioprotection. J Mol Cell Cardiol. 2012 Feb;52(2):448-53.
  3. Halushka MK. Single gene disorders of the aortic wall. Cardiovasc Pathol 2012 Jul;21(4):240-4.
  4. Holmes BJ, Delev NG, Pasternack GR, Halushka MK. Novel cause of sudden cardiac death: IgG4-related disease. Circulation 2012 Jun;125(23):2956-7.
  5. Kohr MJ, Aponte A, Sun J, Gucek M, Steenbergen C, Murphy E. Measurement of s-nitrosylation occupancy in the myocardium with cysteine-reactive tandem mass tags: short communication. Circ Res. 2012 Oct 26;111(10):1308-12.
  6. Kohr MJ, Roof SR, Zweir JL, Ziolo MT. Modulation of myocardial contraction by peroxynitrite. Front Physiol 2012 Dec;3:468
  7. Liu CY, Liu YC, Venkatesh BA, Lima JA, Bluemke DA, Steenbergen C. Heterogeneous distribution of myocardial steatosis-An ex vivo evaluation. Magn Reson Med 2012 Jul;68(1):1-7.
  8. Murphy E, Kohr M, Sun J, Nguyen T, Steenbergen C. S-nitrosylation: a radical way to protect the heart. J Mol Cell Cardiol 2012 Mar;52(3):568-77.
  9. Parson SJ, Russell SD, Bennett MK, Dunn JM, Gilotra NA, Rao S, Harrington C, Freitag TB, Foster MC, Halushka MK. Increased lipofuscin on endomyocardial biopsy predicts greater cardiac improvement in adolescents and young adults. Cardiovasc Pathol 2012 Jul;21(4):317-23.

CLINICAL CHEMISTRY

  1. Marzinke MA, Jarrar P, Atkinson M, Humphrey RL, Detrick B, Sokoll LJ. Origin of a false positive urine pregnancy test in a patient with membranoproliferative glomerulonephritis type I. Clin Chim Acta 2012 Jan;413(1-2):361-3.
  2. Sokoll LJ, Chan DW, Klee GG, Roberts WL, van Schaik RH, Arockiasamy DA, Broyles DL, Carlson CM, Mizrahi IA, Pierson TB, Tam JE. Multi-center analytical performance evaluation of the Access Hybritech® p2PSA immunoassay. Clin Chim Acta 2012 Aug 16;413(15-16):1279-83.
  3. Tian Y, Esteva FJ, Song J, Zhang H. Altered expression of sialylated glycoproteins in breast cancer using hydrazide chemistry and mass spectrometry. Mol Cell Proteomics 2012 Jun;11(6):M111.011403.
  4. Tosoian JJ, Loeb S, Feng Z, Isharwal S, Landis P, Elliot DJ, Veltri R, Epstein JI, Partin AW, Carter HB, Trock B, Sokoll LJ. Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer. J Urol 2012 Oct;188(4):1131-6
  5. Yang SJ, Zhang H. Analysis by reversible reaction to hydrazide beads and mass spectrometry. Anal Chem 2012 Mar;84(5):2232-8.
  6. Yang W, McCrae MA. The molecular biology of rotaviruses X: intercellular dissemination of rotavirus NSP4 requires glycosylation and is mediated by direct cell-cell contact through cytoplasmic extrusions. Arch Virol 2012 Feb;157(2):305-14.

CYTOPATHOLOGY

  1. Ali SZ, Leteurtre E. The official nomenclature and terminologies in diagnostic cytopathology: history, evolution, applicability and future. Ann Pathol 2012 Dec;32(6):e3-7.
  2. Laiq Z, Bishop JA, Ali SZ. Liver lesions in children and adolescents: cytopathologic analysis and clinical correlates in 44 cases. Diagn Cytopathol 2012 Jul;40(7):586-91.
  3. Li QK, Gabrielson E, Zhang H. Application of glycoproteomics for the discovery of biomarkers in lung cancer. Proteomics Clin Appl 2012 Jun;6(5-6):244-56.
  4. Holmes BJ, Hruban RH, Wolfgang CL, Ali SZ. Fine needle aspirate of autoimmune pancreatitis (lymphoplasmacytic sclerosing pancreatitis): cytomorphologic characteristics and clinical correlates. Acta Cytol 2012;56(3):228-32.
  5. Maleki Z, Erozan Y, Geddes S, Li QK. Endorectal ultrasound-guided fine needle aspiration: A useful diagnostic tool for peri-rectal and intraluminal lesions. Acta Cytol 2012 Dec 6;57(1):9-18
  6. Olson MT, Ali SZ. Myxofibrosarcoma: cytomorphologic findings and differential diagnosis on fine needle aspiration. Acta Cytol 2012 Jan;56(1):15-24.
  7. Olson MT, Tatsas AD, Ali SZ. Cytotechnologist-attended on-site adequacy evaluation of thyroid fine-needle aspiration: comparison with cytopathologists and correlation with the final interpretation. Am J Clin Pathol 2012 Jul;138(1):90-5.
  8. Olson MT, Wakely PE Jr, Weber K, Siddiqui MT, Ali SZ. Postradiation sarcoma: Morphological findings on fine-needle aspiration with clinical correlation. Cancer Cytopathol 2012 Oct 25;120(5):351-7.
  9. Subhawong AP, Ali SZ, Tatsas AD. Nodular lymphocyte-predominant Hodgkin lymphoma: Cytopathologic correlates on fine-needle aspiration. Cancer Cytopathol 2012 Aug;120(4):254-60.
  10. Subhawong AP, Subhawong TK, Ali SZ. Large cell transformation of mycosis fungoides on fine needle aspiration: an unusual case mimicking classical hodgkin lymphoma. Acta Cytol 2012 May;56(3):321-4.
  11. Syed R, Bishop JA, Ali SZ. Sacral and presacral lesions: Cytopathologic analysis and clinical correlates. Diagn Cytopathol 2012 Jan;40(1):7-13.
  12. Tatsas AD, Owens CL, Siddiqui MT, Hruban RH, Ali SZ. Fine-needle aspiration of intrapancreatic accessory spleen: cytomorphologic features and differential diagnosis. Cancer Cytopathol 2012 Aug;120(4):261-8.
  13. Tatsas AD, Phelan DF, Gravitt PE, Boitnott JK, Clark DP. Practice patterns in cervical cancer screening and human papillomavirus testing. Am J Clin Pathol 2012 Aug;138(2):223-9.
  14. Whitworth SA, Subhawong AP, Rosenthal DL, Ali SZ. Clear cell adenocarcinoma of the lower urinary tract: Cytopathologic characteristics and differential diagnoses. Cancer Cytopathol 2012 Oct 25;120(5):308-12.
  15. Zheng G, Schmieg J, Guan H, Ali SZ. Blastic plasmacytoid dendritic cell neoplasm: cytopathologic findings. Acta Cytol 2012 Feb;56:204-8.

GI / LIVER PATHOLOGY

  1. Arnold CA, Moreira RK, Lam-Himlin D, De Petris G, Montgomery E. Whipple disease a century after the initial description: increased recognition of unusual presentations, autoimmune comorbidities, and therapy effects. Am J Surg Pathol 2012 Jul;36(7):1066-73.
  2. Bai H, Gayyed MF, Lam-Himlin DM, Klein AP, Nayar SK, Xu Y, Khan M, Argani P, Pan D, Anders RA. Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies. Hum Pathol 2012 Sep;43(9):1376-85.
  3. Bai H, Zhang N, Xu Y, Chen Q, Khan M, Potter JJ, Nayar SK, Cornish T, Alpini G, Bronk S, Pan D, Anders RA. Yes-associated protein regulates the hepatic response after bile duct ligation. Hepatology 2012 Sep;56(3):1097-107
  4. Brosnan JA, Iacobuzio-Donahue CA. A new branch on the tree: next-generation sequencing in the study of cancer evolution. Semin Cell Dev Biol 2012 Apr;23(2):237-42.
  5. Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee J, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 2012 Apr;142(4):796-804.
  6. Chen G, Olson MT, O'Neill AO, Norris A, Beierl K, Harada S, Debeljak M, Rivera-Roman K, Finley S, Stafford A, Gocke CD, Lin MT, Eshleman JR. A virtual pyrogram generator to resolve complex pyrosequencing results. J Mol Diagn 2012 Mar;14:149-59.
  7. Chenna V, Hu C, Pramanik D, Aftab BT, Karikari C, Campbell NR, Hong SM, Zhao M, Rudek MA, Khan SR, Rudin CM, Maitra A. A polymeric nanoparticle encapsulated small-molecule inhibitor of hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to smoothened antagonists. Mol Cancer Ther 2012 Jan;11(1):165-73.
  8. Crane CH, Iacobuzio-Donahue CA. Keys to personalized care in pancreatic oncology. J Clin Oncol 2012 Nov 20;30(33):4049-950.
  9. Cui Y, Brosnan JA, Blackford AL, Sur S, Hruban RH, Kinzler KW, Vogelstein B, Maitra A, Diaz LA Jr, Iacobuzio-Donahue CA, Eshleman JR. Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity. Clin Cancer Res 2012 Dec 1;18(23):6519-30
  10. Fu B, Yachida S, Morgan R, Zhong Y, Montgomery EA, Iacobuzio-Donahue CA. Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon. Am J Clin Pathol 2012 Sep;138(3):356-66.
  11. Gupta S, Pramanik D, Mukherjee R, Campbell NR, Elumalai S, de Wilde RF, Hong SM, Goggins MG, De Jesus-Acosta A, Laheru D, Maitra A. Molecular determinants of retinoic acid sensitivity in pancreatic cancer. Clin Cancer Res 2012 Jan 1;18(1):280-9.
  12. Hong SM, Omura N, Vincent A, Li A, Knight S, Yu J, Hruban RH, Goggins M. Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res. 2012 Feb;18(3):700-12.
  13. Hong SM, Vincent A, Kanda M, Leclerc J, Omura N, Borges M, Klein AP, Canto MI, Hruban RH, Goggins M. Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer. Clin Cancer Res 2012 Aug 15;18(16):4303-12.
  14. Iacobuzio-Donahue CA. Personalized medicine in pancreatic cancer: prognosis and potential implications for therapy. J Gastrointest Surg 2012 Sep;16(9):1651-2.
  15. Iacobuzio-Donahue CA, Velculescu VE, Wolfgang CE, Hruban RH. Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing. Clin Cancer Res 2012 Aug 15;18(16):4257-65.
  16. Kanda M, Matthaei H, Wu J, Hong SM, Yu J, Borges M, Hruban RH, Maitra A, Kinzler K, Vogelstein B, Goggins M. Presence of somatic mutations in most early –stage pancreatic intraepithelial neoplasia. Gastroenterol 2012 Apr;142(4):730-3.
  17. Le A, Lane NA, Hamaker M, Bose S, Barbi J, Tsukamoto T, Rojas CJ, Slusher BS, Zhang H, Zimmerman LJ, Liebler DC, Slebos R, Lorkiewicz P, Higashi RM, Fan WMT, Dang CV. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in human B lymphocytes. Cell Metab. 2012 Jan 4;15(1):110-21.
  18. Le A, Rajeshkumar NV, Maitra A, Dang CV. Conceptual framework for cutting the pancreatic cancer fuel supply. Clin Cancer Res 2012 Aug;18(16):4285-90.
  19. Liu TC, Nguyen TT, Torbenson MS. Concurrent increase in mitosis and apoptosis: a histological pattern of hepatic arterial flow abnormalities in post-transplant liver biopsies. Mod Pathol 2012 Dec;25(12):1594-8.
  20. Maitra A, Leach SD. Disputed paternity: the uncertain ancestry of pancreatic ductal neoplasia. Cancer Cell 2012 Dec;22(6):701-3.
  21. Matsukuma KE, Montgomery EA. Tubular carcinoids of the appendix: the CK7/CK20 immunophenotype can be a diagnostic pitfall. J Clin Pathol 2012 Jul;65(7):666-8
  22. Matthaei H, Norris-Kirby A, Tsiatis AC, Olino K, Hong SM, dal Molin M, Goggins M, Canto M, Horton KM, Jackson KD, Capelli P, Zamboni G, Bortesi L, Furukawa T, Egawa S, Ishida M, Ottomo S, Unno M, Motoi F, Wolfgang CL, Edil BH, Cameron JL, Eshleman JR, Schulick RD, Maitra A, Hruban RH. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2012 Feb;255(2):326-33.
  23. Matthaei H, Wu J, Dal Molin M, Debeljak M, Lingohr P, Katabi N, Klimstra DS, Adsay NV, Eshleman JR, Schulick RD, Kinzler KW, Vogelstein B, Hruban RH, Maitra A. GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct. HPB (Oxford) 2012 Oct;14(10):677-83.
  24. Matthaei H, Wylie D, Lloyd MB, Dal Molin M, Kemppainen J, Mayo SC, Wolfgang CL, Schulick RD, Langfield L, Andruss BF, Adai AT, Hruban RH, Szafranska-Schwarzbach AE, Maitra A. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res. 2012 Sep 1;18(17):4713-24.
  25. McDonald OG, Maitra A, Hruban RH. Human correlates of provocative questions in pancreatic pathology. Adv Anat Pathol 2012 Nov;19(6):351-62.
  26. Mizuma M, Rasheed ZA, Yabuuchi S, Omura N, Campbell NR, de Wilde RF, De Oliveira E, Zhang Q, Puig O, Matsui W, Hidalgo M, Maitra A, NV RK.. The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models. Mol Cancer Ther. 2012 Sep;11(9):1999-2009
  27. Montgomery E, Voltaggio L, Canto MI. Much ado about very little (lamina propria)? Gastrointest Endosc 2012 Jan;75(1):19-22.
  28. Pramanik D, Campbell NR, Das S, Gupta S, Chenna V, Bisht S, Sysa-Shah P, Bedja D, Karikari C, Steenbergen C, Gabrielson KL, Maitra A, Maitra A. A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy. Oncotarget 2012 Jul;3(6):640-50
  29. Salaria SN, Streppel MM, Lee LA, Iacobuzio-Donahue CA, Montgomery EA. Sessile serrated adenomas: high-risk lesions? Hum Pathol 2012 Nov;43(11):1808-14.
  30. Singhi AD, Jain D, Kakar S, Wu TT, Yeh MM, Torbenson M. Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma. Am J Surg Pathol. 2012 May;36(5):710-5.
  31. Singhi AD, Lazenby AJ, Montgomery EA. Gastric adenocarcinoma with chief cell differentiation: a proposal for reclassification as oxyntic gland polyp/adenoma. Am J Surg Pathol 2012 Jul;36(7):1030-5.
  32. Streppel MM, Vincent A, Mukherjee R, Campbell NR, Chen SH, Konstantopoulos K, Goggins MG, Van Seuningen I, Maitra A, Montgomery EA. Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon. Hum Pathol 2012 Oct;43(10):1755-63.
  33. Wood LD, Hruban RH. Pathology and molecular genetics of pancreatic neoplasms. Cancer J 2012 Nov;18 (6):492-501.
  34. Xu Y, Chenna V, Hu C, Sun HX, Khan M, Bai H, Yang XR, Zhu QF, Sun YF, Maitra A, Fan J, Anders RA. Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (nanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma. Clin Cancer Res 2012 Mar 1;18(5):1291-302.
  35. Yachida S, Vakiani E, White CM, Zhong Y, Saunders T, Morgan R, de Wilde RF, Maitra A, Hicks J, Demarzo AM, Shi C, Sharma R, Laheru D, Edil BH, Wolfgang CL, Schulick RD, Hruban RH, Tang LH, Klimstra DS, Iacobuzio-Donahue CA. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol 2012 Feb;36(2):173-84.
  36. Yachida S, White CM, Naito Y, Zhong Y, Brosnan JA, Macgregor-Das AM, Morgan RA, Saunders T, Laheru DA, Herman JM, Hruban RH, Klein AP, Jones S, Velculescu V, Wolfgang CL, Iacobuzio-Donahue CA. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Clin Cancer Res 2012 Nov;18(22):6339-47.
  37. Yu J, Li A, Hong SM, Hruban RH, Goggins M. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res 2012 Feb;18(4):981-92.
  38. Yu J, Walter K, Omura N, Hong S-M, Young A, Li A, Vincent A, Goggins M. Unlike pancreatic cancer cells pancreatic cancer associated fibroblasts display minimal gene induction after 5-aza-2′-deoxycytidine. PLoS One 2012 Sept;7(9):e43456.

GENITOURINARY PATHOLOGY

  1. Albadine R, Hyndman ME, Chaux A, Jeong JY, Saab S, Tavora F, Epstein JI, Gonzalgo ML, Pavlovich CP, Netto GJ. Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center. Hum Pathol 2012 Feb;43(2):254-60.
  2. Al Hussain T, Nagar MS, Epstein JI. Gleason pattern 5 is frequently underdiagnosed on prostate needle core biopsy. Urology 2012 Jan;79:178-81.
  3. Amin A, Epstein JI. Noninvasive micropapillary urothelial carcinoma: a clinicopathologic study of 18 cases. Hum Pathol 2012;43:2124-8
  4. Bagnasco SM. Protein kinase Cα comes to the rescue of aquaporin 2. Am J Physiol Renal Physiol 2012 Jul;303(1):F35-6.
  5. Bagnasco SM, Subramanian AK, Desai NM. Fungal infection presenting as giant cell tubulointerstitial nephritis in kidney allograft. Transpl Infect Dis 2012 Jun;14(3):288-91.
  6. Berman DM, Bosenberg MW, Orwant RL, Thurberg BL, Draetta GF, Fletcher CD, Loda M. Investigative pathology: leading the post-genomic revolution. Lab Invest 2012 Jan;92(1):4-8.
  7. Brimo F, Epstein JI. Immunohistochemical pitfalls in prostate pathology. Hum Pathol 2012 Mar;43:313-24.
  8. Brimo F, Epstein JI. Selected common diagnostic problems in urological pathology: perspectives from a large genitourinary consult service. Arch Pathol Lab Med 2012 Apr;136:360-71.
  9. Carter HB, Partin AW, Walsh PC, Trock BJ, Nelson WG, Coffet DS, Singer EA, Epstein JI. Gleason score 6 adenocarcinoma: Should it be labeled as cancer. JCO 2012 Dec;30:4294-6.
  10. Chang A, Amin A, Gabrielson E, Illei P, Roden RB, Sharma R, Epstein JI. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol 2012 Oct;36(10):1472-6.
  11. Chaux A, Brimo F, Gonzalez-Roibon N, Shah S, Schultz L, Rizk JM, Argani P, Hicks J, Netto GJ. Immunohistochemical evidence of dysregulation of the Mammalian target of rapamycin pathway in primary and metastatic pheochromocytomas. Urology 2012 Sep;80(3):736.e7-736.e12.
  12. Chaux A, Cohen JS, Schultz L, Albadine R, Jadallah S, Murphy KM, Sharma R, Schoenberg MP, Netto GJ. High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: a study using formalin-fixed, paraffin-embedded archival tissues. Hum Pathol 2012 Oct;43(10):1590-5.
  13. Chaux A, Fajardo DA, Gonzalez-Roibon N, Partin AW, Eisenberger M, Deweese TL, Netto GJ. High-grade prostatic adenocarcinoma present in a single biopsy core as associated with increased extraprostatic extension, seminal vesicle invasion, and positive surgical margins at prostatectomy. Urology 2012 Apr;79(4):863-8.
  14. Chaux A, Karram S, Miller JS, Fajardo DA, Lee TK, Miyamoto H, Netto GJ. High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center. Hum Pathol 2012 Jan;43(1):115-20.
  15. Chaux A, Peskoe SB, Gonzalez-Roibon N, Schultz L, Albadine R, Hicks J, De Marzo AM, Platz EA, Netto GJ. Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer. Mod Pathol 2012 Nov;25(11):1543-9.
  16. Chaux A, Schultz L, Albadine R, Hicks J, Kim JJ, Allaf ME, Carducci MA, Rodriguez R, Hammers HJ, Argani P, Reuter VE, Netto GJ. Immunoexpression status and prognostic value of mammalian target of rapamycin and hypoxia-induced pathway members in papillary cell renal cell carcinomas. Hum Pathol 2012 Dec;43(12):2129-37.
  17. Epstein JI. The diagnosis of limited adenocarcinoma of the prostate. Histopathol 2012 Jan;60:28-40.
  18. Epstein JI, Feng Z, Trock BJ, Pierorazio PM. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using The modified Gleason grading system and factoring in tertiary grades. Eur Urol 2012 May;61:1019-24.
  19. Epstein JI, Leclercq NR. Diagnostic issues of prostate biopsies: PIN-like ductal adenocarcinoma. Ann Pathol 2012 Apr;32:132-6.
  20. Han JS, Toll AD, Carter B, Landis P, Lee S, Epstein JI. Low prostate specific antigen and no Gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant cancer at radical prostatectomy. Urology 2012 Oct;80(4):883-8.
  21. Kryvenko ON, Epstein JI. Histologic criteria and pitfalls in the diagnosis of lymphovascular invasion in radical prostatectomy specimens. Am J Surg Pathol 2012 Dec;36:1865-73.
  22. Kryvenko ON, Jankowski M, Chitale DA, Tang D, Rundle A, Trudeau S, Rybicki BA. Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer. Mod Pathol 2012 Jul;25(7):1023-32.
  23. Lovejoy CA, Li W, Reisenweber S, Thongthip S, Bruno J, de Lange T, De S, Petrini JH, Sung PA, Jasin M, Rosenbluh J, Zwang Y, Weir BA, Hatton C, Ivanova E, Macconaill L, Hanna M, Hahn WC, Lue NF, Reddel RR, Jiao Y, Kinzler K, Vogelstein B, Papadopoulos N, Meeker AK; for the ALT Starr Cancer Consortium. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet 2012 Jul;8(7):e1002772
  24. Miyamoto H, Izumi K, Yao JL, Li Y, Yang Q, McMahon LA, Gonzalez-Roibon N, Hicks DG, Tacha D, Netto GJ. GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor. Hum Pathol 2012 Nov;43(11):2033-40.
  25. Netto GJ. Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? Nat Rev Urol 2012 Jan;9(1):41-51.
  26. Netto GJ, Cheng L. Emerging critical role of molecular testing in diagnostic genitourinary pathology. Arch Pathol Lab Med 2012 Apr;136(4):372-90.
  27. Pisitkun T, Gandolfo MT, Knepper M, Bagnasco SM. Application of system biology principles to protein biomarker discovery: urinary exosomal proteome in renal transplantation. Proteomics Clin Appl 2012 June;6(5-6):268-78.
  28. Ross HM, Kryvenko O, Cowan J, Simko JP, Wheeler TM, Epstein JI. Do adenocarcinomas of the prostate with Gleason score (GS) <6 have the potential to metastasize to lymph nodes? Am J Surg Pathol 2012 Sep;36(9):1346-52.
  29. Sfanos KS, Aloia AL, De Marzo AM, Rein A. XMRV and prostate cancer—a 'final' perspective. Nat Rev Urol 2012 Feb;9:111-8.
  30. Sfanos KS, De Marzo AM. Prostate cancer and inflammation: the evidence. Histopathology 2012 Jan;60(1):199-215.
  31. Toll A, Epstein JI. Invasive low grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 case. Am J Surg Pathol 2012 Jul;36:1081-6.
  32. Toubaji A, Sutcliffe S, Chaux A, Lecksell K, Hicks J, De Marzo AM, Platz EA, Netto GJ. Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: a tissue microarray and digital imaging analysis-based study of 428 cases. Hum Pathol 2012 Nov;43(11):1852-65.
  33. Van Neste L, Bigley J, Toll A, Otto G,Clark J, Delree P, Van Criekinge W, Epstein JI. A tissue biopsy based epigenetic multiplex PCR assay for prostate cancer detection. BMC Urol 2012 June;12:16.

GYNECOLOGIC PATHOLOGY

  1. Ayhan A, Mao TL, Seckin T, Wu CH, Guan B, Ogawa H, Futagami M, Mizukami H, Yokoyama Y, Kurman RJ, Shih IM. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Int J Gynecol Cancer 2012 Oct;22(8):1310-5.
  2. Chang CL, Hsu YT, Wu CC, Yang YC, Wang C, Wu TC, Hung CF. Immune mechanism of the antitumor effects generated by bortezomib. J Immunol 2012 Sep 15;189(6):3209-20.
  3. Guan B, Gao M, Wu CH, Wang TL, Shih IeM. Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions. Neoplasia 2012 Oct;14(10):986-93.
  4. Hung C-F, Chiang AJ, Tsai H-H, Pomper MG, Kang TH, Roden RR, Wu T-C. Ovarian cancer gene therapy using HPV-16 pseudovirion carrying the HSV-tk gene. PLoS ONE 2012 July;7(7):e40983.
  5. Jones S, Wang TL, Kurman RJ, Nakayama K, Velculescu VE, Vogelstein B, Kinzler KW, Papadopoulos N, Shih IeM. Low-grade serous carcinomas of the ovary contain very few point mutations. J Pathol. 2012 Feb;226(3):413-20.
  6. Kang TH, Mao C-P, He L, Tsai YC, Liu K, La V, Wu T-C, Hung C-F. Tumor-targeted delivery of IL-2 by NKG2D leads to accumulation of antigen-specific CD8+ T cells in the tumor loci and enhanced anti-tumor effects. PLoS ONE 2012 Apr;7(4):e35141
  7. Kshirsagar M, Jiang W, Shih IeM. DNA damage response is prominent in ovarian hgh-grade serous carcinomas, especially those with Rsf-1 (HBXAP) overexpression. J Oncol 2012;2012:621685.
  8. Kuhn E, Kurman RJ, Sehdev AS, Shih IeM. Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol 2012 Sep;31(5):416-22.
  9. Kuhn E, Kurman RJ, Soslow RA, Han G, Sehdev AS, Morin PJ, Wang TL, Shih IeM. The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma. Am J Surg Pathol 2012 Dec;36(12):1826-34.
  10. Kuhn E, Kurman RJ, Vang R, Sehdev AS, Han G, Soslow R, Wang TL, Shih IeM. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions. J Pathol 2012 Feb;226(3):421-6.
  11. Kuhn E, Wu RC, Guan B, Wu G, Zhang J, Wang Y, Song L, Yuan X, Wei L, Roden RB, Kuo KT, Nakayama K, Clarke B, Shaw P, Olvera N, Kurman RJ, Levine DA, Wang TL, Shih IeM. Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. J Natl Cancer Inst 2012 Oct 3;104(19):1503-13.
  12. Murphy KM, Descipio C, Wagenfuehr J, Tandy S, Mabray J, Beierl K, Micetich K, Libby AL, Ronnett BM. Tetraploid partial hydatidiform mole: a case report and review of the literature. Int J Gynecol Pathol 2012 Jan;31(1):73-9.
  13. Seidman JD, Yemelyanova A, Cosin JA, Smith A, Kurman RJ. Survival rates for international federation of gynecology and obstetrics stage III ovarian carcinoma by cell type: a study of 262 unselected patients with uniform pathologic review. Int J Gynecol Cancer 2012 Mar;22(3):367-71.
  14. Sheu JJ, Guan B, Tsai FJ, Hsiao EY, Chen CM, Seruca R, Wang TL, Shih IeM. Mutant BRAF induces DNA strand breaks, activates DNA damage response pathway, and up-regulates glucose transporter-1 in nontransformed epithelial cells. Am J Pathol 2012 Mar;180(3):1179-88.
  15. Vang R, Gupta G, Wu LS, Yemelyanova AV, Kurman RJ, Murphy KM, DeScipio C, Ronnett BM. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis. Am J Surg Pathol 2012 Mar;36:443-53.
  16. Vang R, Visvanathan K, Gross A, Maambo E, Gupta M, Kuhn E, Li R, Ronnett BM, Seidman JD, Yemelyanova A, Shih IM, Shaw PA, Soslow RA, Kurman RJ. Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol 2012 May;31:243–53.
  17. Wu CH, Mao TL, Vang R, Ayhan A, Wang TL, Kurman RJ, Shih IeM. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Int J Gynecol Pathol 2012 Jul;31(4):297-303.
  18. Yap KL, Fraley SI, Thiaville MM, Jinawath N, Nakayama K, Wang J, Wang TL, Wirtz D, Shih IeM. NAC1 is an actin-binding protein that is essential for effective cytokinesis in cancer cells. Cancer Res 2012 Aug 15;72(16):4085-96.

HEMATOLOGIC PATHOLOGY

  1. Burns KH, Boeke JD. Human transposon tectonics. Cell 2012 May 11;149(4):740-52
  2. Duffield AS, Aoki J, Levis M, Cowan K, Gocke CD, Burns KH, Borowitz MJ, Vuica-Ross M. Clinical and pathologic features of secondary acute promyelocytic leukemia. Am J Clin Pathol 2012 Mar;137(3):395-402.
  3. McCall CM, Mudali S, Arceci RJ, Small D, Fuller S, Gocke CD, Vuica-Ross M, Burns KH, Borowitz MJ, Duffield AS. Flow cytometric findings in hemophagocytic lymphohysitiocytosis. Am J Clin Pathol 2012 May;137:786-94.
  4. Wu JM, Vonderheid E, Gocke CD, Moresi JM, Liegeois N, Borowitz MJ. Flow cytometry of lesional skin enhances the evaluation of cutaneous B-cell lymphomas. J Cutan Pathol 2012 Oct;39(10):918-28.

IMMUNOLOGY

  1. Allen JG, Lee MT, Weiss ES, Arnaoutakis GJ, Shah AS, Detrick B. Preoperative recipient cytokine levels are associated with early lung allograft dysfunction. Ann Thorac Surg 2012 Jun;93(6):1843-9.
  2. Amukele TK, Michael K, Hanes M, Miller RE, Jackson JB. External quality assurance performance of clinical research laboratories in sub-saharan Africa. Am J Clin Pathol 2012 Nov;138(5):720-3.
  3. Caturegli P, De Remigis A, Ferlito M, Landek-Salgado MA, Iwama S, Tzou SC, Ladenson PW. Anatabine ameliorates experimental autoimmune thyroiditis. Endocrinology 2012 Sep;153(9):4580-7.
  4. Chen P, Baldeviano G, Ligons D, Talor M, Barin J, Rose NR, Čiháková D. Susceptibility to autoimmune myocarditis is associated with intrinsic differences in CD4+ T cells. Clin Exp Immunol 2012 Aug;169(2):79-88.
  5. Barbesino G, Sluss PM, Caturegli P. Central hypothyroidism in a patient with pituitary autoimmunity: evidence for TSH-independent thyroid hormone synthesis. J Clin Endocrinol Metab 2012 Feb;97(2):345-50.
  6. Barin JG, Baldeviano GC, Talor MV, Wu L, Ong S, Quader F, Chen P, Zheng D, Caturegli P, Rose NR, Cihakova D. Macrophages participate in IL-17-mediated inflammation. Eur J Immunol 2012 Mar;42(3):726-36.
  7. Barin JG, Rose NR, Ciháková D. Macrophage diversity in cardiac inflammation: a review. Immunobiology 2012 May;217(5):468-75.
  8. Bishop JA, Sharma R, Netto G, Illei PB. Thyroid transcription factor 1 expression in a case of renal collecting duct carcinoma-Reply. Human Pathol 2012 July;43(7):1154.
  9. Cimino-Mathews A, Sharma R, Illei PB. Detection of human papillomavirus in small cell carcinomas of the anus and rectum. Am J Surg Pathol 2012 Jul;36(7):1087-92.
  10. Guaraldi F, Landek-Salgado MA, Hutfless S, Samoni F, Talor MV, Matos PG, Salvatori R, Rose NR, Caturegli P. Pituitary antibodies in women with Hashimoto's thyroiditis: prevalence in diagnostic and prediagnostic sera. Thyroid 2012 May;22(5):509-15.
  11. Hamad AR, Arcara K, Uddin S, Donner T. The potential of Fas ligand (apoptosis-inducing molecule) as an unconventional therapeutic target in type 1 diabetes. Front Immunol 2012;3:196.
  12. Iwama S, De Remigis A, Bishop JA, Kimura HJ, Caturegli P. Hurthle cells predict hypothyroidism in interferon-γ transgenic mice of different genetic backgrounds. Endocrinology 2012 Aug;153(8):4059-66.
  13. Landek-Salgado MA, Leporati P, Lupi I, Geis A, Caturegli P. Growth hormone and proopiomelanocortin are targeted by autoantibodies in a patient with biopsy-proven IgG4-related hypophysitis. Pituitary 2012 Sep;15(3):412-9.
  14. Landek-Salgado MA, Rose NR, Caturegli P. Placenta suppresses experimental autoimmune hypophysitis through soluble TNF receptor 1. J Autoimmun. 2012 May;38(2-3):J88-96.
  15. Maters AW, Wright CV, Lee MT, Schwichtenberg G, Detrick B. Detection of type-specific antibodies to HSV-1 and HSV-2: comparative analysis of a chemiluminescence immunoassay with a conventional ELISA. Diagn Microbiol Infect Dis 2012 Jul;73(3):273-4.
  16. Miller FW, Pollard KM, Parks CG, Germolec DR, Leung PS, Selmi C, Humble MC, Rose NR. Criteria for environmentally associated autoimmune diseases. J Autoimmun. 2012 Dec;39(4):253-8.
  17. Sadegh-Nasseri S, Chou CL, Hartman IZ, Kim A, Narayan K. How HLA-DM works: recognition of MHC II conformational heterogeneity. Front Biosci (Schol Ed) 2012 Jun;4:1325-32.
  18. Webb TJ, Li X, Giuntoli RL 2nd, Lopez PH, Heuser C, Schnaar RL, Tsuji M, Kurts C, Oelke M, Schneck JP. Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer Res 2012 Aug 1;72(15):3744-52.

INFORMATICS

  1. Cornish TC, Swapp RE, Kaplan KJ. Whole-slide imaging: routine pathologic diagnosis. Adv Anat Pathol 2012 May;19(3):152-9.
  2. Kim B, Barker JB, Hruban RH, Sandone C, Cornish TC. The Johns Hopkins Atlas of Pancreatic Pathology: developing an interactive Atlas and teaching algorithm for the Apple iPad. J Biocommun 2012;38(1):4-10.
  3. Lai H, Detrick B, Fishman EK, Gerstenblith G, Brinker JA, Hollis BW, Bartlett J, Cofrancesco J Jr, Tong W, Tai H, Chen S, Bhatia S, Lai S. Vitamin D deficiency is associated with the development of subclinical coronary artery disease in African Americans with HIV infection: a preliminary study. J Investig Med 2012 Jun;60(5):801-7.
  4. Lai H, Fishman EK, Gerstenblith G, Brinker JA, Tong W, Bhatia S, Detrick B, Lai S. Vitamin D deficiency is associated with significant coronary stenoses in asymptomatic African American chronic cocaine users. Int J Cardiol 2012 Jul 12;158(2):211-6.
  5. Lai H, Gerstenblith G, Fishman EK, Brinker J, Kickler T, Tong W, Bhatia S, Hong T, Chen S, Li J, Detrick B, Lai S. Vitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infection. Clin Infect Dis 2012 Jun;54(12):1747-55.

MEDICAL MICROBIOLOGY

  1. Bishop JA, Nelson AM, Merz WG, Askin FB, Riedel S. Evaluation of the detection of melanin by the Fontana-Masson silver stain in tissue with a wide range of organisms including Cryptococcus. Hum Pathol 2012 Jun;43(6):898-903.
  2. Dumler JS. The biological basis of severe outcomes in Anaplasma phagocytophilum infection. FEMS Immunol Med Microbiol. 2012 Feb;64(1):13-20.
  3. Forman MS, Advani S, Newman C, Gaydos CA, Milstone AM, Valsamakis A. Diagnostic performance of two highly multiplexed respiratory virus assays in a pediatric cohort. J Clin Virol 2012 Oct;55(2):168-72.
  4. Frevert U, Movila A, Nikolskaia OV, Raper J, Mackey ZB, Abdulla M, McKerrow J, Grab DJ. Early invasion of brain parenchyma by African trypanosomes. PLoS One 2012 Aug;7(8):e43913.
  5. Kwiatkowski NP, Babiker WM, Merz WG, Carroll KC, Zhang SX. Evaluation of nucleic acid sequencing of the D1/D2 region of the large-subunit of the 28S rDNA and the Internal Transcribed Spacer region using SmartGeneTM IDN software for identification of filamentous fungi in a Clinical Laboratory. J Mol Diagn 2012 Jul;14(4):393-401.
  6. Mahmud A, Lee R, Munfus-McGray D, Kwiatkowski N, Subramanian A, Neofytos D, Carroll K, Zhang SX. Actinomucor elegans as an emerging cause of mucormycosis: case report and review. J Clin Microbiol 2012 March;50(3):1092-5.
  7. Meriden Z, Marr K, Lederman HM, Illei PB, Villa K, Riedel S, Carroll KC, Zhang SX. Ochrochonis gallopava infection in a patient with chronic granulomatous disease. Med Mycol 2012 Nov;50(8):890-6.
  8. Milstone AM, Perl TM, Valsamakis A. Epidemiology of respiratory viruses in children admitted to an infant/toddler unit. Am J Infect Control. 2012 Jun;40(5):462-4.
  9. Reller ME, Bodinayake C, Nagahawatte A, Devasiri V, Kodikara-Arachichi W, Strouse JJ, Broadwater A, Østbye T, de Silva A, Woods CW. Unsuspected dengue and acute febrile illness in rural and semi-urban Southern Sri Lanka. Emerg Infect Dis 2012 February;18(2):256-63.
  10. Reller ME, Bodinayake C, Nagahawatte A, Devasiri V, Kodikara-Arachichi W, Strouse JJ, Flom JE, Østbye T, Woods CW, Dumler JS. Unsuspected rickettsioses among patients with acute febrile illness, Sri Lanka, 2007. Emerg Infect Dis 2012 May;18(5):825-9.
  11. Riedel S. Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis. Diagn Microbiol Infect Dis 2012 Jul;73(3):221-7.
  12. Riedel S, Dionne K, Ellis C, Duffield A, Carroll KC, Parrish NM. Mycobacterium szulgai: an unusual cause of disseminated mycobacterial infections. Infection 2012 Aug;40(4):463-8
  13. Seah C, Richardson SE, Tsui G, Yu B, Thornback J, McTaggart L, Boggild A, Wengenack NL, Zhang SX. Comparison of the FXGTM: RESP (Asp +) real-time PCR assay with direct immunofluorescence and calcofluor white staining for the detection of Pneumocystis jirovecii in respiratory specimens. Medical Mycology 2012 Apr;50(3):324-7.
  14. Sydnor ER, Greer A, Budd AP, Pehar M, Munshaw S, Neofytos D, Perl TM, Valsamakis A. An outbreak of human parainfluenza virus 3 infection in an outpatient hematopoietic stem cell transplantation clinic. Am J Infect Control 2012 Sep;40(7):601-5.
  15. Tan KE, Ellis BC, Lee R, Stamper PD, Zhang SX, Carroll KC. Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and cost-effectiveness. J Clin Microbiol 2012 Oct;50(10):3301-8
  16. Zhang SX. Non-culture based methods in diagnostic mycology. Clin Microbiol Newsletter 2012 July; 34(13):101-5

MOLECULAR PATHOLOGY

  1. Argani P, Yonescu R, Morsberger L, Morris K, Netto GJ, Smith N, Gonzalez N, Illei PB, Ladanyi M, Griffin CA. Molecular Confirmation of the t(6;11)(p21;q12) Renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum. Am J Surg Pathol 2012 Oct;36(10):1516-26.
  2. Belchis DA, Shekitka K, Gocke CD. A unique, histopathologic lesion in a subset of patients with spontaneous pneumothorax. Arch Pathol Lab Med. 2012 Dec;136(12):1522-7.
  3. Descipio C, Conlin L, Rosenfeld J, Tepperberg J, Pasion R, Patel A, McDonald MT, Aradhya S, Ho D, Goldstein J, McGuire M, Mulchandani S, Medne L, Rupps R, Serrano AH, Thorland EC, Tsai AC, Hilhorst-Hofstee Y, Ruivenkamp CA, Van Esch H, Addor MC, Martinet D, Mason TB, Clark D, Spinner NB, Krantz ID. Subtelomeric deletion of chromosome 10p15.3: Clinical findings and molecular cytogenetic characterization. Am J Med Genet A. 2012 Sep;158A(9):2152-61.
  4. Gocke CD, Mason J, Brusca L, Laosinchai-Wolf W, Higgs C, Newell H, Masters A, Friar L, Karp J, Griffiths M, Wei Q, Labourier E. Risk-based classification of leukemia by cytogenetic and multiplex molecular methods: results from a multicenter validation study. Blood Cancer J 2012 July;2:e78-e86.
  5. Jinawath N, Zambrano R, Wohler E, Palmquist MK, Hoover-Fong J, Hamosh A, Batista DA. Mosaic trisomy 13: understanding origin using SNP array. J Med Genet 2011 May;48(5):323-6.

NEUROPATHOLOGY

  1. Chiang PM, Fortna RR, Price DL, Li T, Wong PC. Specific domains in anterior pharynx-defective 1 determine its intramembrane interactions with nicastrin and presenilin. Neurobiol Aging. 2012 Feb;33(2):277-85.
  2. Codispoti K-E, Beason-Held LL, Kraut MA, O'Brien RJ, Rudow G, Pletnikova O, Crain B, Troncoso JC, Susan Resnick SM. Longitudinal brain activity changes in asymptomatic Alzheimer disease. Brain and Behavior 2012;2(3):221–30.
  3. Eberhart C. Three down and one to go: modeling medulloblastoma subgroups. Cancer Cell 2012;21:137-8. (review)
  4. Gertz B, Wong M, Martin LJ. Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice. J Neuropathol Exp Neurol 2012 Feb;71(2):162-77.
  5. Guo Z, Rudow G, Pletnikova O, Codispoti KE, Orr BA, Crain BJ, Duan W, Margolis RL, Rosenblatt A, Ross CA, Troncoso JC. Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease. Mov Disord 2012 Sep 15;27(11):1379-86.
  6. Lim KJ, Rajan K, Eberhart CG. Effects of Zeng Sheng Ping/ACAPHA on malignant brain tumor growth and notch signaling. Anticancer Res 2012 Jul;32(7):2689-96.
  7. Lin A, Rodriguez FJ, Karajannis MA, Williams SC, Legault G, Zagzag D, Burger PC, Allen JC, Eberhart CG, Bar EE. BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants. J Neuropathol Exp Neurol 2012 Jan;71(1):66-72.
  8. Orr BA, Eberhart CG. Nature versus nurture in glioblastoma: microenvironment and genetics can both drive mesenchymal transcriptional signature. Am J Pathol 2012 May;180(5):1768-71.
  9. Orr BA, Haffner MC, Nelson WG, Yegnasubramanian S, Eberhart CG. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival inmalignant glioma. PLoS One 2012 Jul 19;7(7):e41036.
  10. Raabe EH, Eberhart CG. Methylome alterations "mark" new therapeutic opportunities in glioblastoma. Cancer Cell 2012 Oct 16;22(4):417-8.
  11. Rodriguez FJ. Peripheral nerve sheath tumors: the elegant chapter in surgical neuropathology. Acta Neuropathol 2012 Mar;123(3):293-4.
  12. Rodriguez FJ, Folpe AL, Giannini C, Perry A. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol 2012 Mar;123(3):295-319.
  13. Rodriguez FJ, Lewis-Tuffin LJ, Anastasiadis PZ. E-cadherin's dark side: Possible role in tumor progression. Biochim Biophys Acta 2012 Aug;1826(1):23-31.
  14. Rodriguez FJ, Orr BA, Ligon KL, Eberhart CG. Neoplastic cells are a rare component in human glioblastoma microvasculature. Oncotarget 2012 Jan;3(1):98-106.
  15. Rodriguez FJ, Perry A, Rosenblum MK, Krawitz S, Cohen KJ, Lin D, Mosier S, Lin MT, Eberhart CG, Burger PC. Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity. Acta Neuropathol 2012 Nov;124(5):627-41.
  16. Rodriguez FJ, Stratakis CA, Evans DG. Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes. Acta Neuropathol 2012 Mar;123(3):349-67.
  17. Savonenko AV, Melnikova T, Hiatt A, Li T, Worley PF, Troncoso JC, Wong PC, Price DL. Alzheimer's therapeutics: translation of preclinical science to clinical drug development. Neuropsychopharmacology 2012 Jan;37(1):261-77.
  18. Tabbarah AZ, Carlson AW, Oviedo A, Ketterling RP, Rodriguez FJ. Identification of t(1;19)(q12;p13) and ploidy changes in an ependymosarcoma: a cytogenetic evaluation. Clin Neuropathol 2012 May-Jun;31(3):142-5.
  19. Tsao W, Jeong YH, Lin S, Ling J, Price DL, Chiang PM, Wong PC. Rodent models of TDP-43: recent advances. Brain Res. 2012 Jun 26;1462:26-39.

OPHTHALMIC PATHOLOGY

  1. Asnaghi L, Ebrahimi KB, Schreck KC, Bar EE, Coonfield ML, Bell WR, Handa J, Merbs SL, Harbour JW, Eberhart CG. Notch signaling promotes growth and invasion in uveal melanoma. Clin Cancer Res 2012 Feb;18(3):654-65.
  2. Rodriguez FJ, Ligon AH, Horkayne-Szakaly I, Rushing EJ, Ligon KL, Vena N, Garcia DI, Cameron JD, Eberhart CG. BRAF Duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper. J Neuropathol Exp Neurol 2012 Sep;71(9):789-94.

SURGICAL PATHOLOGY

  1. Amin A, Epstein JI. Noninvasive micropapillary urothelial carcinoma: a clinicopathologic study of 18 cases. Hum Pathol 2012;43:2124-8
  2. Al Hussain T, Nagar MS, Epstein JI. Gleason pattern 5 is frequently underdiagnosed on prostate needle core biopsy. Urology 2012 Jan;79:178-81.
  3. Argani P, Yonescu R, Morsberger L, Morris K, Netto GJ, Smith N, Gonzalez N, Illei PB, Ladanyi M, Griffin CA. Molecular Confirmation of the t(6;11)(p21;q12) Renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum. Am J Surg Pathol 2012 Oct;36(10):1516-26.
  4. Begum S. Molecular changes in smoking-related lung cancer. Expert Rev Mol Diagn. 2012 Jan;12(1):93-106.
  5. Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, Taube JM, Koch WM, Westra WH. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol 2012 Dec;36(12):1874-82.
  6. Bishop JA, Maleki Z, Valsamakis A, Ogawa T, Chang X, Pai SI, Westra WH. Application of the Hybrid Capture 2 assay to squamous cell carcinomas of the head and neck: A convenient liquid-phase approach for the reliable determination of human papillomavirus status. Cancer Cytopathol 2012 Feb 25;120(1):18-25.
  7. Bishop JA, Ogawa T, Chang X, Illei PB, Gabrielson E, Pai SI, Westra WH. HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. Am J Surg Pathol 2012 Jan;36(1):142-8.
  8. Bishop JA, Sharma R, Netto G, Illei PB. Thyroid transcription factor 1 expression in a case of renal collecting duct carcinoma-Reply. Human Pathol 2012 July;43(7):1154
  9. Bishop JA, Teruya-Feldstein J, Westra WH, Pelosi G, Travis WD, Rekhtman N. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol 2012 Mar;25(3):405-15.
  10. Bishop JA, Westra WH. NUT midline carcinomas of the sinonasal tract. Am J Surg Pathol. 2012 Aug;36(8):1216-21.
  11. Bishop JA, Wu G, Tufano RP, Westra WH. Histological patterns of locoregional recurrence in Hürthle cell carcinoma of the thyroid gland. Thyroid 2012 Jul;22(7):690-4
  12. Brimo F, Epstein JI. Selected common diagnostic problems in urological pathology: Perspectives from a large genitourinary consult service. Arch Pathol Lab Med 2012 Apr;136:360-71.
  13. Brimo F, Epstein JI. Immunohistochemical pitfalls in prostate pathology. Hum Pathol 2012 Mar;43:313-24.
  14. Carter HB, Partin AW, Walsh PC, Trock BJ, Nelson WG, Coffet DS, Singer EA, Epstein JI. Gleason score 6 adenocarcinoma: Should it be labeled as cancer. JCO 2012Dec;30:4294-6.
  15. Chang A, Amin A, Gabrielson E, Illei P, Roden RB, Sharma R, Epstein JI. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol 2012 Oct;36(10):1472-6.
  16. Cimino-Mathews A, Lin BM, Chang SS, Boahene KD, Bishop JA. Small cell carcinoma ex-pleomorphic adenoma of the parotid gland. Head Neck Pathol 2012 Dec;6(4):502-6.
  17. Cimino-Mathews A, Sharma R, Illei PB. Detection of human papillomavirus in small cell carcinomas of the anus and rectum. Am J Surg Pathol 2012 Jul;36(7):1087-92.
  18. El-Naggar AK, Westra WH. P16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretive relevance and consistency. Head Neck 2012 Apr;34(4):459-61.
  19. Epstein JI. The diagnosis of limited adenocarcinoma of the prostate. Histopathol 2012 Jan;60:28-40.
  20. Epstein JI, Feng Z, Trock BJ, Pierorazio PM. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using The modified Gleason grading system and factoring in tertiary grades. Eur Urol 2012 May;61:1019-24.
  21. Epstein JI, Leclercq NR. Diagnostic issues of prostate biopsies: PIN-like ductal adenocarcinoma. Ann Pathol 2012 Apr;32:132-6.
  22. Han JS, Toll AD, Carter B, Landis P, Lee S, Epstein JI. Low prostate specific antigen and no Gleason score upgrade despite more extensive cancer during active surveillance predicts insignificant cancer at radical prostatectomy. Urology 2012 Oct;80(4):883-8.
  23. Kryvenko ON, Epstein JI. Histologic criteria and pitfalls in the diagnosis of lymphovascular invasion in radical prostatectomy specimens. Am J Surg Pathol 2012 Dec;36:1865-73.
  24. Malinowska I, Kwiatkowski DJ, Weiss S, Martignoni G, Netto G, Argani P. Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction. Am J Surg Pathol 2012 May;36(5):783-4.
  25. Ross HM, Kryvenko O, Cowan J, Simko JP, Wheeler TM, Epstein JI. Do adenocarcinomas of the prostate with Gleason score (GS) <6 have the potential to metastasize to lymph nodes? Am J Surg Pathol 2012 Sep;36(9):1346-52.
  26. Ross H, Martignoni G, Argani P. Renal cell carcinoma with clear cell and papillary features. Arch Pathol Lab Med 2012 Apr;136(4):391-9.
  27. Singhi AD, Califano J, Westra WH. High-risk human papillomavirus in nasopharyngeal carcinoma. Head Neck 2012 Feb;34(2):213-8.
  28. Singhi AD, Cimino-Mathews A, Jenkins RB, Lan F, Fink SR, Nassar H, Vang R, Fetting JH, Hicks J, Sukumar S, De Marzo AM, Argani P. MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors. Mod Pathol 2012 Mar;25(3):378-87.
  29. Toll A, Epstein JI. Invasive low grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 cases. Am J Surg Pathol 2012 Jul;36:1081-6.
  30. Van Neste L, Bigley J, Toll A, Otto G,Clark J, Delree P, Van Criekinge W, Epstein JI. A tissue biopsy based epigenetic multiplex PCR assay for prostate cancer detection. BMC Urol 2012 June;12:16.
  31. Wakely PE Jr, Ali SZ, Bishop JA. The cytopathology of malignant peripheral nerve sheath tumor : a report of 55 fine-needle aspiration cases. Cancer Cytopathol 2012 Oct 25;120(5):334-41.

TRANSFUSION MEDICINE

  1. Aizire J, McConnell MS, Mudiope P, Mubiru M, Matovu F, Parsons TL, Elbireer A, Nolan M, Janoff EN, Fowler MG. Kinetics of nevirapine and its impact on HIV-1 RNA levels in maternal plasma and breast milk over time after perinatal single dose nevirapine. J Acquir Immune Defic Syndr 2012 Aug;60(5):483-8.
  2. Amukele TK, Michael K, Hanes M, Miller RE, Jackson JB. External quality assurance performance of clinical research laboratories in sub-saharan Africa. Am J Clin Pathol 2012 Nov;138(5):720-3.
  3. Brunker, PAR. Immunology IV: clinical applications in health and disease. Transfusion 2012 Aug;52(8):1836.
  4. Cousins MM, Swan D, Margaret CA, Hoover DR, Eshleman SH. Analysis of HIV using a high resolution melting (HRM) diversity assay: automation of HRM data analysis enhances the utility of the assay for analysis of HIV incidence. 12/2012. PLoS One 7(12):e51359.
  5. Eipl K, Nakabiito C, Bwogi K, Motevalli M, Roots A, Blagg L, Jackson JB. Seroprevalence of unexpected red blood cell antibodies among pregnant women in Uganda.Immunohematol 2012 Dec;28(4):115-7.
  6. Guo N, Wang J, Ness P, Yao F, Bi X, Li J, Yun Z, Guo X, Huang Y, Dong X, Tiemuer MH, He W, Ma H, Huang M, Liu J, Wright DJ, Nelson K, Shan H; for the NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) International Component. First-time donors responding to a national disaster may be an untapped resource for the blood centre. Vox Sang 2012 May;102(4):338-44.
  7. Guo N, Wang J, Ness P, Yao F, Dong X, Bi X, Mei H, Li J, He W, Lu Y, Ma H, Wen X, Huang M, Liu J, Wright DJ, Shan H; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. Demographics of apheresis platelet donors in five blood centers in China. Transfusion 2012 Mar:52(3):560-6.
  8. Jackson JB, Onyango-Makumbi C. Reply to "Were the interests of the vulnerable truly served? The predictable failure of HIV immune globulin". JAIDS 2012 Sept;61(1):e10-12.
  9. James MM, Wang L, Donnell D, Cousins MM, Barlow-Mosha L, Fogel J, Towler WI, Agwu AL, Bagenda D, Mubiru M, Musoke P, Eshleman SH. Use of a high resolution melting (HRM) assay to analyze HIV diversity in HIV-infected Ugandan children. Ped Infect Dis 2012 Nov;31(11):e222-e228.
  10. Jerrard GA, Liu J, Case R, Motevalli M, Bolton SG, King KE, Beigel J, Jackson JB. Implications of weight and body mass index for plasma donation and health. ISRN Hematology;2012(2012),Article ID 937585, 5 pages.
  11. Kacker S, Frick KD, Gaydos CA, Tobian AAR. Costs and effectiveness of neonatal male circumcision. Arch Pediatr Adolesc Med 2012;166:910-8.
  12. Karafin MS, Blagg L, Tobian AAR, King KE, Ness PM, Savage WJ. ABO antibody titers are not predictive of hemolytic reactions due to incompatible platelet transfusions. Transfusion 2012 Oct;52(10):2087-93
  13. Karafin M, Fuller A, Savage WJ, King KE, Ness PM, Tobian AAR. The impact of apheresis platelet manipulation on corrected count increment. Transfusion 2012 June;52:1221-7.
  14. Karafin M, Shirey RS, Ness PM, King KE. Antigen matched red cell transfusions for patients with sickle cell disease at The Johns Hopkins Hospital. Immunohematology 2012;28:3-6.
  15. Karafin MS, Shirey RS, Ness PM, King KE, Keefer J. A case study of a child with chronic hemolytic anemia due to a Donath-Landsteiner-positive, IgM anti-I autoantibody. Pediatr Blood Cancer 2012 Nov;59(5):953-5.
  16. Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, Mueller AC, Jacobson LP, Margolick JB, Brown J, Rinaldo CR, Quinn TC, Eshleman SH. Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. AIDS Res Hum Retroviruses 2012 Aug;28(8):816-22.
  17. Pagano MB, Hobbs W, Linenberger M, Delaney M. Plasma and red cell exchange transfusions for erythropoietic protoporphyria: a case report and review of the literature. J Clin Apher 2012 Dec;27(6):336-41.
  18. Reynolds SJ, Laeyendecker O, Nakigozi G, Gallant JE, Huang W, Hudelson SE, Quinn TC, Newell K, Serwadda D, Gray RH, Wawer MJ, Eshleman SH. Antiretroviral drug susceptibility among HIV-infected adults failing antiretroviral therapy in Rakai, Uganda. AIDS Res Hum Retroviruses 2012 Dec;28(12):1739-44.
  19. Savage WJ, Savage JH, Tobian AAR, Thoburn C, Hamilton RG, Schroeder JT, Ness PM. Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions. Transfusion 2012 Mar;52(3):575-81.
  20. Tobian AAR, Gray RH. Benefits of male circumcision - Reply. JAMA 2012 Feb;307(5):457. (Letter).
  21. Tobian AAR, Kigozi G, Gravitt PE, Xiao C, Serwadda D, Eaton K, Kong X, Wawer MJ, Nalugoda F, Quinn TC, Gray RH. Risk factors for human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa. AIDS 2012 Jul 31;26(12):1555-65
  22. Tobian AAR, Kigozi G, Redd AD, Serwadda D, Kong X, Oliver AE, Nalugoda F, Quinn TC, Gray RH, Wawer MJ. Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda. J Infect Dis 2012 Feb;205:486-90.
  23. Zeng P, Wang J, Huang Y, Guo X, Li J, Wen G, Yang T, Yun Z, He M, Liu Y, Yuan Y, Schulmann J, Glynn S, Ness P, Jackson JB, Shan H; for the Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. The human immunodeficiency virus-1 genotype diversity and drug resistance mutations profile of volunteer blood donors from Chinese blood centers. Transfusion 2012 May;52(5):1041-9.